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Abstract 
Different aspects of self-assembly and self-sorting of metallo-supramolecular have been 
investigated in this thesis. Starting with self-sorting, four different 9,9'-spirobifluorene de-
rivatives substituted with pyridine were synthesized as racemates as well as in enatiomeri-
cally pure form and used to investigate self-discrimination and self-recognition during the 
assembly of two different rhombic systems consisting of two ligands and two metal ions; 
Pd- or Pt-corner (M2L2). The two systems differ in the lengths of the spacer between the 
spirobifluorene and the metal-binding pyridine, the smaller one having no spacer and the 
long one having an ethynylspacer.   
For the ligand with the shorter spacer a crystal structure of the homochiral complex was 
obtained, confirming the preference for self-recognition of the system, which was also ob-
served in the NMR- and mass spectra. In the case of the larger ligand no self-sorting be-
havior was observed. The ability of the larger ligand to form a catenane was established by 
mass, 1H-NMR-spectroscopy and crystallography.  
The small spirobifluorene based ligand was used with Pd(II)to form a M6L12-sphere, and 
several attempts were made to confirm the presence of the M6L12-species. A smaller M2L4-
cage was formed with a third synthesized spirobifluorene derivative and confirmed by 
mass spectroscopy.  
Two ligands with both a soft and a hard metal-binding site were synthesized and used in 
complexation experiments with Ti(IV), Pd(II) and Pt(II) in order to obtain a self-assembled 
supramolecular multicomponent complex. We succeeded in performing the first complexa-
tion steps with both ligands, preparing for the final complexation event.  
Lastly, a ligand based on a thiophene core with bipyridine as the metal binding unit was 
synthesized and tested for its ability to form a triple helix with Fe(II) and undergo spin 
crossover.   
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 Abbreviations 
ALOX  = aluminum oxide 
BINOL = 1,1'-bi-2-naphthol 
COSY  = correlation spectroscopy 
CPDIPS = [(3cyanopropyl) diisopropylsilyl]-acetylene  
D  = diffusion coefficient 
DLS  = dynamic light scattering 
DNA  = deoxyribonucleic acid 
DMF  = dimethylformamide 
DMSO = dimethyl sulfoxide 
DOSY  = diffusion ordered spectroscopy  
dppf  = 1,1'-bis(diphenylphosphino)ferrocene 
dppp  = 1,3-bis(diphenylphosphino)propane 
EDTA  = ethylenediaminetetraacetic acid 
EI  = electron ionization 
ESI  = electrospray ionization 
FT  = fourier transformation 
h  = hours 
HETTAP = heterochiral terpyridine and phenanthroline complex formation 
ICR  = ion cyclotron resonance 
IRMPD = infrared multiphoton dissociation 
NMR  = nuclear magnetic resonance 
MOM  = methoxymethyl ether  
MS  = mass spectrometry 
RT  = room temperature 
SCO  = spin crossover 
T½  = transition temperature 
TBAF  = tetra-n-butylammonium fluoride 
Tf  = triflate 
THF  = tetrahydrofurane 
TIPS  = triisopropylsilyl 
TLC  = thin layer chromatography 
TMS  = trimethylsilyl 
TOF  = time-of-flight 
UV  = ultraviolet

 1 Introduction 
Organic chemistry is centered on carbon-atoms and the covalent bonds they form, but its 
concepts are not able to describe the bonding observed in inorganic complexes such as 
hexol (([Co(NH3)4(OH)2]3Co(SO4)3) to its full extent. Until the late 19th century, chemists 
had been struggling to explain the difference in bonding behavior of the chloride anions of 
Co(NH3)6Cl3 and Co(NH3)5Cl3. When treated with aqueous silver nitrate, three chloride 
ions of Co(NH3)6Cl3 could be precipitated as silver chloride, whereas only two chloride 
ions could be precipitated from Co(NH3)5Cl3.1 In 1893 Alfred Werner presented his theory 
suggesting that despite cobalt’s valence of three, six ammonia or water molecules were 
bound directly to the metal in an octahedral fashion. Removing one ammonia molecule 
from [Co(NH3)6]Cl3 resulted in one chloride-ion taking its place as a metal ligand resulting 
in [Co(NH3)5Cl]Cl2. Alfred Werner spent the rest of his career proving his theory experi-
mentally and eventually received the Nobel Prize in chemistry in 1913.1,2  
The theory of Alfred Werner revolutionized inorganic chemistry and laid the basis for the 
development of coordination chemistry, which by now has advanced into an interdiscipli-
nary science connecting organic chemistry and biochemistry with inorganic chemistry. 
One of the resulting disciplines is supramolecular chemistry, which combines organic lig-
ands and transition metals to form large non-covalently bound architectures.3  
Supramolecular chemistry was first described by J.M. Lehn in 1978, who defined it as the 
“chemistry of molecular assemblies and of the intermolecular bond“.4 Starting with the 
accidental synthesis of dibenzo[18]crown-6 and the subsequent  discovery of its ability to 
bind potassium ions by Pedersen,5 supramolecular chemistry has undergone an enormous 
development and has become an important area of chemical research,6,7 spanning areas 
such as molecular informatics, artificial molecular machines, and catalysis.8–11 
Metal-ligand bonds play an important role in the assembly of supramolecular entities, to-
gether with other non-covalent bonds. Hydrogen bonds, π-π-stacking and hydrophobic ef-
fects, to only mention a few, all help assemble and stabilize a non-covalent association of 
two molecules into a supramolecular structure.12 Even though non-covalent bonds are gen-
erally much weaker than covalent bonds, the number of bonds stabilizes the assembly 
while allowing it to be dynamic in its response to changes in the environment.3,12 
The ability to stabilize yet render space for adaptability is the reason that supramolecular 
interactions are wide spread in nature and are the basis of the evolution of life. Without the 
formation of micelles and membranes and the resulting compartmentalization of eukary-
otes, life as we know it would not have been possible.13 Many cellular components such as 
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enzymes, DNA and microtubules form via self-assembly and depend on the dynamic na-
ture of supramolecular chemistry.14 The advantages of cellular machinery based on non-
covalent bonds are many, for instance the energy needed to form and break non-covalent 
bonds is much lower than the corresponding energies for covalent bonds. Such abilities are 
highly sought after when chemists design new artificial products, which is why chemists 
often turn to nature for inspiration and nature has many stories to tell.  
The DNA-strand is the carrier of gene information and is itself a supramolecular aggregate. 
The assembly of two single stranded DNA molecules into a supramolecular double helix 
relies not only on hydrogen bonding between the base pairs (through Watson-Crick base 
pairing) but also on hydrophobic forces. These forces keep the base pairs in the center of 
the helix while leaving the charged phosphate groups on the outside. When adding two 
complementary DNA-strands to an aqueous solution they will self-assemble into a stable 
double helix. The strands can be separated or denatured by heating the solution, yet upon 
cooling the strands will self-assemble again.15 The self-organization and the reversibility of 
the process form the basis of storage and replication of genetic information.   
Another important part of the cell’s machinery are the enzymes, which are made out of one 
or more strands of amino acids that are bent into the specific shape by the use of a mixture 
of disulfide bonds, hydrogen bonding, dispersion forces, and hydrophobic effects. In many 
cases the functional enzyme consists of several subunits of proteins which are held togeth-
er by non-covalent forces. Out of many possible forms an enzyme with the correct amino 
acid sequence under the right conditions always reaches its functional or native state. Due 
to the dynamic and reversible nature of non-covalent forces the enzyme is able to run 
through the different possible conformations without getting stuck in a local minimum. 
When correctly folded, the enzyme can exhibit a remarkable selectivity towards a singular 
biomolecule catalyzing a specific reaction yielding only one regio - and/or stereoisomer 
again by supramolecular forces. By heating a human enzyme or changing the pH of its 
environment, the enzyme can be denatured and lose its function. However, when restoring 
the optimal conditions, the enzyme will often renature and regain its function.15 
An example of an enzyme catalyzing such a regioselective reaction is human chymotryp-
sin, a serine protease found in the digestive tract. Chymotrypsin catalyzes the cleavage of 
peptide bonds specifically after large hydrophobic side-chains. The active site of the en-
zyme is equipped with a serine (Ser 195), an asparagine (Asp 102), and a histidine (His 57) 
which form the active triad, which is the site where the peptide bond is cleaved. Moreover, 
chymotrypsin has a hydrophobic pocket near the active site perfectly engineered to ac-
commodate aromatic side chains of amino acids such as phenylalanine, trypsin or trypto-
phan or large hydrophobic groups such as methionine.16 Nature has designed chymotrypsin 
to fulfill one specific task: to hydrolyze peptide bonds after specific amino acids. Supramo-
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lecular chemistry attempts to transfer the abilities seen in molecular machines to synthetic 
systems able to perform functions not previously available outside the biological realm.17  
 
1.1 Essential Structural Understanding 
Cooperativity can be described as the effect when the binding of one ligand to a receptor 
influences the binding of the next ligand.18 This effect is wide spread in nature, and can be 
divided into positive and negative cooperativity. Positive cooperativity arises when binding 
of one ligand to an acceptor with multiple binding sites increases the affinity of the accep-
tor for a second ligand. In the case of negative cooperativity, binding of one ligand leads to 
decreased binding affinity for subsequent ligands.14 An example of positive cooperativity 
in nature is the binding of oxygen to hemoglobin. Able to bind four molecules of O2 per 
hemoglobin, binding of one O2 induces an allosteric change in the other binding sites, in-
creasing the affinity of the protein for the next O2-molecule. Due to cooperative binding 
hemoglobin is able to transport 1.7 times the amount of O2 compared to non-cooperative 
binding.14   
The metal-ligand bonds in supramolecular assemblies can also be examined for their abil-
ity to show cooperativity. When Lehn and coworkers examined a supramolecular assembly 
system consisting of two tridentate tris-bipyridine ligands and three Ag(I)-ions forming a 
double helix, they came to the conclusion that the assembly showed positive cooperativi-
ty.19 This result was rather surprising since one would expect the repulsive forces of the 
charged metal-ions as well as the interligand repulsion in the complex to have a negative 
influence on the formation of the helix. About ten years later Ercolani was able to refute 
the results by Lehn using the site binding model, which clearly separated the intermolecu-
lar and intramolecular processes of self-assembly.18 However, Piguet et al. discovered an 
attractive intermetallic interaction related to the solvation energy (∆Eexp,solCuCu ), when trying to 
fit the experimental data of Lehn’s helix-system to the site binding model indicating that 
positive cooperative effects are not impossible in multimetallic complexes.20 Further exam-
inations of this effect prompted the need for a system where only the intermetallic distance 
changed, such as the Tröger’s Base derivatives synthesized by Lützen et al. (Figure 
1.1).21,22 
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In cooperation with Piguet and coworkers measurements of the effective concentration of 
the helices formed by L1, L2 and L3 with Ag(I) or Cu(I) by UV-titration were performed 
which indicated a very high degree of preorganization. In fact the effective concentration 
for the complex formed by Cu(I) and L1 is the largest reported to date for a helix. A much 
more interesting and counterintuitive result is that when the intermetallic distance in the 
helices increases, the intermetallic repulsion increases as well. The result is that the com-
plex formed by L1 is more stable than the one formed by L3. By taking not only the cou-
lombic contribution into account, as in the gas phase, but also the solvation energies repre-
sented by the Born equation produces Equation 1.1 which correlates the difference in in-
termetallic interactions between the ligands �∆ELk, sol
M,M -∆EL1,sol
M,M �  and is able to reproduce the 
results obtained by UV-titration.23 
∆���,���
�,� − ∆���,���
�,� = ∆∆��������
��,�� + ∆∆������������
��,�� + 2∆∆�����������
��,��  
Equation 1.1: Difference in intermetallic interactions between ligands L1 and Lk (k=2,3), where the term 
∆∆��������
��,�� describes the difference in formation free energies for the complexes between ligand L1 and Lk 
(k=2,3), the term ∆∆������������
��,�� decribes the difference in solvation free energies of the complex when the 
ligands are increasing in size from L1 and Lk (k=2,3) and the term 2∆∆�����������
��,�� describes the difference in 
solvation free energies for the free ligands L1 and Lk (k=2,3).  
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Figure 1.1 Tröger’s Base derivatives synthesized by Lützen et al. for helicate complexes. 
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So not only does the solvation energy play a role in the self-assembly of the helices synthe-
sized by Lützen, it actually dominates coulombic effect when elongating the spacer be-
tween the Tröger’s Base and the metal-binding unit from L1 to L3. 
Understanding the forces that control the self-assembly of supramolecular entities can help 
explain why systems, that are very similar on a molecular level, behave differently on a 
macroscopic level. In the end, this could take supramolecular chemistry towards successful 
design and engineering of functional aggregates. 
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2 Scope of the thesis 
The goal of the thesis is to reach a better understanding of supramolecular forces which 
govern the different functionalities displayed by supramolecular aggregates.  
It is possible to form helices diastereoselectively using chiral ligands. However, helices can 
also bear intrinsic properties not exhibited by the uncomplexed ligands. Examples of this 
could be host-guest-recognition, catalysis, or change of electronic characteristics. Among 
the latter is the phenomenon of spin crossover, which describes the change in spin state of 
a metal-ion when subjected to change in pressure or temperature. Spin crossover can also 
be facilitated by distortion of the ligand field of the metal using rigid ligands. Part of this 
thesis focuses on the synthesis of ligands able to bind Fe(II) in a distorted octahedral ligand 
field and examination of the spin crossover abilities of the resulting complexes.  
Using one ligand with one metal-ion can only result in a limited number of supramolecular 
structures and further restricts the complexity of the architectures of the assemblies. If in-
stead a multicomponent system is used with more than one ligand of more than one metal 
ion, it is possible to form different complex structures using the same components simply 
by changing the solvent or the counterion. The synthesis of such a multicomponent system 
is a target of this thesis. 
Another interesting feature of certain self-assembled systems is their ability to display self-
sorting and discriminate between ligands, which differ either in their structure or chirality. 
Part of this thesis therefore aims atthe synthesis and investigation of M2L2-systems, which 
are able to discriminate between different enantiomers of the same ligand. Starting from 
M2L2-complexes, the next step is to increase the size of the complex, aiming at producing 
M2L4- and M6L12-complexes.  
Different ligands adapted to the desired complexation approach according to modeling 
studies will be synthesized and tested for their ability to form complexes as mentioned 
above. NMR- and mass spectroscopy will be used to identify the formed complexes.  
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3 Spin crossover 
3.1 Background 
Similar to biological multicomponent systems, supramolecular self-assembled aggregates 
can bear functions not seen for the separate components. An example is the catalytic activi-
ty displayed by supramolecular cages,24 another is the occurrence of spin crossover (SCO) 
in supramolecular entities.25–27  
Spin crossover was first described by Cambi and Malatesta in 1937 when they examined a 
Fe(II)-complex.28 The fact that a Fe(II)-complex was the center of the discovery of the 
SCO-phenomenon is very indicative of the importance of Fe(II) in the field. Although 
complexes of many first row d4-d7-configured transition metals are able to display SCO in 
an octahedral ligand field, the most examples are found with complexes with d6 Fe(II). Due 
to the relatively high spin pairing energy (compared to other d6-ions) the high spin  config-
uration of Fe(II) is more accessible (Figure 3.1).29 The difference between the spin pairing 
energy and the ligand field splitting energy in a given complex determines whether SCO 
occurs or not.  
 
Figure 3.1 Diagram of the electronic configuration in the low spin and high spin state in an octahedral lig-
and field 
As shown in Figure 3.1, the transition from low spin (LS) to high spin (HS) in an octahe-
dral ligand field results in the transfer of two electrons from the t2g to the eg atomic orbital. 
This shift of electrons results in a series of electronic and macroscopic changes. The most 
obvious is the color change which accompanies the transition between the spin states and 
which can be very significant in Fe(II)-complexes. It is a simple method to determine 
whether SCO has happened or not. Another effect of the SCO is the change in magnetic 
behavior of the complex. In the low spin configuration all electrons are paired and the mol-
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ecule is therefore diamagnetic. When the high spin configuration is obtained the complex 
becomes paramagnetic due to the four unpaired electrons. The population of the antibond-
ing eg-orbitals is also the origin of another effect of the SCO, the increase of the molecular 
volume through elongation of the metal-ligand-bond.29  
However, if the energy needed to pair two electrons in one orbital (pairing energy) is lower 
than the energy required to push one electron into the higher orbital (field splitting energy) 
SCO will not occur. Different methods changing external factors can be used to facilitate 
the spin transfer and decrease the difference between the pairing and field splitting energy. 
Adding extra energy by raising the temperature can in some cases induce a SCO from low 
spin to high spin. Since the low spin state has a shorter metal-ligand distance than the high 
spin state, increasing the pressure stabilizes the low spin configuration. Lastly steric effects 
can help distort the ligand field, destabilizing the low spin configuration.29 
When measuring the SCO, the changes in magnetism and volume are exploited. The 
change from dia- to paramagnetic can be followed using magnetic susceptibility (χ(T)), a 
proportionality constant describing the magnetization of the complex in response to a mag-
netic field, versus temperature. This results in spin transition curves such as those shown in 
Figure 3.2. The fraction of high spin (γHS) is calculated from the magnetic susceptibility 
and is plotted on the y-axis versus the temperature on the x-axis.29  
The temperature at which the fraction of high spin to low spin is 0.5 is called the transition 
temperature (T½) and describes the thermal dependence of an SCO-system. The most 
 
Figure 3.2 Different types of spin transition curves a) gradual b) abrupt c) with hysteresis d) two-step. The 
high-spin fraction (γHS) is depicted on the y-axis, the temperature is on the x-axis.  
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common type of transition curve is the gradual transition shown in Figure 3.2a. A gradual 
transition indicates that the cooperativity between the metal centers is low, i.e. the spin 
transition in one complex does not or hardly affect the neighboring complex. A high coop-
erativity results in an abrupt spin transition curve, as shown in Figure 3.2b. Hysteresis oc-
curs if the complex can be brought back to its original spin state at two different transition 
temperatures (Figure 3.2c), as a consequence of very high cooperativity. This cooperativity 
can be a result of covalent bonds between the metal centers, the formation of hydrogen 
bonds or π-π-stacking effects. The bistability of compounds of this type is very important 
when considering application of supramolecular complexes exhibiting SCO. Another im-
portant phenomenon within SCO is the stepwise spin transition as shown in Figure 3.2d. 
This kind of stepwise SCO is often seen in dinuclear complexes, where the transition to 
high spin of one metal-center stabilizes the low spin configuration of the other metal-center 
in the complex.29  
Bistability or even tristability, as seen in complexes with a two-step transition curve, is the 
basis for the application of SCO-compounds in information storage.30,31 Other applications 
for compounds able to undergo SCO, include switching devices, displays and temperature 
sensors.30–32  
By combining the SCO-concept with supramolecular chemistry, capabilities typical for 
supramolecular assemblies can influence the SCO-properties and help fine tune the transi-
tion temperature. An example of this behavior is the tetrahedral capsule synthesized by 
Nitschke et al.; Mixing a tripodal imine-ligand with Fe(II) resulted in the formation of a 
tetrahedral supramolecular capsule, which can undergo SCO and encapsulate different 
guest molecules such as Br- and CS2. Addition and encapsulation of the guest molecules 
caused a small stabilization of the high spin state of the complex.26 Batten and coworkers 
were able to form a supramolecular nanoball, which packs inefficiently in solid state leav-
ing interstitial cuboctahedral cavities in the crystal lattice which can be occupied by differ-
ent solvents. The nanoporous material is able to respond to temperature changes and irradi-
ation and with SCO. Furthermore, the nature of the solvent has a great impact on the spin 
transition from broadening to complete loss of SCO-behavior.33 Hannon et al. were able to 
form a triple helical cylinder complex with Fe(II), which display full spin transition curves 
when combined with the anions PF6- and BF4-. When ClO4- is used as anion, the two metal 
centers in the complex become non-equivalent and the result is a two-step spin transition 
curve indicating a stable HS-LS-state.27  
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In our own group, Dr. Jens Bunzen observed 
the formation of a high spin complex when 
mixing the enantiomerically pure ligand (both 
(R) or (S)) in Figure 3.3 with Fe(II) in 
CD2Cl2/DMSO-d6 (3:1). Instead of a red/brown 
solution typical for low spin Fe(II)-complexes 
the solution turned green indicating a high spin 
complex. This observation was confirmed by 
1H-NMR-spectroscopy and mass-spectroscopy, 
which suggested the formation of an M2L3-
complex with Fe(II). Changing the solvent to 
CD2Cl2/CD3CN (3:1) resulted in a red solution 
of the low spin complex.34 The electron with-
drawing carboxymethyl-group combined with 
the rigid angle induced by the BINOL therefore 
seemed capable of distorting the ligand field of the Fe(II)-ion resulting in a high spin com-
plex.  
 
3.2 Synthesis of the ligands 
The goal is to develop a system able to participate in spin crossover and which, ideally, 
undergoes hysteresis. The ligand synthesized by Bunzen forms a high spin complex with 
Fe(II), however, it does not exhibit hysteresis. Nevertheless, we were hoping to be able to 
design a library of ligands based on the BINOL-ligand.  
We decided to keep the metal binding 5-carboxymethyl-5'-ethynyl-2,2'-bipyridine in our 
series of ligands using the synthesis previously performed by J. Bunzen.34 However instead 
of BINOL, simpler and cheaper core units would be used, since a large, enantiomerically 
pure core is not necessary for the SCO to occur. 
The central unit connecting the substituted bipyridines is expected to induce an angle be-
tween the two metal binding sites of the ligand, that could potentioally distort the ligand 
field of the metal to such an extent, that the metal would adopt the high spin configuration.  
Just like the ligand by Bunzen (Figure 3.3) the core and the bipyridine were connected via 
an ethynyl spacer using the Sonogashira-reaction. Five membered heterocycles, such as 
furane, thiophene and pyrrole, were chosen as core molecules. By substituting the hetero-
cycles in different positions, it is possible to vary the angles of the ligands (Figure 3.4).  
 
Figure 3.3 SCO-ligand synthesized by Bunzen 
3.2 Synthesis of the ligands 11 
OX
X
   
2,5-substituted furan 2,5-substituted thio-phene 
2,5-substituted pyr-
role 
   
2,4-substituted furan 2,4-substituted thio-phene 
2,4-substituted pyr-
role 
Figure 3.4 Core units for ligand for SCO 
Dihalogenated heterocycles are needed for the cross-coupling reaction. 2,5-
Diiodothiophene and 2,4-dibromothiphene are both commercially available, but this was 
not the case for the furane- or pyrrole-derivatives, which therefore had to be synthesized in 
the lab.  
L. Volbach attempted synthesizing different di-brominated and di-iodinated furanes and 
pyrroles, however this proved to be rather difficult and partly because the poor stability of 
the final products.35 Therefore, we started looking for other five-membered heterocyclic 
systems with the possibility to be substituted in the 2,5- and 2,4-positions. In the search we 
came upon 1,3-thiazole, which, according to Grubb et al., can be dihalogenated in good 
yields starting from commercially available 2-amino-1,3-thiazole or 1,3-thiazolidine-2,4-
dione (Scheme 3.1 and Scheme 3.2).36  
N
S
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N
S
Br
NaNO2, CuSO4, NaBr,
H3PO4, HNO3
24%
NaHCO3, Br2,
CHCl3
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H3PO4, HNO3
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S
I
20%
1 2
3
 
Scheme 3.1 Synthesis of core molecules starting from 2-amino-1,3-thiazole 
Grubb et al. performed the synthesis on a large scale in order to use the synthesis in an 
industrial context.36 However, the synthesis was scaled down from 25 g of starting material 
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to 1-5 g. This had a great influence on the yields of the reactions, since significant amounts 
of product are lost especially during work-up and purification. 
2-Bromo-1,3-thiazole, 1, was synthesized by a variation of the Sandmeyer-reaction and 
purified by steam distillation (Scheme 3.1). During the steam distillation we ended up hav-
ing about 1.5 g of the product 1 in about 500 mL of solvent. When trying to extract such a 
small amount of product from a comparably large amount of solvent much of the product 
stays in the reaction mixture, lowering the yield significantly. This explains why the yield 
did not reach the yield of 86% presented in the literature.36 A corresponding reaction was 
carried out using NaI instead of NaBr resulting in 2-iodo-1,3-thiazole 3 in a yield of 20%. 
The low yield is due to the instability of the product, which is light-sensitive. Careful 
shielding from light should result in an increase of the yield of the reaction.  
Bromination of 1 (Scheme 3.1) proceeded without problems until the work-up. Grubb et al. 
used vacuum sublimation to purify 2,5-dibromo-1,3-thiazole 2, which was a white solid.36 
In our case sublimation of the crude product resulted in an oil, which according to NMR-
spectra is the desired product 2 in a yield of 18%. The reaction was only performed once, 
in order to assess if the method is applicable for our purposes. As an alternative work-up 
method column chromatography is suggested, since sublimation on such small amounts is 
not feasible.  
The synthesis of 4 was performed according to the protocol of Grubb et al.36 and can be 
seen in Scheme 3.2. Starting from 1,3-thiazolidine-2,4-dione the deoxygenation followed 
by bromination resulted in 4 in a yield of 54%. Again, the crude product was purified by 
sublimation resulting in a low yield compared to the literature.36  
The metal-binding unit is based on a bipyridine with an electron withdrawing ester group 
and an ethynyl spacer. 2-aminopyridine was iodinated by a comproportionation of I2 and 
HIO4 resulting in 5-iodo-2-aminopyridine 5 in a yield of 81% (Scheme 3.2). Next, a varia-
tion of the Sandmeyer-reaction resulted in the 5-iodo-2-bromopyridine 6 which has two 
halogens with a different reactivity towards Sonogashira-conditions.37–39 Trimethylsilyla-
cetylene was therefore selectively coupled to the 5-position to obtain 7 in a yield of 76%.  
 
Scheme 3.2 Synthesis of core molecule 4 based on 1,3-thiazolidine-2,4-dione 
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Next, 7 was coupled to methyl-2-chloropyridine-5-carboxylate by a Negishi-coupling40 
under the conditions previously used by J. Bunzen34 resulting in bipyridine 8 (Scheme 3.3). 
Deprotection with KF produced 9, which can participate in Sonogashira-reactions.  
The synthesis of ligand 10 with 2,5-diiodothiophene was attempted by L. Volbach using 
the conditions described in Scheme 3.4. However, it was only possible to isolate the mono-
substituted product. When performing the reaction again it was noticed that a yellow pre-
cipitate formed during the course of the reaction, which glows under UV-light. An attempt 
to purify the crude product via column chromatography only resulted in the mono-
substituted product as previously described; however, examining the remaining crude 
product at the top of the column with UV-light indicated that the product might be present 
in the crude remnant. The remnant was extracted with methanol and acetone, but neither 
 
Scheme 3.3 Synthesis of the metal-binding unit 9 
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solvent was able to resolve the product. Instead, it was speculated that it might be possible 
to filter off the precipitate directly after the reaction. 
 
Scheme 3.4 Synthesis of ligand 10 
Therefore, the reaction was carried out again, and the yellow precipitate was filtered off. 
However, finding a solvent able to dissolve ligand 10, in order to perform NMR-
spectroscopy, proved to be rather difficult. In the end, the pyridines were protonated using  
deuterated trifluoroacetic acid finally obtaining the desired 1H-NMR-spectrum, which, 
along with the ESI-MS spectrum, confirmed the synthesis of 10, which was used in com-
plexation studies. 
To further purify the product, it was heated in THF and filtered off while warm. A CHN-
analysis was performed revealing that the product was still impure. Due to its poor solu-
bility it is very difficult to further purify 10.  
An alternative could be to add hexyloxy-groups at the 3- and 4-positions of the thiophene 
in order to increase the solubility. Also, exchange of the ester-group for another electron-
drawing groups which is more soluble such as a cyano-group could alter the solubility. To 
obtain a ligand with a different angle between the metal binding sites, the reaction should 
be carried out with 2,4-dibromothiophene. Since bromines have a lower reactivity in So-
nogashira-reactions, it might be necessary to adjust the conditions. However, as the solu-
bility problems are expected to be the same, it would be important to solve these problems 
first.  
Furthermore, 2,5-dibromo-1,3-thiazole 2 and 2,4-dibromo-1,3-thiazole 4 should be tested 
in a Sonogashira-reaction with 9, taking into account both the decreased reactivity of the 
bromines as well as the solubility-issues.  
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3.3 Complexation 
To investigate the SCO-abilities of ligand 10, we decided to follow the method used by 
Bunzen to form the high spin SCO-system with the spirobifluorene ligand.34 We therefore 
mixed ligand 10 with Fe(BF4)2·6H2O in two different solvent mixtures: CD2Cl2/CD3CN 
and CD2Cl2/DMSO-d6 both in a ratio of 3:1. A photo of the resulting mixtures is shown in 
Figure 3.5. On the left picture one can see the result of the complexation in 
CD2Cl2/CD3CN, which instantaneously produced a deep red solution, indicating the for-
mation of a low spin Fe(II)-complex. On the other hand using CD2Cl2/DMSO-d6 as sol-
vent, resulted in a yellow suspension of ligand 10, and it is therefore reasonable to assume, 
that no complexation has occurred.  
Both solutions were measured by 1H-NMR-spectroscopy. However, the spectrum of the 
yellow solution showed no ligand peaks at all, supporting the assumption that no complex 
has formed in CD2Cl2/DMSO-d6. The com-
plex mixture in CD2Cl2/CD3CN-complex, 
on the other hand, produced one set of 
peaks in 1H-NMR-spectrum between 9 and 
3 ppm, (Figure 3.6). Unfortunately, it is not 
possible to compare the complex-spectrum 
directly with the 1H-NMR-spectrum of the 
free ligand, since the pure ligand is only 
soluble in CF3COOD. Nevertheless, thor-
ough investigation of the complex 
1H-NMR-spectrum reveals, that the inte-
grals match with the ligand. When the peak 
at 3.76 ppm, which corresponds to the  
methoxygroup, was integrated to 6, the 
protons in the aromatic region integrated to 14, which matched the number of aromatic 
protons in the ligand. The broadness of the signals is also an indication of a complexation 
event. Therefore, we can assume that a complexation has happened.  
 
Figure 3.5 Photo of ligand 10 with Fe(BF4)2·6H2O in 
two different solvent mixtures. 
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Figure 3.6 1H-NMR-spectrum of ligand 10 with Fe(BF4)2·6H2O in CD2Cl2/CD3CN 
To confirm the formation of the Fe(II)-helicate, mass spectra were measured (Figure 3.7). 
When describing mass spectra, the general notation metal:ligand:anion/cation is used. In 
the case of the helix formed by ligand 10 and Fe(II) with BF4- as the anion the notation 
would be 2:3:1(BF4-). In some cases an uncharged solvent molecule is loosely attached to 
the solvent. If one molecule of acetonitrile was attached the notation would be 2:3:1(BF4-) 
+ CH3CN.  
The base peak in the resulting mass spectrum is at 445.3 m/z and, carries a charge of +4, 
which matches the calculated spectrum and isotope pattern for a 2:3:0-helix. No other sig-
nificant peaks are found in the spectrum, thereby confirming the formation of a Fe(II)-
triple helix.  
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Figure 3.7 ESI mass spectrum (positive mode) of ligand 10 with Fe(BF4)2·6H2O in CD2Cl2/CD3CN. The 
notation corresponds to Metal:Ligand:Anion.  
The complex mixture in CD2Cl2/CD3CN produces a red complex at room temperature. 
Heating to 40°C does not change the color and thus does most likely not prompt a spin 
change. It is however remarkable, that changing the solvent from CD2Cl2/CD3CN to 
CD2Cl2/DMSO-d6 completely changes the complexation abilities.  
Since Fe(II) has an octahedral coordination 
geometry, the complex can form three differ-
ent stereoisomers: (Δ,Δ), (Δ,Λ) or (Λ,Λ). In 
the case of (Δ,Δ) and (Λ,Λ) the complex 
would be symmetric and the number of sig-
nals in the 1H-NMR-spectrum would be the 
same as in the uncomplexed ligand. If, the 
configuration around the metal centers is 
(Δ,Λ), two sets of signals could be seen in 
the spectrum. From the 1H-NMR-spectrum 
obtained of the complex, it is difficult to de-
termine whether one or two sets of signals 
are present (Figure 3.6). The only signal that 
can be positively identified is the methyl 
ester-signal at 3.75 ppm. Only one peak is 
seen, indicating the formation of a symmetric 
 
Figure 3.8 PM6-modelled structure of Ligand 10 
with Fe(BF4)2·6H2O (Λ,Λ) 
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complex. However, as can be seen in the modeled structure of the complex (Figure 3.8), 
the methyl ester is rather far away from the metal center, and is probably not affected much 
by the conformation around the Fe(II). A crystal structure could elucidate the confor-
mation, but so far no crystals have been obtained from the crystallization attempts of the 
complex. 
  
3.4 Conclusion 
We were able to form a triple helix from ligand 10 and Fe(II) and confirm its formation by 
mass spectrometry. So far, it has not been possible to produce the complex in the high spin 
configuration due to solubility problems. These problems can be overcome by testing dif-
ferent solvents and possibly modifying the ligand by adding substituents in the 3-position 
of the thiophene. This should not interfere with the complexation abilities of the ligand, as 
the protons of the thiophene point outwards on the complex as illustrated in Figure 3.8.  
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4.1 Background 
Just as the constitution of the folded enzyme predetermines the amino acid sequence, 
chemists can design a molecule featuring the information needed to form a specific supra-
molecular entity. The design can be in the form of a specific number of binding sites or 
sterically rigid bonds or groups. These programmed interactions take us from mere self-
assembly to self-sorting, which again can be divided into narcissistic (self-recognition) and 
social self-sorting (self-discrimination).41,42  
The term self-recognition was first introduced by Lehn to describe the phenomenon ob-
served when mixing the bipyridine-ligands in Figure 4.1 with Cu(I) and Ni(II).43 Even 
when mixing both chelating ligands with both ions, only the homoleptic double and triple 
helicates are formed with no detectable crossover products. The coordination number and 
the geometry of the two metals along with the difference in the flexibility of the linker in 
the two ligands ensure complete self-recognition.  
However, self-sorting does not only occur with constitutionally different ligands but also 
with ligands differing only in their chiral conformation. An example of chiral self-
recognition is the system by Lützen (Figure 1.14), build up from the C2-symmetric 
Tröger’s base. The racemic Tröger’s base derivatives (L1, L2 and L3) were complexated 
with Ag(I) resulting in discrete dinuclear helices without formation of any polymeric or 
 
Figure 4.1 Two different tris-bipyridine ligands form two homoleptic complexes with Ni2+ and Cu+ 
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oligomeric complexes as confirmed by mass spectroscopy. 1H-NMR-measurement further 
indicated formation of only homoleptic complexes with the same configuration around the 
metal center even as the distance between the chiral center and the metal binding unit was 
increased from a C–C single bond to a butadienyl group.22  
 
Figure 4.2 Illustration of the complexes synthesized by Lützen et al. using Trögers Base derivatives as 
ligands together with the Stang-corner 
Employing square planar cis-protected Pd(II) and Pt(II) complexes of the Stang-type44  
(also referred to as the Pd- and Pt-corners) together with ligands L4 and L5 (Figure 4.2) 
results in complexation and formation of discrete dinuclear rhombs. Yet crystal structures 
of the complexes reveal that the complexation is stereoselective resulting only in the heter-
ochiral complexes. This is one of the rare examples of self-discriminatory behavior dis-
played by supramolecular assemblies.45  
The selectivity of the aforementioned ligands in complex solution can be ascribed to the 
inherent chirality of the Tröger’s base. Synthesized in 1887 by 
Julius Tröger46, the (Figure 4.3) unique structure of the Tröger’s 
Base is rigid with an angle ranging from 80° to 114°.47,48 Due to 
the methylene bridge between the amines inversion around the 
nitrogen atoms is prevented, so the molecule is chiral.49 The chi-
rality is the origin of the Tröger’s Base popularity as a part of 
supramolecular aggregates with applications in catalysis and as 
receptors.50–52  
 
  
 
Figure 4.3 Tröger’s Base 
4.2 Synthesis of the ligands 21 
4.2 Synthesis of the ligands 
The Tröger’s base is not the only chiral molecule able to control 
the stereochemistry of its complexes. The spirobifluorene, first 
synthesized by Clarkson and Gomberg in 1930, contains a spiro 
carbon, which connects the two separate π-systems, and is not chi-
ral if not substituted (Figure 4.4).53 By substituting the spirobifluo-
rene in the 2,2'-position with crown ethers Prelog founded the basis 
of the use of D2-symmetric spirobifluorenes in chiral 
recognition.54–58   
Since the spirobifluorene can be easily halogenated in the 2,2'-positions and thereby be-
come chiral, we decided to base further investigations into self-sorting on the spirobifluo-
rene. Similarly to the complexation with the Tröger’s base derivatives, we wanted to look 
closer at the self-sorting behaviour of ligands with different spacer lengths. To this end two 
target molecules, Spf1 and Spf2, were designed (Figure 4.5). The two ligands differ only 
in the length of the spacer between the chiral spirobifluorene core and the metal binding 
pyridine.  
 
Figure 4.5 Spirobifluorene target molecules  
The synthesis of the spirobifluorene core (III in Scheme 3.1) is known from the literature53 
and has been a standard synthesis in the Lützen group. The synthesis begins with a 
Sandmeyer reaction performed on 2-aminobiphenyl resulting in 2-iodobiphenyl (II) 
(Scheme 4.1). Next, a Grignard reaction was carried out using 9-fluorenone, followed by 
condensation using HCl, yielding the spirobifluorene core (III). 
 
Figure 4.4 
Non-substituted Spiro-
bifluorene 
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Functionalization of III in the 2 and 2'-position to obtain the racemic D2-symmetric spiro-
bifluorene was performed via 2,2'-diamino-9,9'-spirobifluorene (VI) as shown in Scheme 
4.2.  
 
Scheme 4.2 Synthesis of racemic 2,2'-diiodo-9,9'-spirobifluorene VII.59 
2,2'-diamino-9,9'-spirobifluorene (VI) can be synthesized via two different routes from 
9,9'-spirobifluorene (III). Electrophilic aromatic substitution results in the bromo- and the 
nitro-derivatives IV and V respectively.60,61 V can be converted into VI using palladium as 
 
Scheme 4.1 Synthesis of 9,9'-spirobifluorene III 
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a catalyst and LiHMDS as the ammonia equivalent62, while IV can be reduced using 
NaBH4 to obtain VI. Lastly, a Sandmeyer reaction results in 2,2'-diiodo-9,9'-
spirobifluorene VII. However, separation of the functionalized spirobifluorenes (IV-VII) 
into its enantiomers failed. Attempts to separate diastereomers formed with enantiomeri-
cally pure BINOL-derivatives were also unsuccessful.59   
Instead, it was decided to try the method of Toda which we elaborated further in our group, 
where the 2,2'-dihydroxy-9,9'-spirobifluorene (X in Scheme 4.3) is separated by clathrate 
formation. The synthesis of X from III is shown in Scheme 4.3. 
 
Scheme 4.3 Synthesis of 2,2'-dihydroxy-9,9'-spirobifluorene X 
Functionalization of III is done via acylation of the 2,2'-positions using acetyl chloride and 
results in racemic VIII. Next, a Baeyer-Villiger oxidation was performed producing the 
ester IX, which can be hydrolyzed into 2,2'-dihydroxy-9,9'-spirobifluorene (X).59 
Spirobifluorene X can be separated into both enantiomers using (R,R)-(+)-2,3-dimethoxy-
N,N,N',N'-tetracyclohexylsuccindiamide. However, we also found that it is possible to per-
form the separation of X on HPLC using CHIRALPAK®IA and CHCl3/iPrOH (95:5) as the 
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eluent.63 The enantiomerically pure 2,2'-dihydroxy-9,9'-spirobifluorene X was kindly made 
available for further synthesis by Dipl. Chem. Caroline Stobe. 
The next synthetic step is common to all ligands, the formation of the 2,2'-ditriflate-9,9'-
spirobifluorene. Employing triflic anhydride in CH2Cl2 and triethylamine, the reaction was 
performed on both entantiomers to produce spirobifluorene (R)- and (S)-11 in good yields 
(Scheme 4.4).59 
The triflate is crucial for the following synthesis, since it is a far better leaving group than 
the hydroxyl-ion due it being mesomerically-stabilized. From compound 11 it is possible 
to perform a Suzuki-reaction using the 4-pyridineboronic acid pinacol ester, as shown in 
Scheme 4.5.64,65 
 
Scheme 4.5 Synthesis of ligand 12 
The Suzuki-cross-coupling is catalyzed by Pd(0). However, we often use a Pd(II)-catalyst, 
since Pd(0) is air-sensitive, which complicates handling even when working under an ar-
gon-atmosphere. In this case Pd(dppf)Cl2 is used which is reduced to Pd(0) in situ.66 We 
also used the pyridineboronic acid pinacol esters instead of the boronic acid, as the boronic 
acid esters are much more stable than their corresponding acids.  
 
Scheme 4.4 Synthesis of the spirobifluorene 11 
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The reaction to obtain ligand 12 was initially performed on racemic 11 with three equiva-
lents of 4-pyridineboronic acid pinacol ester in quantitative yield. However, when employ-
ing the same conditions on the (R)-enantiomer only the mono-substituted product was ob-
tained. Using five equivalents of the pinacol ester finally resulted in the formation of the 
product in quantitative yield.  
Ligand 15, with the ethynyl spacer, can be obtained using two different synthetic routes as 
shown in Scheme 4.6.  
 
Scheme 4.6 Retrosynthesis of ligand 15 
Either we can separate ligand 15 between the spirobifluorene and the ethynyl spacer result-
ing in 4-ethynylpyridine and spirobifluorene 11. Or the separation can be performed be-
tween the pyridine and the ethynyl spacer leaving us with 2,2'-diethynyl-9,9'-
spirobifluorene 14 and 4-iodopyridine. Since we already have synthesized 11 it is tempting 
to use it in a Sonogashira-reaction with 4-ethynylpyridine. However, in order to obtain the 
4-ethynylpyridine one has to perform several synthetic steps involving the 4-iodopyridine, 
which is known to be very light- and heatsensitive. We therefore preferred to attach the 
ethynyl spacer on the spirobifluorene, which is very stable and not prone to degradation.    
The synthesis of ligand 15, which was obtained in an overall yield of 24% from 11 for the 
(R)-enantiomer, can be seen in Scheme 4.7. The synthesis of the racemic product 13 was 
performed by Niklas Struch.  
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Scheme 4.7 Synthesis of Ligand 15 from 11 
Starting with a two-fold Sonogashira-reaction using commercially available trimethylsilyl-
acetylene the spacer was added to (R)-11 affording (R)-13 in 88% yield.67 The following 
deprotection with K2CO3 gave unexpected low yields, even though only one spot was ob-
served on the reaction-TLC. After the first purification by column chromatography product 
14 was obtained in a yield of 50%. Examination of the aqueous phase by TLC showed that 
it contained UV-active components, and extraction of the aqueous phase with CH2Cl2 pro-
duced the desired spirobifluorene 14 in a total yield of 62%. Finding 14 in the aqueous 
phase is rather unexpected, since the compound is devoid of heteroatoms. The possibility 
that the ethynyl has not been protonated after deprotection is unlikely, since methanol is 
more acidic than ethynyl.  
The last step in the synthesis of ligand 15 was first performed with 4-iodopyridine as pre-
viously carried out by Piehler, but did unfortunately not produce the desired product. In-
stead the starting material was recovered. We ascribed this to the poor stability of the 
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4-iodopyridine. A more stable though less reactive alternative to the iodo-derivative is the 
4-bromopyridine, which was used in the form of the HCl-salt increasing the stability of the 
reactant. The Sonogashira-reaction requires harsher conditions to compensate for the low 
reactivity of 4-bromopyridine. However, at elevated temperatures 4-bromopyridine might 
decompose, so a temperature of 60°C was chosen as a compromise. The use of four equiv-
alents of 4-bromopyridine with 7% of Pd-catalyst resulted in ligand 15 in a yield of 54%, 
with remnants of both starting materials still present in the reaction.  
We also synthesized the pseudo enantiomerI of ligands 15 and 12, by adding methylgroups 
to the 7,7'-position resulting in ligand 20 and 21 (Scheme 4.8).  
                                               
I Pseudo enantiomers are two ligands with opposite chirality as expected for enantiomers, but differ in for 
example substitution. 
 
Scheme 4.8 Retrosynthesis of ligands 20 and 21 
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We started from spirobifluorene 11 and performed a Kumada-coupling, which resulted in 
spirobifluorene 16 with two methyl-groups in quantitative yields (Scheme 4.9).68  
The reactivity of the 9,9'-spirobifluorene resembles that of the fluorene closely, which 
makes it possible to selectively perform an electrophilic aromatic substitution in the 2,2'-
position resulting in the spirobifluorene 17.60  
Only one reaction route is possible for the synthesis of ligand 21 as shown in Scheme 4.8 
Ligand (S)-21 was obtained in a yield of 69% from 17 using 4-pyridineboronic acid pina-
col ester in a Suzuki-reaction. This reaction was performed by Thorsten Piehler.  
However, two routes are available for the synthesis of the ligand 20 (Scheme 4.8). We can 
use spirobifluorene 17 in a Sonogashira-Hagihara-coupling with 4-ethynylpyridine, or we 
add the ethynyl spacer to the spirobifluorene resulting in the molecule 19, which can be 
reacted with 4-iodopyridine.  
 
Scheme 4.9 Synthesis of spirobifluorene 17 
 
Scheme 4.10 Synthesis of ligand (S)-21 from 17 performed by Piehler 
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Previously, the Sonogashira-reaction had been carried out by Piehler, who used 17 and the 
HCl-salt of 4-etynylpyridine under varying conditions, however with no result as shown in 
Scheme 4.11.  
N
N
20
N
Br
Br
17
+
Pd2dba3·CH3Cl], dppf,
CuI, (iPr)2NH, THF,
60°C, 72h
[Pd(PPh3)4], CuI,
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HCl
 
Scheme 4.11 Attempts to synthesize ligand 20 from spirobifluorene 17 by Piehler 
We therefore decided to perform the synthesis of ligand 20 analogous to the synthesis of 
ligand 15, as shown in Scheme 4.12.   
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Scheme 4.12 Synthesis of ligand 20 from 11 
Starting from spirobifluorene 17, a double Suzuki-coupling was carried out, utilizing a 
TMS-ethynylboronic acid methylester synthesized from B(OMe)3 and TMS-acetylene 
deprotonated by n-butyllithium. Using 250 mg of (R)-17 and resulted in 18 in a yield of 
34%. The low yield may be explained by inaccuracy during the transfer of the TMS-
ethynylboronic acid methylester to the reaction. When performing the reaction of the 
(S)-enantiomer of 18 the synthesis was carried out more carefully, resulting in a yield of 
71%. Deprotection proved to be an unexpectedly difficult task. The reaction resulted in 
five spots on the TLC, which were difficult to separate. Consequently, significant amount 
of product was lost during the chromatographic separation. 
Lastly a Sonogashira-coupling analogous to the one carried out in Scheme 4.6 was per-
formed on 19 resulting in the ligand 20. Again we had problems with the reactivity of the 
4-bromopyridine and consequently significant amounts of both reactants were recovered 
after column chromatography. In addition a very small amount of reactant was used in the 
4.3 Complexation 31 
synthesis of the (R)-enantiomer, further lowering the yield. The desired (S)-enantiomer 20 
was obtained in an overall yield of 10% over five steps.     
The four enantiomerically pure 9,9'-spirobifluorene-ligands (R)-12, (R)-15, (S)-20 and (S)-
21 as well as the racemic ligands were selected for further investigation in complexation 
studies.     
 
4.3 Complexation       
For the complexation of the spirobifluorene ligands (R)-12, (R)-15 (S)-20 and (S)-21, the 
Stang-corners44 Pd(dppp)(OTf)2 and Pt(dppp)(OTf)2 were used. The Stang-corners induce 
a 90° angle into the resulting complexes due to the cis-directionality of the Pt(II) – and 
Pd(II)-species. 
 
4.3.1 Small spirobifluorene rhombs 
We investigated complexes of both the (R)-enantiomer but also the racemic ligand 12 with 
the Pd- or Pt-corner. Employing the enatiomerically pure ligand can only result in the ho-
mochiral complexes. When the racemic ligand is used three different complexes can arise 
as shown in Figure 4.6. 
   
R,R R,S S,S 
Figure 4.6 Illustration of the possible 2:2-complexes of racemic ligand 12 
The R,R- and the S,S-complexes are enantiomers, while the R,S-complex is a diastereomer 
of the two others. The ratio of the three determines whether self-recognition, self-
discrimination or no self-sorting effects are taking place. In the case of pure self-
recognition, only the two homochiral complexes would be present. Therefore the 
1H-NMR-spectrum would be symmetrical, that is, only one set of signals would be present. 
If on the other hand pure self-discrimination is happening, the 1H-NMR-spectrum would 
have two sets of signals of equal intensity, corresponding to each of the enantiomers com-
prising the 2:2-complex. In the case of no self-sorting effects one would expect three sets 
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of signals: One set from the two homochiral complexes and another from the heterochiral 
complex in a statistical ratio of 2(homo):2(hetero). Since the two homochiral complexes 
are enantiomers, they are chemically and magnetically equivalent and result in only one set 
of signals. One rarely sees pure self-recognition or self-discrimination. More often the lig-
and shows a preference by deviating from the statistical ratio of no self-sorting and the 
relative intensities of the signals in the 1H-NMR-spectrum can be used to assess the self-
sorting behaviour of the ligand.  
Complexes of ligand 12 and the Pd- or Pt-corner have been investigated in CD2Cl2/CD3CN 
(3:1) by Piehler and Hovorka. The complexations were repeated with the help of 
R. Hovorka69 and spectra of the mixture of (R)-12 with [Pd(dppp)](OTf)2 is shown in Fig-
ure 4.7. 
The complex spectra are compared to the 1H-NMR-spectrum of the racemic ligand 12. 
Using H,H-COSY it was not possible to assign all protons with certainty. The second pro-
ton of the pyridine (marked with a light blue star) and protons 3 and 6 of the spirobifluo-
rene (marked with an orange and a brown star respectively) could not be found in the 1H-
NMR-spectra of the complex.  
Comparing the spectrum of the free ligand with the spectrum of the mixture of the enanti-
omerically pure ligand (Figure 4.7a and b respectively) all the signals have shifted upon 
 
Figure 4.7 1H-NMR-spectrum of a) ligand rac-12 b) ligand (R)-12 with Pd(dppp)(OTf)2 c) ligand rac-12 
with Pd(dppp)(OTf)2 all in CD2Cl2/CD3CN (3:1). 
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addition of the Pd-corner indicating that complexation has taken place. However, only one 
set of signals is present in both spectra indicating the selective formation of one distinct 
species. Interestingly, the proton in the 2-position of the pyridine (red star) hardly shifts at 
all in response to complexation, even though it is closest to the pyridine-N, which com-
plexates to the metal. Similar spectra are obtained when using [Pt(dppp)](OTf)2 (spectra 
not shown).  
Comparing the spectrum of the complexated ligand (R)-12 with the complexated racemic 
ligand 12 (Figure 4.7b and c respectively) the spectra differ from each other indicating that 
this is not an example of pure self-recognition. Instead, there seems to be a preference to-
wards the homochiral complex, since the intensities of the homochiral complex are much 
larger than the intensities of the heterochiral complex (Figure 4.7c). 
Next, we performed a DOSY-experiment (diffusion ordered spectroscopy) of the mixture 
of ligand rac-12 and Pt(dppp)(OTf)2 to assess how many different species are present in 
the solution (See Figure 4.8).  In a 1H-DOSY-NMR experiment the diffusion coefficient 
(D) is derived from the attenuation of the NMR-signals undergoing a pulsed field gradient 
experiment. Since the attenuation is proportional to the diffusion coefficient, the hydrody-
namic radius can be obtained by inserting the measured diffusion coefficient into the 
Stokes-Einstein equation (Equation 4.1).  
� =
�� × �
6�ηD
 
Equation 4.1 Stokes-Einstein equation, where r is the hydrodynamic radius, kb is the Boltzmann constant, T is 
the temperature, η is the viscosity of the solvent and D is the diffusion coefficient. 
However, there are some limitations to the method. Since the hydrodynamic radius ob-
tained is an expression of the diffusion, large molecules with large cavities, able to let the 
solvent pass through the molecule, will diffuse faster and result in a smaller hydrodynamic 
radius. Also, the accuracy of the method is impaired when using mixtures of solvents, 
since their viscosity cannot be precisely estimated. Nevertheless, when taking these limita-
tions into account, it is possible to derive valuable information from a 1H-DOSY-NMR-
experiment. 
As can be seen in the spectrum (Figure 4.8) the 1H-NMR-peaks of the complex only pro-
duce one set of signals in the 1H-DOSY-NMR, telling us, that only species of one size are 
present in the solution even when the racemic ligand 12 is used.  
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Figure 4.8 1H-DOSY-NMR-spectrum of ligand rac-12 with Pt(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1). 
The signals of the homo – and the heterochiral complexes are very similar and overlap in 
most cases, which is why it is difficult to assess the exact ratio of the two species. We 
therefore looked to the 31P-NMR-spectra, which are simpler and therefore easier to com-
pare. The resulting spectra are shown in Figure 4.9.  
 
Figure 4.9  31P-NMR-spectrum of a) ligand rac-12 with Pd(dppp)(OTf)2 b) ligand (R)-12 with 
Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1). 
The spectrum of the enantiomerically pure ligand mixed with Pd-corner (Figure 4.9b) 
shows only one peak as expected. When using the racemic ligand two peaks in the ratio of 
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3:1 are present. The larger peak originates from the two homochiral species 
[(dppp)2Pd2((R)-12)2](OTf)4 and [(dppp)2Pd2((S)-12)2](OTf)4, since we established from 
the 1H-NMR-spectrum that the homochiral species was predominant. The small peak orig-
inates from the heterochiral species [(dppp)2Pd2((R)-12)(S)-12)](OTf)4.The ratio is 3:1 and 
the same ratio is also found in the 31P-NMR-spectrum of a mixture of rac-12 with 
[Pt(dppp)](OTf)2 as shown in Figure 4.10. 
 
Figure 4.10 31P-NMR-spectrum of ligand rac-12 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1). 
The 1H-NMR-spectra indicate strongly, that ligand 12 has a preference for self-recognition. 
To confirm this mass measurement with ligand 12 were performed. The spectrum is shown 
in Figure 4.11. 
 
Figure 4.11 ESI mass spectrum (positive mode) of ligand (R)-12 with Pd(dppp)(OTf)2 CD2Cl2/CD3CN (3:1) 
diluted in acetone. The notation corresponds to Metal:Ligand:Anion. 
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The base peak of the spectrum is at 1138.2 m/z corresponding to the 2:2-aggregate with 
two triflate-anions. Peaks at 709.2 and 2426 m/z also originate from the 2:2-aggregate con-
firming the selective formation of the desired 2:2-rhomb.  
It is not possible to see the difference between the different stereoisomers and therefore we 
used the pseudoenantiomer ligand (S)-21 together with ligand (R)-12. The two additional 
methyl-groups on ligand 21 make it possible to distinguish between the (R)- and the 
(S)-enantiomer through the m/z-values.  
First we wanted to test whether ligand 21 was able to form the desired 2:2-rhombs and 
therefore mixed ligand (S)-21 with Pt(dppp)(OTf)2 in a stoichiometry of 1:1. A 1H-NMR-
spectrum (Figure 4.12) and a mass spectrum (Figure 4.13) were recorded and both con-
firmed the formation of the desired 2:2-rhomb. 
 
Figure 4.121H-NMR-spectrum of ligand (S)-21 withPd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1). 
Only one set of peaks is seen in the 1H-NMR-spectrum confirming than only one species 
has been formed.  
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Figure 4.13 ESI mass spectrum (positive mode) of ligand (S)-21 with Pt(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) 
diluted in acetone. The notation corresponds to Metal:Ligand:Anion. 
The base peak in the spectrum is at 1254.8 m/z and corresponds to the desired 2:2-rhomb 
with two triflate-anions. In addition, peaks at 1723.1, 1957.5 and 2191.2 m/z originate 
from non-specific aggregates. Since the ability of ligand 21 to form the 2:2-rhombs had 
been confirmed, we decided to mix ligand (S)-21 and ligand (R)-12.   
Ligand (S)-21, ligand (R)-12 and Pt(dppp)(OTf)2 (or Pd(dppp)(OTf)2) were mixed in a 
ratio of 1:1:2 in CD2Cl2/CD3CN (3:1). The resulting mass spectrum is shown in Figure 
4.14. 
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Figure 4.14 ESI mass spectrum (positive mode) of ligand (R)-12 and ligand (S)-21 with Pt(dppp)(OTf)2 in 
CD2Cl2/CD3CN (3:1) diluted in CH3CN. The notation corresponds to Metal:Ligand:Anion. 
The spectrum shows one large set of three peaks at 1226.8, 1240.8 and 1254.8 m/z corre-
sponding to the three possible 2:2-stereoisomers. The presense of the three different com-
plexes confirms that the self-assembly process is not completely diastereoselective. Since 
the ratio of the peaks differ from the statistical 1:2:1-ratio in the favor of the homochiral 
species, this further confirms the findings from the NMR-spectra.  
The ratio between the peaks is about 1:0.9:1, strongly favoring the two homochiral species 
over the heterochiral one.  
Furthermore, Dipl. Chem. Georg Meyer-Eppler was able to obtain a crystal structure of the 
homochiral rhomb from the racemic ligand 12 after stirring for 24 h. This result is signifi-
cant since normally, the heterochiral complex crystallizes somewhat easier than the homo-
chiral assemblies. The crystal structure of the rhomb is shown in Figure 4.15.  
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Figure 4.15 Crystal structure of the homoleptic complex of (S)-12 and Pd(dppp)(OTf)2  from 
rac-12. Color code: dark grey: carbon, light grey, hydrogen, red: phosphorous, light blue: 
nitrogen, dark blue: palladium  
The selective formation of 2:2-rhombs of ligand 12 and the Pd- and Pt-corners was con-
firmed by mass spectrometry and 1H-NMR-spectroscopy. Furthermore, we were able to 
elucidate the self-sorting behavior of ligand 12 using 1H- and 31P-NMR-spectroscopy and 
confirm this by mass spectrometry using the pseudoenantiomer 21. The self-recognition 
abilities of ligand 12 were further supported when a crystal structure of the homochiral 
complex was obtained from the racemic mixture. 
 
4.3.2 Large spirobifluorene rhombs 
We have established that ligand 12 displays self-recognition during the formation of dinu-
clear metallosupramolecular rhombs upon coordination to cis-protected palladium(II) or 
platinum(II)-ions and the findings from the 1H-NMR-spectrum and mass spectra were con-
firmed by a crystal structure.  
Next, we were interested in investigating the complexation of ligand 15, which has an ad-
ditional ethynyl spacer between the spirobifluorene and the pyridine. Therefore, ligand (R)-
15 was complexated with Pd(dppp)(OTf)2 in CH2Cl2/CH3CN (3:1) and characterized by 
mass spectrometry and NMR-spectroscopy to investigate the behavior of this larger ligand 
upon coordination.70  
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The 1H- and 31P-NMR-spectra of the complexation of ligand (R)-15 with Pd(dppp)(OTf)2 
can be seen in Figure 4.16 while the 31P-NMR-spectra are shown in Figure 4.17. Both 
spectra were measured at room temperature as well as at 243 K. The signals were assigned 
using H,H-COSY-NMR. It was not possible to assign proton 3 of the spirobifluorene (or-
ange star) with certainty. Also assignment of the protons in spectrum c at low temperature 
was not possible.  
Starting with 1H-NMR-spectrum of the complex of (R)-15 with Pd(dppp)(OTf)2 at room 
temperature (Figure 4.16b), we see one dominating set of well-resolved signals. This set 
contains the same number of signals compared to the spectrum of the free ligand (Figure 
4.16a). Several signals are shifted upfield after complexation. As seen before, the protons 
in the 1-position closest to the pyridine-nitrogen have not shifted much (marked with a red 
star), as opposed to the proton 1 on the spirobifluorene (green star) and the proton in the 2-
position of the pyridine (light blue star). This strongly indicates that the complexation has 
resulted in a symmetrical complex. The same experiment had previously been performed 
by Piehler and Hovorka, who came to the same conclusion. 
 
Figure 4.16 1H-NMR-spectra of a) Ligand (R)-15 in CD2Cl2/CD3CN (3:1) b) Ligand (R)-15 with 
Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) at RT c) Ligand (R)-15 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN 
(3:1) at 243K. The black arrows indicate parts of a second, smaller set of signals. 
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In addition small, broad peaks in the 1H-NMR-spectrum are observed (marked with black 
arrows in Figure 4.16b). This second set of signals was not present in the spectra of the 
pure ligand (R)-15. When lowering the temperature to 243 K (Figure 4.16c) these peaks are 
enlarged and become sharper. Only one peak is visible in the 31P-NMR-spectrum of (R)-15 
with Pd(dppp)(OTf)2 at room temperature (Figure 4.17 left), but upon cooling another set 
of signals appears (Figure 4.17 right). The signal in the 31P-NMR-spectrum appears to split 
up into two doublets, indicating the presence of two sets of magnetically different phos-
phorous-atoms. It therefore seems that a second, less symmetric species is present in the 
mixture. Moreover, this second species seems to be in equilibrium with the symmetric 
complex. 
  
Figure 4.17 31P-NMR-spectrum of Ligand (R)-15  with Pd(dppp)(OTf)2 in CH2Cl2/CH3CN (3:1) at RT (left) 
and at 243 K (right). 
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To identify the second species and confirm the formation of the desired 2:2-complex, mass 
spectroscopy measurements were performed. The resulting mass spectrum can be seen in 
Figure 4.18. The base peak at 1186.3 m/z originates from the 1:1- as well as the 2:2-
complex with triflate as the anion as judged from the isotope pattern and the charge of the 
peaks. This confirms the formation of the supramolecular rhomb. Interestingly, the rather 
large peak at 1631.7 m/z results from a 4:4:5-complex. A peak at 2522.6 m/z corresponds 
to the 2:2:3-complex. Underneath this same peak a 4:4-complex with six triflate-ions is 
also found. This 4:4-species was also seen in the measurements performed by Piehler and 
Hovorka, confirming the reproducibility of this experiment. This 4:4-species is not simply 
a non-specific aggregate as we have seen before, but judging from the 1H- and 31P-NMR-
spectra the 4:4-complex originates from a defined structure, which is in equilibrium with 
the 2:2-complex.  
The mass spectrum reveals that the second set of signals in the 1H-NMR-spectrum could 
originate from the 4:4-complex observed in the mass spectrum. This leaves three structural 
possibilities for the 4:4-complex: a catenane (two interlocked rings71), a macrocycle or a 
sandwich-complex (Figure 4.19). 
 
 
Figure 4.18 ESI mass spectrum (positive mode) of ligand (R)-15 with Pd(dppp)(OTf)2 in CH2Cl2/CH3CN 
(3:1). The notation corresponds to Metal:Ligand:Anion. 
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Starting with the macrocycle, this structure is not planar but folded into itself, resulting in 
magnetically different P-atoms. If the two 2:2-rhombs in the sandwich complex are layered 
exactly on top of each other, we would expect two signals in the 31P-NMR-spectrum. 
However, if the 2:2-rhombs are not arranged directly on top of each other, this could result 
in the emergence of more than two 31P-signals. A catenane-complex would also result in at 
least two different P-atoms, however similar metallosupramolecular catenanes have previ-
ously only been observed in aqueous solution as a result of the hydrophobic effect.72–75    
Mass spectrometry combined with IRMPDII-measurements was used to distinguish be-
tween the three structures. When irradiating the complex with a laser, the weakest bond is 
expected to break first. In case of a sandwich complex one would expect to find a 2:2:2- or 
2:2:3-complex after the first irradiation. If instead a macrocycle has been formed, the 
emergence of a 2:3-complex with an undefined number of anions would be a proof of its 
existence, since this fragment cannot arise from the two other structures. The absence of 
the fragments mentioned above would be an indication of the formation of a catenane.    
The IRMPD-measurements were performed by Piehler and Hovorka on the 4:4:5-ion. It 
was hoped that the formation of the macrocycle and the sandwich complex could be ruled 
out. However, it is difficult to distinguish between fragmentation of the catenane and the 
sandwich complex, since both are expected to produce a 2:2-complex with and unknown 
number of anions. After irradiation of the 4:4:5-complex for two seconds, one of the Pd-
corners and an anion was separated from the complex resulting in a 3:4:4 - and a 1:0:1-
fragment. Three seconds of irradiation resulted in the separation of one ligand from the 
3:4:4-fragment to produce a 3:3:4-fragment. Further irradiation of the fragment, lead to the 
alternating separation of one metal and one ligand. Since no separation of a 2:2:2-fragment 
was observed, a sandwich-structured complex is highly unlikely. Furthermore, we cannot 
with certainty rule out the formation of a macrocycle, because the fragmentation pattern 
does not allow the formation of a 3:2-complex.  
We therefore still needed more information to determine the structure of the 4:4-complex, 
so crystallization attempts were made in different solvents by me in cooperation with Dipl. 
Chem. Georg Meyer-Eppler. It is important to emphasize, that the chances of obtaining 
crystals of the 4:4-species compared to the 2:2-species are relatively slim considering the 
                                                
II Infrared multiphoton dissociation 
 
Figure 4.19 Illustration of the possible structures for 4:4-complex c) catenane b) sandwich complex and 
c) macrocycle 
44 4 Self-Sorting 
ratio between the two complexes. Nevertheless, using ethylacetate as the antisolvent we 
were able to obtain a crystal structure, which proved the 4:4-complex to be a catenane. The 
crystal structure is shown in the space filling and the stick model in Figure 4.20. The two 
rhombs are placed almost parallel and fit exactly into each other with the spirobifluorene 
core filling out the cavities perfectly. From the crystal structure, one could assume that π-π-
stacking plays a role in the interaction of the two rhombs (Figure 4.20, purple and yellow 
respectively). The stick model also suggests that the protons from the spirobifluorene in-
teract with the π-system of the pyridine. The dense packing of the catenane might also ex-
plain why it crystallizes better than the rhombic structure.  
From the crystal structure we can explain the signals in the 1H- and 31P-NMR-spectra. The 
four ligands comprising the catenane can be divided into two outer and two inner ligands 
in environments differing from the environment in the 2:2-rhomb, resulting in two differ-
ent sets of signals shifted compared to the signals from the rhomb. The phosphorous-ions 
become magnetically different upon cooling. The 1,3-bis(diphenylphosphino)propane-
ligand (dppp) on adjacent palladium(II)-ions needs to twist in order to accommodate the 
benzene rings. At room temperature the two adjacent dppp-ligands are able rotate around 
the Pd-P-bond and the P-ions are therefore indistinguishable from each other. Upon cool-
ing the rotation decreases and the ligands are locked in an unsymmetrical position resulting 
in two magnetically different P-atoms. The crystal structure also demonstrates that the 
formation of the catenane is not a result of hydrophobic effects, but instead of a template 
effect.70   
 
  
  
Figure 4.20 Crystal structure of the catenane of ligand (R)-15 with Pd(dppp)(OTf)2, on the left in the space 
filling model and on the right in the stick model.  Color code: grey: carbon, yellow: phosphorous, blue: 
nitrogen, green: palladium 
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We also wanted to investigate the self-sorting behavior of ligand (R)-15 during formation 
of the 2:2-rhomb by the means of pseudoenantiomer ligand (S)-20 (Figure 4.21). Due to 
the extra methylgroups in ligand (S)-20, the two enantiomers can be distinguished from 
each other.  
 
Figure 4.21 Pseudoenantiomer of lig-
and 15 
We started with establishing the ability of ligand 20 to form a rhombic structure, to ensure 
its usefulness together with ligand (R)-15. Therefore (S)-20 was mixed with 
Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) and stirred for 24 hours. The resulting 1H-NMR-
spectrum (Figure 4.22b) was compared to the spectrum of the free ligand (Figure 4.22a).  
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Figure 4.22 1H-NMR-spectra of a) Ligand (S)-20 in CD2Cl2/CD3CN (3:1) b) Ligand (S)-20 with 
Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) at RT c) Ligand (S)-20 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) 
at 233 K 
The number of signals in the red and blue spectra is constant, while many signals are shift-
ed, indicating the formation of only one spe-
cies. A rather large upfield shift of about 
0.1 ppm is seen for the peak belonging to the 
proton next to the pyridine-N (at 8.5 ppm. 
marked with a red star), further confirming the 
complexation of the pyridine-entity to the Pd-
corner. Generally, the changes in shifts are 
very similar to the ones seen in the complexa-
tion of ligand (R)-15 (Figure 4.16). The peaks 
were assigned via H,H-COSY-NMR. It was 
not possible to assign proton 3 and 6 (marked 
with an orange and a brown star respectively) 
with certainty. More importantly, no peaks 
indicating the formation of a catenane are pre-
sent. This confirms the observation from the 
crystal structure of the catenane of (R)-15 
 
Figure 4.23 31P-NMR-spectrum of a) ligand 
(S)-20 with Pd(dppp)(OTf)2 at RT b) ligand 
(S)-20 with Pd(dppp)(OTf)2 at 243 K 
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(Figure 4.20), that the cavity of the catenane is too small to accommodate the methyl 
groups of (S)-20. 
The 1H- and 31P-NMR-spectra were record-
ed at 233 K (See Figure 4.23c and Figure 
4.23b respectively). Interestingly, the two 
protons at the pyridine in the 1H-NMR-
spectrum split up when lowering the tem-
perature to 233 K. Similarly, a second peak 
emerges in the 31P-NMR-spectrum at low 
temperatures compared to the spectrum 
recorded at room temperature. Since none 
of the other signals display similar behav-
ior, a possible explanation is that the 
movement around the Pd-N-bond decreases 
on cooling of the complex, thereby locking 
the pyridine, which results in two different 
possible positions for the pyridine-protons 
as well as the P-atoms. A modeled structure 
of the complex is shown in Figure 4.24. 
To investigate the ability of ligand (S)-20 to form mixed complexes with ligand (R)-15, a 
1:1 mixture of the two ligands with one equivalent of Pd(dppp)(OTf)2 was prepared and 
1H- and 31P-NMR-spectra were measured (See Figure 4.25 and Figure 4.26 respectively). 
In the case of self-recognition, two different supramolecular rhombs would be formed and 
the mixed spectrum would be a superimposition of the two separate complexes. This will 
not be the case, if self-discrimination is the major effect during complexation, instead the 
1H-NMR-spectrum of the mixed complex would display a new set of signals, which cannot 
be found in any of the separate complexes. Again, pure self-discrimination or self-
recognition is rare, and it is more likely to find a preference towards one of the two. If no 
self-sorting is taking place we will see an intensity-ratio of homo:hetero:homo of 1:2:1. 
 
 
Figure 4.24 Minimized structure of the complex of 
ligand (S)-20 and Pd(dppp)OTf2 
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Figure 4.25  1H-NMR-spectra of a) Ligand (S)-20 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) b) Ligand 
(R)-20 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) at RT c) Ligands (S)-20 and  (R)-15 with 
Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) at RT d) Ligands (S)-20 and  (R)-15 with Pd(dppp)(OTf)2 in 
CD2Cl2/CD3CN (3:1) at 233 K. 
From the 1H-NMR-spectra we can conclude that all three possible complexes have formed 
since signals originating from the two homochiral complexes can be seen along with sig-
nals not belonging to either of the homochiral species. It is also worth noticing that no 
peaks corresponding to the catenane are present in the mixed structure. Upon cooling to 
233 K, the most significant change happens around the peaks corresponding to the pyri-
dine-protons (Figure 4.25d). The signal from proton 2 on the pyridine (marked with a red 
star) splits into four peaks, while the signal corresponding to proton 3 on the pyridine 
(marked with a light blue star) splits into at least two peaks. In the 31P-NMR-spectrum two 
peaks in the relative intensity of 1:0.75 are present (Figure 4.26a), indicating the formation 
of two species. The two peaks correspond to each of the complexes of ligands (R)-15 and 
(S)-20. Apparently, the change in the chemical environment upon formation of the mixed 
complex is not significant enough to result in a third and fourth signal from the phospho-
rous. No change is seen in the 31P-NMR-spectrum upon cooling the complex solution 
(Figure 4.26b). 
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In order to investigate whether self-
discrimination or self-recognition is 
preferred in the self-assembly of lig-
and 15 and 20, a closer look was tak-
en at the 1H-NMR-spectra. As men-
tioned earlier, when no self-sorting is 
taking place, the ratio of ho-
mo:hetero:homo is statistical, making 
it twice as likely that (R)- and 
(S)-enantiomers form a complex in 
solution than two (R)- or two (S)-
enantiomers. Consequently the ratio 
of homo:hetero:homo complexes is 
1:2:1. In the 1H-NMR-spectrum we 
would expect to see four sets of sig-
nals in total; Two for each of the ho-
mochiral complexes and two for the 
heterochiral complex. Since the two 
ligands comprising the heterochiral 
complex are different, we expect to 
see two sets of signals. This results in 
a ratio of 1(homo):1(hetero):1(hetero):1(homo) in case of a statistical distribution.    
Therefore we were looking for three distinct peaks in the 1H-NMR-spectrum, correspond-
ing to the two homochiral complexes and the heterochiral one. We were able to find a sec-
tion in the 1H-NMR-spectra between 7.90 and 7.70 ppm (Figure 4.27). Comparing the 
spectrum of the complex of ligand (S)-20 (Figure 4.27c) and ligand (R)-15 (Figure 4.27a) 
with the spectrum of the mixed solution (Figure 4.27b), it becomes apparent that an addi-
tional sets of doublet of doublets have formed (green star) which cannot be found in either 
of the spectra of the individual ligands. These peaks must belong to the heterochiral com-
plex. Next to these peaks, two sets of doublets originating from the complex of ligand 
(S)-20 can be seen (black arrows) indicating that the new set of signals belongs to ligand 
(S)-20 in the heterochiral complex. The intensities of the sets of doublets are roughly 1:1, 
indicating that the mixture is statistical for ligand (S)-20. It was not possible to find a simi-
lar set of signals for ligand (R)-15 and the heterochiral complex, therefore it is not possible 
to perform the same investigation for the homochiral complex comprised of (R)-15 and the 
heterochiral complex.   
 
 
Figure 4.26 31P-NMR-spectrum of a) Ligands (S)-20 and  
(R)-15 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) at RT 
b) Ligands (S)-20 and  (R)-15 with Pd(dppp)(OTf)2 in 
CD2Cl2/CD3CN (3:1) at 233 K 
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Figure 4.27 Section of the 1H-NMR-spectra of a) Ligand (R)-15 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) 
b) Ligands (S)-20 and  (R)-15 with Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1) c) Ligand (S)-20 with 
Pd(dppp)(OTf)2 in CD2Cl2/CD3CN (3:1). The green stars indicate peaks arising from the mixed complex. The 
black arrows indicate the presence of the peaks originating from ligand (S)-20 in the mixed spectrum. 
We therefore turned to mass spectrometry, to help get further information on the mixed 
complex of (R)-15 and (S)-20 as well as the complex of (S)-20. The mass spectrum of the 
mixed complex is shown in Figure 4.28.  
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Figure 4.28 ESI mass spectrum (positive mode) of ligand (R)-15 and ligand (S)-20 with Pd(dppp)(OTf)2 in 
CD2Cl2/CD3CN (3:1). The notation corresponds to Metal:Ligand:Anion. 
In the spectrum we see a series of peaks at 1185.2, 1200.2 and 2213.3 m/z, which are suit-
ed to evaluate the self-sorting behavior of ligand (R)-15. The two larger peaks at 1185.2 
and 2213.3 m/z can be assigned to the 1:1-complexes of each of the pseudoenantiomers 
(R)-15 and (S)-20. However, underneath the two peaks the doubly charged 2:2-complex of 
both pseudo enantiomers can be observed. In addition, the signal in between at 1200.2 m/z 
corresponds to the mixed complex of (R)-15 and (S)-20. We also observed peaks originat-
ing from the 1:2-complex (at 800.3 m/z) as well as both of the 1:1-complexes (1099.2 and 
1111.2 m/z), which probably are fragments resulting from the measurement in the mass 
spectrometer, since the 1H-NMR-spectra do not indicate formation of asymmetric species.  
It should be possible to deduce the selectivity of the ligands from their intensity in the mass 
spectra. Here we look at the three signals at 1185.2, 1200.2 and 1213.2 m/z, the only set of 
all three signals originating from all the three possible 2:2-complexes. However, overlap-
ping the homochiral 2:2-complexes are the corresponding 1:1-complexes. Therefore this 
should only be a rough estimate 
 
52 4 Self-Sorting 
Figure 4.29 is a detail of the spectrum of the mixed complexes of ligands (R)-15 and ligand 
(S)-20 showing the peaks corresponding to each of the homochiral and the heterochiral 
complexes. In addition, the 1:1-complexes of both ligands are also present in the spectrum 
overlapping the homochiral 2:2-complexes. Therefore comparison of the intensities is not 
straight forward. The 2:2-complexes are doubly charged and therefore display two peaks 
per mass in the spectrum, while the 1:1-complexes are singly charged and only display one 
peak per mass (Figure 4.29). This means, that every second peak originating from the 2:2-
complex is covered by a peak from the 1:1-complex. To determine which peak is the high-
est of the 2:2-complex, a simulation of the peaks of both 2:2-complexes was done in 
Bruker Data Analysis 4.0, which showed that the peaks at 1186.7 and 1214.8 m/z are the 
highest for the 2:2-complexes of ligand (R)-15 and (S)-20 respectively. The intensities of 
the peaks at 1186.7 and 1214.8 m/z where compared with the peak from the heterochiral 
complex at 1200.2 m/z. This resulted in a ratio of 1((R)-15):2.7((R)-15/(S)-20):1.4((S)-20), 
which matches the statistical distribution of 1:2:1 expected from the 1H-NMR-spectrum 
quite well, although the ratio is not a perfect 1:2:1-ratio. An explanation for this could be 
the additional peaks at 800.3, 1099.2 and 1111.2 m/z in the mass spectrum (Figure 4.28), 
which all contain one or both ligands. It is possible that these fragments disturb and alter 
the ratio between the 2:2-rhombs. If no fragments were present it is possible that the ratio 
would change into the expected 1:2:1-ratio. Further mass measurements would have to be 
performed in order to verify this assumption and confirm the statistical distribution of the 
 
Figure 4.29 Section of the ESI positive of ligand (R)-15 and ligand (S)-20 with Pd(dppp)(OTf)2 in 
CH2Cl2/CH3CN (3:1). The signalsets from the homochiral complexes are marked in red. 
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complexes. However, the experiments so far suggest that ligand 15 displays little self-
sorting behavior.   
We also investigated the complexation and self-sorting of ligand 15 in other solvents: Ace-
tone-d6 and DMF-d7, with interesting results. The complexation in acetone of ligand (R)-15 
1H- and 31P-NMR-spectra were recorded and compared to the uncomplexed ligand (Figure 
4.30 and Figure 4.31). 
 
Figure 4.30  1H-NMR-spectra of a) Ligand (R)-15 in acetone-d6 b) Ligand (R)-15 with Pd(dppp)(OTf)2 in 
acetone-d6 
The protons closest to the metal-binding pyridine-N are all shifted compared to the free 
ligand. Similar to what we observed in CD2Cl2/CD3CN a second set of peaks (marked with 
black arrows) is found in the spectrum, with a relative intensity of 1:0.4 (Figure 4.30b). 
The second set of signals originating from the catenane seems to have a greater intensity in 
acetone than in CD2Cl2/CD3CN. This is confirmed by the 31P-NMR-spectrum (Figure 
4.31), where the two doublets are present even at room temperature. The protons were as-
signed using H,H-COSY-NMR. It was not possible to assign proton 6 of the spirobifluo-
rene (marked with a brown star) unambiguously.  
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Figure 4.31 31P-NMR-spectrum of ligand (R)-15 
with Pd(dppp)(OTf)2 in acetone-d6 at RT 
A mass spectrum was recorded in acetone which is shown in Figure 4.32. Many of the 
peaks recur compared to the spectrum recorded in CD2Cl2/CD3CN (Figure 4.28). The base 
peak at 518.1 m/z originates from two species, the 2:2:02+- and the 1:1:0+-complexes. The 
peak at 1631.0 m/z corresponds to the 4:4:53+-complex, the 2:2:22+- and the 1:1:1+-
complex can be found at 1186.2 m/z. When looking very closely at the peak at 1186.2 m/z, 
it is possible to a very small set of peaks originating from the 4:4:4-complex.  
In addition, we see a peak at 1854.3 m/z corresponding to the 6:6:84+-complex, which 
probably originates from a non-specific aggregate during the measurement resulting in the 
loose assembly of a 4:4- and a 2:2-complex. Another possibility is that three 2:2-
complexes have assembled, but it is more likely that two species find each other rather than 
three. The peak at 777.2 m/z could not be identified. 
The formation of the desired 2:2-rhomb in acetone-d6 was confirmed. It was also made 
plausible, that catenane-formation is favored in acetone-d6 compared to the mixture of di-
chloromethane and acetonitrile.  
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The complex of ligand (S)-20 with Pd(dppp)(OTf)2 in acetone was also investigated by 1H- 
and 31P-NMR (See Figure 4.33 for 1H-NMR-spectrum). As in CD2Cl2/CD3CN (Figure 
4.22) only one species is formed since only one set of signals can be observed. The 
31P-NMR-spectrum shows only one peak, confirming the result from the 1H-NMR-
spectrum (Figure 4.33). The shift of proton 1 and 2 on the pyridine (marked with a red and 
green star respectively) is more significant than in CD2Cl2/CD3CN. The spectrum is well 
resolved and all peaks could be assigned via H,H-COSY-NMR. Again, no signals corre-
sponding to the catenane are observed, confirming that ligand 20 is not able to form a cate-
nane, due to the two additional methyl groups in the 7,7'-position. 
 
Figure 4.32 ESI mass spectrum (positive mode) of ligand (R)-15 with Pd(dppp)(OTf)2 in acetone. The nota-
tion corresponds to Metal:Ligand:Anion. 
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Figure 4.33 1H-NMR-spectrum of a) ligand (S)-20 in acetone-d6 b) ligand (S)-20 with Pd(dppp)(OTf)2 in 
acetone-d6. 
A mass spectrum of the complex of ligand (S)-20 with the Pd-corner in acetone was ob-
tained and the result is shown in Figure 4.34. The largest peak in the spectrum at 
1214.2 m/z originates from the desired 2:2-complex with two triflate anions as well as the 
1:1-complex with one triflate anion. It was not possible to identify all peaks in the spec-
trum, but most seem to be 1:1- or 1:0-complexes with an unknown anion. This is supported 
by the 1H-NMR-spectrum, which shows no signals corresponding to an asymmetrically 
substituted ligand.  
Interestingly, a peak at 1668.9 m/z can be ascribed to the 4:4:5-complex. As discussed ear-
lier, the crystal structure of ligand (R)-15 (Figure 4.20) indicates that catenane-formation 
with ligand 20 should be highly disfavored. The 1H-NMR-spectrum (Figure 4.33b) only 
shows one species and no additional smaller peaks that could indicate the formation of 
another species. The presence of a 4:4-complex in the mass spectrum is therefore most 
likely due to non-specific interactions, similar to the 6:6:5-complex that was seen earlier in 
the spectrum of ligand (R)-15 in acetone (Figure 4.32). This could be confirmed by an 
MS/MS-experiment, where the ion at 1668.9 m/s was isolated and fragmented. In the case 
of a non-specific aggregate the weakest bond would brake first resulting in a 2:2:22+- and a 
2:2:33+-complex. This is still to be done. However, when looking closer at the peak at 
1214.2 m/z, no sign of a 4:4:4-complex is seen, as opposed to the corresponding peak in 
the spectrum of the complex of (R)-15 (Figure 4.32). This strongly indicates, that ligand 20 
is not able to form a catenane and that the peak at 1668.9 m/z is a result of non-specific 
aggregation.  
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Figure 4.34 ESI mass spectrum (positive mode) of ligand (S)-20 with Pd(dppp)(OTf)2 in acetone. The nota-
tion corresponds to Metal:Ligand:Anion. 
Together with the 1H-NMR-spectrum the mass spectrum of the Pd-complex of ligand 
(S)-20 confirms the formation of the 2:2-complex in acetone. Upon mixing the two ligands 
(S)-20 and (R)-15 in acetone, the 1H-NMR-spectrum suggests that both of the homochiral 
complexes as well as the heterochiral complex have been formed, since peaks from both 
the separate complexes can be seen along with peaks belonging to neither species (Figure 
4.35). Also we can see signals from the catenane present in the mixture (marked with black 
arrows) indicating that formation of the catenane is possible even in the presence of ligand 
20.  
We also recorded a 31P-NMR-spectrum which is shown in Figure 4.36. Here we see one 
large peak next to a smaller peak. In addition the two doublets previously seen in the 31P-
NMR-spectrum of ligand (R)-15 in CD2Cl2/CD3CN (Figure 4.17) as well as in acetone 
(Figure 4.31). It seems that 31P-signals for both (R)-15 and (S)-20 as well as the catenane 
are present, confirming our observations from the 1H-NMR-spectrum.  
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Figure 4.35 1H-NMR-spectra of a) ligand (S)-20 with Pd(dppp)(OTf)2 b) ligands (S)-20and (R)-15 with 
Pd(dppp)(OTf)2 c) ligand (R)-15 with Pd(dppp)(OTf)2 all in acetone-d6. 
The solution was measured on the Q-TOF and the resultant spectrum is shown in Figure 
4.37. The base peak is at 1200.2 m/z and corresponds to the doubly charged heterochiral 
2:2-complex of the two ligands (S)-20 and (R)-15. On either side of the mixed peak, small-
er peaks originating from the 
homoleptic 2:2- and 1:1-
complexes of each ligand can be 
seen. The mass spectrum con-
firms the formation of both the 
two homochiral and the hetero-
chiral complex. However, it was 
not possible to find a signal cor-
responding to the catenane in the 
mass spectrum, which is surpris-
ing since both the 31P- and 1H-
NMR-spectra indicate its for-
mation. In the future, additional 
mass measurements on finding 
the 4:4-complex could confirm 
the desired outcome.  
 
 
Figure 4.36 31P-NMR-spectrum of ligands (S)-20 and (R)-15 with 
Pd(dppp)(OTf)2 in acetone-d6. 
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In this case our main objective was to determine the ratios of homo and heterochiral com-
plex. Therefore, we again compared the 1H-NMR-spectra of the single ligands and the 
mixture. Like before, the challenge was to find three non-overlapping peaks belonging to 
each species in the mixed spectrum.  
A section of the three spectra is shown in Figure 4.38. This section was chosen because of 
the few sections, where it was possible to distinguish clearly between signals of the hetero-
chiral and the homochiral complexes. Two peaks were identified in the mixed spectrum 
(Figure 4.38b), where one belongs to the complex of ligand (S)-20 while the other belongs 
to the heterochiral complex. When integrating the two peaks the intensity of both equal to 
one. A ratio of 1:1 of one specific hetero- and homoleptic signal indicates a statistical dis-
tribution of the self-recognition and self-discrimination processes. This is the same effect 
that was seen in CD2Cl2/CD3CN (3:1) (See Figure 4.28).   
 
 
Figure 4.37 ESI mass spectrum (positive mode) of ligand (R)-15 and ligand (S)-20 with Pd(dppp)(OTf)2 in 
acetone. The notation corresponds to Metal:Ligand:Anion. 
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Figure 4.38 Section of the 1H-NMR-spectra of a) Ligand (R)-15 with Pd(dppp)(OTf)2 in acetone-d6 b) Lig-
ands (S)-20 and  (R)-15 with Pd(dppp)(OTf)2 in acetone-d6 c) Ligand (S)-20 with Pd(dppp)(OTf)2 in acetone-
d6. Peaks originating from the catenane are marked with black arrows. 
 
Again, we were looking for three signals in the mass spectrum resulting from all three pos-
sible 2:2-complexes. The section is shown in Figure 4.39. The same method that was used 
for the complex in CD2Cl2/CD3CN was applied here and the peaks at 1186.7, 1200.2 and 
1214.8 m/z were compared. The resultant ratio of 1((R)-15):3.1((R)-15/(S)-20):0.8((S)-20) 
indicates self-discriminating behavior of the ligands and differs markedly from the result 
obtained from the 1H-NMR-spectrum. In this case, it is difficult to assess if the discrepancy 
is due to fragmentation of the 2:2-complex in the mass spectrum (Figure 4.37). It has not 
been possible to identify many of the other peaks in the spectrum for example at 798.3 m/z. 
Nevertheless, the isotope pattern and the charge of +1 indicated a 1:1:1-complex with an 
unknown anion. Interestingly, no fragments containing the ligand are seen which adds 
more credibility to this spectrum compared to the one made in CD2Cl2/CD3CN (Figure 
4.29).  In order to confirm the results obtained from these mass spectra, more mass meas-
urements would have to be made to obtain fully identifiable spectra.  
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Figure 4.39 Section of ESI mass spectrum (positive mode) of ligand (R)-15 and ligand (S)-20 with 
Pd(dppp)(OTf)2 in acetone. 
The complexation of ligand (R)-15 and (S)-20 was also measured in DMF-d7. In the case of 
the separate complexes of the ligands, the resulting 1H-NMR-spectra were compared to the 
uncomplexed ligand and both indicated formation of a complex. Only one set of signals 
was present, however, the signals corresponding to the pyridine protons as well as the sig-
nals from the triphenylphosphine of the Pd(II) were broadened indicating a rapid exchange 
on the NMR time scale. Due to the broadness of the peaks in the 1H-NMR-spectrum it is 
not possible to conclude about the identity of aggregate in the solution without the help of 
mass spectroscopy. The 1H-NMR-spectrum of the mixed complex is shown in Figure 
4.40c.  
What we have seen in the spectra of the separate complexes also holds true for the mixed 
complex: the protons near the complexation center are unusually broad. Only protons situ-
ated far away from the complexing pyridine appear as sharp signals. Apparently, the con-
formation around Pd-N-bond is very labile on an NMR-time-scale, thereby broadening the 
signals. 
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Figure 4.40 1H-NMR-spectra of a) ligand (R)-15 with Pd(dppp)(OTf)2 b) ligand (S)-20 with Pd(dppp)(OTf)2 
c) ligands (S)-20 and (R)-15 with Pd(dppp)(OTf)2 all in DMF-d7. 
Looking at the mixed 1H-NMR-spectrum it seems to be a superposition of the 1H-NMR-
spectra of the separate ligands (Figure 4.40). However, because of the broadness of the 
signals it is difficult to make a finite statement about the self-sorting behavior of the lig-
ands in DMF. A mass spectrum could tell us more, but DMF is a difficult solvent to spray 
into the mass spectrometer due to its high boiling point. Dissolving the complex in CH3CN 
or acetone could change the self-sorting behavior. In the future, it would therefore be inter-
esting to investigate self-sorting of ligands 15 and 20 in other solvents such as THF or pure 
CH3CN, which both can be sprayed into the mass spectrometer. 
 
  
4.4 Conclusion 63 
4.4 Conclusion 
We have been able to reproduce the formation of rhombs of ligand (R)-12, and confirm the 
preference of ligand 12 towards formation homochiral aggregates with the help of 
pseudoenantiomer ligand 21. ´ 
Using ligand 15 also resulted in the formation of the desired 2:2-rhombs as well as a 4:4-
catenane structure as observed in the 1H-NMR- and mass spectra and confirmed by crystal 
structure obtained of the catenane of (R)-15. The formation of the catenane was also inves-
tigated in acetone-d6, and inspection of the 1H-NMR-spectra suggests that the formation of 
the catenane is favored in acetone. More studies have to be carried out in DMF-d7 and in 
other solvents. 
The self-sorting behavior of the ligand (R)-15 using the pseudoenantiomer (S)-20 was also 
investigated in different solvents. In CD2Cl2/CD3CN and acetone-d6 no selectivity for the 
enantiomers was observed in the 1H-NMR-spectra. It was not possible to perform mass 
spectrometry on the complexes in the DMF-solution, due to the high boiling point of the 
solvent and the solution can therefore not be investigated further. Ideally, crystal structures 
could help elucidate whether homo- or heterochiral or both complexes have formed. How-
ever, several crystallization experiments have been attempted but so far no measurable 
crystals have been produced. 
The change in selectivity going from the small ligand 12 to the large ligand 15 is signifi-
cant. Increasing the length of the linker changes the selectivity from preferred self-
recognition to no selectivity, emphasizing the importance of the linker length in self-
sorting. This could be investigated further with crystal structures of the obtained complex-
es. Also, more flexible linkers could be investigated for their influence on the selectivity.   
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5.1 Background 
As described in the previous chapter 4.3.1, substituted spirobifluorenes are able to partici-
pate in complex formation forming supramolecular rhombs, which display self-sorting 
abilities. However, so far only 2:2- or 4:4-complexes of spirobifluorenes have been de-
scribed. Larger complexes involving more than four ligands present an interesting subject 
and are presented in the following chapter.  
Through the last two decades many different synthesis of large self-assembled metal-based 
structures have been presented.76–80 The interest in such large supramolecular structures is 
not just aesthetical but also has a functional aspect. The formation of larger complexes 
means the cavities within the aggregate becomes larger and can thus accommodate larger 
or more guest molecules. Furthermore, functionalization of the cavity with, for example, 
hydrophobic groups or electron withdrawing substituents can give rise to a binding pocket 
displaying specificity towards certain molecules or facilitating otherwise unfavorable reac-
tions. 
Fujita and coworkers presented a supramolecular cage assembled of six Pd-ions and four 
tridentate pyridine-ligands. This cage was shown to be able to influence the photodimeriza-
tion of two molecules of the asymmetric 1-methylacenaphtylene when irradiated resulting 
only in the syn- and head-to-tail isomers. The supramolecular cage is able to accommodate 
only two substrates positioned head-to-tail in respect to each other and, in doing so, facili-
tates the formation of only one isomer.81 Other uses for self-assembled polyhedral struc-
tures could also be imagined such as molecular machines and new materials.82–84   
The formation of the large supramolecular cages can be predicted and designed with quite 
some accuracy. Using metals, with their predefined bonding geometries, together with rig-
id organic ligands often results in the desired and predicted discrete self-assembled struc-
ture.77 This approach, also called the directional-bonding methodology, was tested by Fu-
jita and coworkers when assembling several coordination polyhedra. Using the five differ-
ent ligands shown in Figure 5.1 together with Pd(NO3)2, it was possible to assess which 
ligand angle lead to formation of M24L48-polyhedra rather than M12L24. Having a cavity-
volume of 23000 Å3, the M24L48-structure built from the ligand 3 (Figure 5.1) is the largest 
polyhedral formed to date.83,85 
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Figure 5.1 Ligands synthesized by Fujita et al including angle spans on the basis of the illustration by Fujita 
et al. 85 
An example of a chiral molecule with a rigid core is 1,1′-bi-2-naphthol (BINOL), which 
has been used by the Lützen group to form large complexes. The ligands in Figure 5.2 are 
based on BINOL and were synthesized by Christoph Gütz.86 When mixing racemic 
BINOL1 with Pd(CH3CN)4(BF4)2 and stirring for two days in CD2Cl2:CD3CN 3:1, only 
one species, the M2L4-cage, was detected in the mass-spectrum. Four possible diastereo-
meric structures can be formed during complexation. However, comparing the 1H-NMR-
spectra of the complex formed using the racemic ligand and the complex formed using the 
enantiomerically pure ligand, no difference is found in the spectra. All in all the formation 
of a racemic mixture of the two homochiral complexes was observed revealing a ligand 
displaying self-recognition. 
The BINOL-core can also be used to form even larger complexes, as exemplified by 
BINOL2 (Figure 5.2). Formation of M6L12 was confirmed in DOSY and ESI-MS after 
heating of BINOL2 with Pd(CH3CN)4(BF4)2 in DMSO-d6. In this case, however, no stere-
oselectivity was observed in the self-assembly process.86  
 
 
Figure 5.2 BINOL-Ligands synthesized by Gütz 
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5.2 Synthesis of the ligands 
Just like the BINOLs the substituted spirobifluorenes have a rigid core and a defined angle 
and therefore fulfill the demand for a predefined bonding geometry. Furthermore, the spi-
robifluorenes are also chiral and could be able to form complexes displaying self-sorting. 
Therefore synthesis of ligands based on spirobifluorene, that are potentially able to form 
large supramolecular assemblies with Pd(II) and the formation of these was a key subject 
during this study.  
We therefore looked for a spirobifluorene ligand, which would be able to form an M6L12-
cage. First, we examined the ligands already available such as ligand 12, 15 and 20. Mod-
eling studies suggested, that ligand 12 should be well suited to form a cube with square 
planar Pd(II) without distortion of neither the coordination geometry of the metal nor the 
ligand itself (Figure 5.3).  
  
Figure 5.3 PM6-minimized structure of the M6L12-cube of ligand (R)-12 
Ligand 12 was described previously and the synthesis is described in chapter 4.2. 
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We also aimed at forming a simpler M2L4-cage also using the 
spirobifluorene core. To this end, a different angle between the 
metal-binding entities than the 90° in the previously synthe-
sized ligands is needed. Using a 3-pyridine instead of a 4-
pyridine in the synthesis of ligand 12 results in ligand 22 which 
is shown in Figure 5.4. The angle changes to about 86°, howev-
er the bonding angle to the metal ion is changed drastically as 
can be seen in the modeled structures of the complex with 
Pd(II) in Figure 5.5. The angle between the spirobifluorene core 
and the two metal centers is ca. 67° from the modeled struc-
tures. 
The synthesis of ligand 22 starts from 11, which has previously served as a starting materi-
al for the other spirobifluorene ligands and is performed analogously to the synthesis of 
ligand 12. 
 
 
Figure 5.4 Ligand 22 
 
 
Figure 5.5 PM6-minimized model of the M2L4-complex of ligand (R)-22 
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Scheme 5.1 Synthesis of ligand 22 
The synthesis of ligand 22 was initially performed using three equivalents of 
3-pyridineboronic acid and 7% Pd-catalyst. K3PO4 was added to increase the reactivity of 
the boronic acid ester, since PO43- acts as a fourth ligand to the boron and the transmetalla-
tion to the palladium proceeds faster than without addition of base.64,65 However, only the 
mono-substituted spirobiflourene was obtained. Even when adding five equivalents of the 
boronic acid product 22 could not be isolated. Instead, use of five equivalents of 3-
pyridineboronic acid pinacol ester, while keeping the amount of catalyst constant at 7% 
resulted in racemic 22 in a yield of 63%. So even though the reaction was carried out under 
the exclusion of light it may be possible that the boronic acid was not stable enough to al-
low the reaction to continue until completion. The (R)- and (S)-enantiomers were obtained 
in yields of 70 and 38% respectively. The difference in yield between the enantiomers is 
not readily explained. Most likely presence of water reduced the outcome of the reaction to 
produce (S)-22.   
 
5.3 Complexation 
The complexations of ligands 12 and 22 were carried out in different solvents and the self-
recognition abilities of the smaller M2L4-cage formed by ligand 22 were investigated.  
Several attempts were made with both the racemic and the enantiopure ligand 22 mixed 
with Pd(CH3CN)4(BF4)2 in the following deuterated solvents: Acetone, DMSO, CH3CN 
and CH2Cl2/CH3CN (3:1). The experiments led to different results. The use of the racemic 
ligand generally resulted in peak broadening in the 1H-NMR-spectra with one large “wave” 
spanning the entire aromatic region independent of the solvent (spectra not shown). The 
complex mixture of the racemic ligand with Pd(CH3CN)4(BF4)2 in CD3CN gelated, sug-
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gesting that polymerization had occurred. A mass spectrum of the racemic ligand 22 
showed no significant signals other than the one belonging to the free ligand. The use of 
the enantiopure ligand (R)-22 in DMSO-d6 and acetone-d6 again resulted in 1H-NMR-
spectra, indicating polymerization. We therefore concentrated on the investigation of 
(R)-22 in CD3CN and CD2Cl2/CD3CN (3:1) which gave relatively well-resolved 1H-NMR-
spectra. Since we were using only the enantiopure ligand, it was not possible to investigate 
any potential self-sorting processes.  
Complexation was performed at room temperature as well as at 65°C in a microwave vial. 
The heated solutions were heated in 3 hour intervals and 1H-NMR-spectra were recorded 
after each 3 hour interval. For solutions that were stirred at room temperature, the spectra 
were recorded in intervals of one week. Several 1H-NMR-spectra were recorded during the 
reaction time, the resulting spectra are shown in Figure 5.6.  
The complex spectra are all characterized by broad peaks and a low resolution, which 
made it difficult to compare the spectra and extract information from them. Also, it has not 
been possible to assign the protons using H,H-COSY. 
 
Figure 5.6 1H-spectrum of a) ligand (R)-22 b) ligand (R)-22 with Pd(CH3CN)4(BF4)2 after 1 day c) ligand 
(R)-22 with Pd(CH3CN)4(BF4)2 after 31 days d) ligand (R)-22 with Pd(CH3CN)4(BF4)2 after 49 days all in 
CD2Cl2/CD3CN (3:1). 
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Nevertheless, comparing the spectrum of the free ligand (Figure 5.6a) with the spectra of 
the complexes (Figure 5.6b, c and d) no free ligand is present in the spectra of the com-
plexated ligand 22. All peaks are shifted indicating the formation of a new species. From 
the 1H-NMR-spectra it is not possible to conclude whether the M2L4-cage has been formed 
or not.  
Diffusion-ordered spectroscopy (DOSY) was attempted in order to assess the size of the 
formed complex in solution. Unfortunately, it was not possible to obtain a DOSY-spectrum 
from which it was possible to derive the hydrodynamic radius. We therefore hoped to ob-
tain more information from the mass spectra. 
After ca. three weeks after the complexation, mass spectra were recorded in the mass spec-
trum showing the presence of large amounts of ligand and smaller, unidentified peaks. 
However, a small peak corresponding to the 2:4:1-complex was also present. After about 
one month of alternate stirring at RT and resting at 5°C of the same solution, another mass 
spectrum was recorded, which contained significant amounts of the desired 2:4-complex at 
727.2, 1100.2 and 1134.3 m/z (Figure 5.7). 
 
Figure 5.7 ESI mass spectrum (positive mode) of ligand (R)-22 in CH2Cl2/CH3CN (3:1) at RT 49 days after 
mixing. The notation corresponds to Metal:Ligand:Anion. 
Although quite large amounts of free ligand are present, the base peak is the 727.2 m/z-
peak corresponding to the desired 2:4:13+-complex. Furthermore, small peaks correspond-
ing to half the M2L4-cage have been identified at 523.1 m/z and peaks attributed to 
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M2L5-complexes were seen at 883.9 and 1369.8 m/z. The latter are most likely a result of 
non-specific aggregates. The presence of the M1L2-complex is probably due to fragmenta-
tion of the M2L4-complex in the mass spectrometer. However, quite a large peak originat-
ing from the free ligand was present, indicating that the complexation had not been com-
pleted. 
We therefore decided to investigate the effect of time on the complexation. To do so, an 
ESI mass spectrum of the complex five months after mixing in the same solvents (Figure 
5.8) was recorded. Here significantly less of the free ligand was present and instead the 
largest peak in the spectrum was the one corresponding to the 2:4:13+-complex. When in-
vestigating the complex mixture more closely, it was discovered that a layer of gel had 
formed at the bottom of the solution. It is possible that a fraction of the ligands has pol-
ymerized over time, leaving the M2L4 in solution but at a very low concentration. It is 
therefore not possible to estimate the concentration of the solution. However, this would 
explain why only solvent peaks were visible in the 1H-NMR-spectrum (spectrum not 
shown).  
We therefore focused on investigating the complex in CD3CN, which had also produced 
promising 1H-NMR-spectra (Figure 5.9b). Additional heating produced the spectrum in 
Figure 5.9c. The change from spectrum b to c is pronounced, with one set of signals de-
 
Figure 5.8 ESI mass spectrum (positive mode) of ligand (R)-22 in CH2Cl2/CH3CN (3:1) at RT five months 
after mixing. The notation corresponds to Metal:Ligand:Anion. 
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creasing and another increasing. It was not possible to assign the protons, even for the well 
resoluted peaks. Also the integrals do not match the expected number of eleven protons, 
which could be due to the low signal-to-noise ratio. Again, all signals had shifted com-
pared to the free ligand (Figure 5.9), so it is very likely that one or more complexes have 
formed. However, it was not possible to determine the identity of these complexes using 
only 1H-NMR. 
Therefore, a mass spectrum of ligand (R)-22 in CH3CN which has been heated for seven 
hours at 65°C after 10 days was recorded. The resulting spectrum is shown in Figure 5.10. 
 
Figure 5.9 1H-spectrum of a) ligand (R)-22 b) ligand (R)-22 with Pd(CH3CN)4(BF4)2 after 3h at 65°C and 3 
days after mixing c) ligand (R)-22 with Pd(CH3CN)4(BF4)2 after 7h at 65°C and 10 days after mixing all in 
CD3CN. 
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Figure 5.10 ESI mass spectrum (positive mode) of ligand (R)-22 in CH3CN after 7h at 65°C and 10 days 
after mixing. The notation corresponds to Metal:Ligand:Anion. 
The mass spectrum is very similar to the spectrum of the complexation of (R)-22 in 
CH2Cl2/CH3CN (3:1) (See Figure 5.8). We see the base peak at 727.2 m/z corresponding to 
the desired 2:4-complex. Also, a peak corresponding to the free ligand is present in the 
mass spectrum, but since no free ligand is visible in the 1H-NMR-spectrum (Figure 5.9), it 
is most likely a fragment. From the mass spectrum we expect the formation of one major 
complex, the 2:4-complex. Next, we tried to confirm the formation of the complex using 
1H-DOSY-NMR. The resulting spectrum is shown in Figure 5.11. 
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Figure 5.11 1H-DOSY-NMR of ligand (R)-22 with Pd(CH3CN)4(BF4)2 in CD3CN 
At the top of the DOSY-spectrum the 1H-NMR-spectrum is shown on the x-axis, while the 
diffusion coefficient is shown on the y-axis. Peaks with the same diffusion coefficient will 
have cross peaks (marked in blue) along the same horizontal line.  
The DOSY-spectrum in Figure 5.11 clearly shows that two species of different size are 
present in the solution. We observed more than one set of signals in the 1H-NMR-
spectrum, so it is possible, that the solution has not yet equilibrated. Nevertheless, it was 
possible to calculate the hydrodynamic radius of the largest species in the solution. Using 
the Stokes-Einstein equation (Equation 4.1) the hydrodynamic radius was found to be ca. 
25 Å. This compares well to the size measured on the modeled complex (Figure 5.5), 
which was found to be around 22 Å.  
The data strongly suggests the formation of the desired 2:4-complex of ligand (R)-22 in 
both CD2Cl2/CD3CN (3:1) and CD3CN. No free ligand is present in the complex 1H-NMR-
spectra, and the base peak of the mass spectra originates from the 2:4:1-peak. Also, the 
hydrodynamic radius could be calculated from the DOSY-spectrum of the solution in 
CD3CN and was in the expected range. However, we also see indications of a second spe-
cies in the spectra, which may be due to unfinished equilibration of the complex mixture. It 
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would therefore be interesting to stir and/or heat the complex mixture for a longer period 
of time recording 1H-NMR-spectra after each interval. Moreover, investigation of the pre-
cipitate could contribute with valuable information about the complexation event.   
It has not been possible to form distinct complexes using the rac-22 in CD2Cl2/CD3CN 
(3:1) and CD3CN. Testing this racemic ligand in other solvents such as DMF and THF, 
could help work towards exploring possible self-sorting effects.  
Complexation of ligand 12 into M6L12-cage 
Next we focused on the formation of an even larger 
supramolecular complex. Ligand 12 is not only able 
to form rhombs, but also expected to be able to form 
a supramolecular M6L12-cube (See Figure 5.12) simi-
lar to the one synthesized by C. Gütz using a ligand 
derived from BINOL.86 In this case only the enanti-
omerically pure (R)-ligand is used, since Gütz has 
experienced problems when using the racemic lig-
and. Gütz only obtained broad 1H-NMR-spectra 
which showed no sign of formation of one specific 
aggregate when using racemic ligands.86  
The first complexation attempts were performed in 
DMSO, since Gütz had succeeded in forming a similar coordination cube using BINOL 
substituted with ethynylpyridine as the ligand in this solvent. 
Ligand (R)-12 was mixed with Pd(CH3CN)4(BF4)2 in DMSO and heated to 70°C for three 
hours. The resulting 1H-NMR-spectrum is shown in Figure 5.13. All peaks had shifted in 
response to the complexation, so that no free ligand remains. The number of peaks is con-
stant, indicating the formation of only one distinct species. However, all peaks are broad, 
indicating a dynamic behavior. This also made it difficult to assign the protons by H,H-
COSY-NMR with certainty, and as a result the assignment is an assumption. Only the pro-
tons at the pyridine (green and light blue star in Figure 5.13) could be assigned with cer-
tainty due to their intensity. From the 1H-NMR-spectrum it was difficult to determine if the 
desired M6L12-complex has formed. We therefore turned to 1H-DOSY-experiments.   
 
Figure 5.12 Stylized structure of the tar-
get M6L12-complex. Red: Metal. Blue: 
Ligand 
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During the first DOSY-experiment, the delay times of 150, 200 and 250 s were applied 
between the gradient pulses, since these were expected to fit well with the size of the su-
pramolecular cube as well as the viscosity of the solvent. However, the relaxation did not 
reach zero in any of the three measurements and the delay times were therefore increased 
gradually. Surprisingly the relaxation time finally dropped to zero at a delay time of 
1000 s. This suggested, that the formed complex is significantly larger than the 20 Å pre-
dicted from the modeled structure. The resulting DOSY-NMR-spectrum is shown below in 
Figure 5.14.   
 
Figure 5.13 1H-NMR-spectrum of a) ligand (R)-12 in DMSO-d6 b) ligand (R)-12 with Pd(CH3CN)4(BF4)2 in 
DMSO-d6 
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Figure 5.14 1H-DOSY-NMR of ligand (R)-12 with Pd(CH3CN)4(BF4)2 in DMSO-d6. 
The 1H-DOSY-NMR confirms that only one species is present in the solution. By inserting 
the diffusion coefficient of 2.61 • 10-11 [m2 • s-1] into the the Stokes-Einstein equation 
(Equation 4.1), we were able to calculate the hydrodynamic radius to 14 nm or 140 Å. This 
is significantly bigger than expected for the M6L12-cube, rendering the question what had 
formed in the solution. Similar observations have been made earlier by Fujita.87,88 When 
trying to form a M12L24-cage with Pd(II) in DMSO, the 1H-NMR-spectrum only produced 
broad signals and 1H-DOSY-NMR revealed that the complex was much bigger than ex-
pected. Light scattering experiments showed that a vesicle had formed out of the M12L24-
cage mediated by the counterions, and this was confirmed by TEM-measurements. Fujita 
et al. also observed that over days the single nano-cages formed a large vesicle, which was 
still in equilibrium with the single M12L24-cage.87   
The 1H-DOSY-NMR was therefore repeated 24 hours after mixing the complex, however, 
we didn’t observe any difference. The large structure observed built by ligand (R)-12 
seems to form within 24 hours. Still, 140 Å is not enough to form a large vesicle from the 
M6L12-complex. As mass spectroscopy is unsuited for complexes this large, dynamic light 
scattering measurements (DLS) were performed.  
DLS is an alternative method for measuring the hydrodynamic radius of particles in a solu-
tion based on the Brownian motion using the property of particles to scatter light. The in-
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tensity of the scattered light is measured and correlated to the change of intensity over 
time. Large particles will diffuse slower than small and the change in intensity over time 
will be slower, making it possible to correlate the Brownian motion to size. Since it is still 
the hydrodynamic radius that is being measured, the same limitations apply to the meas-
ured size as in the DOSY-experiments. There are three different size distributions correlat-
ed either to the intensity, the volume or the number. Because the intensity of the scattered 
light of large particles is significantly larger than for small particles, it can be necessary to 
convert the intensity-distribution into a volume- or a number-distribution and thereby erad-
icating intensity-effects originating from small amounts of large particles.   
The measurements were performed on the NMR-solutions in the lab of Prof. Dr. Carsten 
Schmuck with the help of Patryciusz Piotrowski. The intensity distribution showed a small 
peak around 2 nm and a very large peak at around 100 nm. Large particles generally result 
in a greater intensity even if they only make up a minority of all particles present. There-
fore, it is advantageous to convert the intensity distribution into volume- or number-
distribution, when several particles of different size are present in the solution. This gives a 
more accurate picture of the ratio of small and large particles in the mixture. When con-
verting the intensity distribution obtained from the measurements only one peak at around 
2 nm was obtained in both the volume- and number-distribution (Figure 5.15). 
 
Figure 5.15 Size distribution by volume from DLS-measurements of ligand (R)-12 with Pd(CH3CN)4(BF4)2 in 
DMSO. 
Several measurements were performed which gave rise to very similar curves as can be 
seen in Figure 5.15. The size, as determined from the volume-distribution, varied from 
2.045 to 2.416 nm and corresponds very well to the size expected for the M6L12-complex. 
However, certain reservations have to be made, since the solution was both colored and 
fluorescent. These two characteristics decrease the quality and reliability of the measure-
ment, and consequently the results are not unambiguous. Nevertheless, it seems unlikely 
that particles around the size of 14 nm are present in solution after performing the DLS-
measurements. Another 1H-DOSY-experiment was performed on a different batch of the 
solution about one month after mixing. Here the hydrodynamic radius was calculated to be 
around 6 nm. It is not apparent how these different size-measurements come about.  
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Performing mass spectroscopy on the complexes turned out to be unfeasible. Since it is not 
possible to properly spray DMSO in the ESI-chamber, the solution was diluted in CH3CN, 
although the complex may behave differently in a different solvent. The mass spectra (not 
shown) did not exhibit any peaks corresponding to the complete sphere. Instead, a base 
peak at 471.2 m/z was recorded, corresponding to the free ligand. Several other, smaller 
peaks were also found in the spectrum, but these could not be identified. Repeated meas-
urements produced the same result. This can partly be explained with the structure of the 
sphere. The cage is not well suited for the mass spectrometer, since evaporation of the sol-
vents from the cavity of the probe during the experiments would cause the sphere to col-
lapse. However, even in this case it would be expected to see fragments from other species 
than the uncomplexed ligand. A possible solution to obtain a spectrum of the whole sphere 
structure could be addition of a guest molecule, which fits into the cavity and would be 
able to stabilize the sphere. Therefore, additional 1H-DOSY-NMR as well as DLS-
measurements of complex solutions after different times of mixing are necessary to con-
firm the formation of the M6L12-sphere.  
Since identification the M6L12-complex in DMSO proved to be rather difficult, we instead 
turned to other solvents such as acetone-d6, CD3CN and CD2Cl2/CD3CN (3:1) hoping for 
clearer results. As seen earlier with the ligand rac-21 in acetone- d6 the 1H-NMR-spectrum 
of the complex of (R)-12 indicated the formation of a polymeric species. Using CD3CN as 
the solvent gave a similar spectrum and both solutions gelated after a few days. Only the 
solvent mixture CD2Cl2/CD3CN (3:1) resulted in a well resoluted spectrum, but the number 
of signals in the complex did not correspond to the number of signals in the free ligand 
(Figure 5.16a and b). It is therefore likely, that there was more than one species in the solu-
tion. Proton assignment was not possible. 
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Figure 5.16 1H-NMR-spectrum of a) ligand (R)-12 in CD2Cl2/CD3CN (3:1) b) ligand (R)-12 with 
Pd(CH3CN)4(BF4)2 in CD2Cl2/CD3CN (3:1) after 6h at 65°C c) ligand (R)-12 with Pd(CH3CN)4(BF4)2 in 
CD2Cl2/CD3CN (3:1) after 9h at 65°C d) ligand (R)-12 with Pd(CH3CN)4(BF4)2 in CD2Cl2/CD3CN (3:1) after 
12h at 65°C. 
A 1H-DOSY-NMR-experiment confirmed the presence of two species of different but sim-
ilar size in the solution. The solution was therefore heated for another three hours, which 
resulted in the increase of intensity of some peaks and decrease of others. Encouraged by 
this, we heated the solution in three hour-intervals, recording a 1H-NMR-spectrum after 
each interval. The result is shown in Figure 5.16c and d.  
It can be seen that further heating changed the intensity relation between the peaks, one set 
becoming larger than the other. The change in shifts from Figure 5.16b to c and d is due to 
changes in the ratio of CD2Cl2 to CD3CN, since the heating causes evaporation of the sol-
vent. After 9 hours of heating, additional heating did not result in any change, and a 1H-
DOSY-experiment was performed after 12 hours of heating. The resulting DOSY-
spectrum still showed the presence of two species, where the peaks at 8.6 and 8.3 ppm 
(Figure 5.16d) each belong to one of the two different species and have an intensity ratio of 
1:1.4. It was not possible to make a calculation of the hydrodynamic radius because the 
solvent is a mixture of solvents and consequently the viscosity is not known. The mass 
spectra of the complex were also recorded by diluting the solution in CH3CN. Again, the 
spectra only resulted in a peak corresponding to the free ligand along with several unidenti-
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fiably peaks, confirming that mass spectrometry may not be the optimal method to investi-
gate the M6L12-spheere.  
DLS-measurements could have been made on the solution; however, the measurements 
would have been ambiguous, because of the presence of two different species of similar 
size in the solution. This makes it difficult to obtain one sharp and defined signal. To ob-
tain only one species in the solution it could be tried to carry out the complexation in the 
microwave at low intensity.  
5.4 Conclusion 
Ligand 22 based on spirobifluorene has been synthesized and its ability to form an 
M2L4-cage has been tested in different solvents, were pure CH3CN turned out to be the 
most promising. The formation of M2L4-cage using ligand (R)-22 was established in 
CH3CN and CH2Cl2/CH3CN (3:1) by mass and 1H-NMR-spectroscopy. Further experi-
ments to obtain better 1H- and DOSY-NMR-spectra are still to be made. However, we are 
optimistic that it is possible to produce the desired spectra and confirm the formation of 
one singular M2L4-species by NMR-spectroscopy. 
We used ligand (R)-12 in complexation experiments in different solvents aiming to pro-
duce an M6L12-sphere. Using 1H-NMR-spectroscopy and DOSY-experiments it was con-
firmed, that only one species had been formed. The size was assessed using both DOSY-
NMR-spectroscopy and DLS-measurements. 
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6 Multicomponent systems 
The use of more than two components in a single complexation event adds complexity to 
the system and challenges the process of self-sorting adding more possibilities to the equi-
librium. However, it also lets us investigate the how self-sorting proceeds when the condi-
tions are more similar to conditions found in nature. 
 
6.1 Background 
The formation of smaller supramolecular 2:2-rhombs (Chapter 4.3.1, Page 31) as well as 
large self-assembled balls and cubes (Chapter 5.3, Page 68) has been presented. However, 
they are all composed of one ligand forming one distinct interaction with one specific met-
al-ion. Nature on the other hand is able to perform a much higher degree of self-sorting 
forming distinct complex structures from numerous different components. The replication 
of DNA is a good example of this ability to assemble a large, complicated molecule with a 
remarkably small margin of error. Such a high degree of accuracy in artificial systems is 
very difficult to achieve, and therefore not many examples of multicomponent self-
assemblies exist.79,89  
In order to achieve a more complex version of self-sorting including the application of dif-
ferent building blocks, it is crucial that the different interactions differ enough from each 
other to ensure effective self-sorting. To ensure the orthogonality of the different binding 
types and to prevent unwanted interactions one can use interactions of different strengths, 
but also steric effects or metals of different binding geometries.  
Schmittel and coworkers succeeded in the formation of a molecular triangle consisting of 
five components: three different ligands and two different metals (Figure 6.1).90  
 
 
Figure 6.1 Synthesis of isoscelic triangle by Schmittel and Mahata.90  
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The methods employed in this case were the HETTAP (heterochiral terpyridine and phe-
nanthroline complex formation)91 and PHENLOCK92 protocols, which are based on steric 
hindrance to prevent unwanted complexation events. The triangle was synthesized in a one 
pot reaction with all three ligands present in CH3CN/CH2Cl2 (3:1) along with the two metal 
ions all in stoichiometric amounts. Reflux of the mixture for three hours resulted in exclu-
sive formation of the triangle in Figure 6.1). Addition of excess amounts of metal-ions still 
resulted in the clean formation of the triangle.  
 
Figure 6.2 Formation of  tris[2]pseudorotaxanes by Stang et al. adadpted from Stang et al.93 
However, it is also possible to achieve selectivity between different recognition events 
using the orthogonality of different binding modes.93,94 Stang and coworkers used the dif-
ference in strength between directional Pt-bonds and non-directional binding of ammoni-
um-ions by crown-ethers to form two different tris[2]pseudorotaxanes (Figure 6.2).93 An-
other approach is to use the different coordination geometries and the soft and hard nature 
of different metals. Employing Cu(I) and Zn(II), Lehn et al. were able to form a heterome-
tallic grid together with ligand LH with incorporated soft and hard metal-binding sites 
(Figure 6.3).95  
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6.2 Synthesis of the ligands  
As shown above there are many ways to achieve self-sorting in multicomponent systems. 
We decided to use the approach of Lehn et al.95 incorporating soft and hard metal-binding 
sites into the ligand. However, we aimed at forming a larger structure, more exactly a su-
pramolecular cage in the shape of a trigonal bipyramid. 
Previously, Wang et al succeeded in the synthesis of a supramolecular trigonal bipyramid 
using the ligand shown in Figure 6.4.96 The ligand can bind a hard oxophilic and a soft 
nitrophilic metal at either end. Using Al(III), the first complexation is carried out and re-
sults in the formation of a tripodal complex which can be further reacted with ZnBr2 or 
Pd(en)(NO3)2 resulting in a trigonal bipyramidal and a capped octahedral complex respec-
tively as shown in Figure 6.4.  
 
Figure 6.3 Synthesis of heterometallic grid by Lehn et al. adapted from Lehn et al.95 
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Figure 6.4 Synthesis of heterometallic trigonal bipyramid and capped octahedron by Wang et al. 
Both complexes can be chiral due to the octahedral coordination geometry of Al(III).97 The 
tripodal aluminum-complex forms both the fac- and the mer-isomers in solution, but when 
ZnBr2 is added, the homochiral trigonal bipyramid is formed with all aluminum-centers 
either in the Λ – or the Δ-configuration. The capped octahedron resulting from reaction of 
the tripodal Al-complex with Pd(en)(NO3)2 consists of 38 components: 24 ligands, 8 
Al(III)-ions and 6 Pd(II) ions. This large complex is also chiral since all eight Al(III)-ions 
are either in the Λ- or the Δ-configuration.96 
Inspired by the work of Wang et al. a ligand was developed in order to produce a hetero-
nuclear trigonal bipyramid-complex with a larger ligand than used previously in order to 
test the possibility of employing a chiral ligand. As the soft metal binding site 4-pyridine 
was used while the hard metal binding site was to be catechol. These two sites are engi-
neered to bind Pd(II) and Ti(IV) respectively, with high selectivity.  
The target molecule 34 is shown in Scheme 6.1 along with the retrosynthesis. We decided 
to use 1,4-diethynylbenzene as the central building block and substitute it with the iodo-
derivatives of pyridine and catechol.    
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Scheme 6.1 Retrosynthesis of ligand 34  
The 4-iodopyridine was tested again in this Sonogashira-reaction, since it is more reactive 
than the bromo-derivative. Even if the 4-iodopyridine decomposes to a certain extent, the 
higher reactivity could still lead to product formation. 
4-iodopyridine is commercially available; however the price makes it feasible to synthesize 
the molecule. Two different methods were tested starting with the halogen exchange of the 
HCl-salt of 4-chloropyridine seen on the right in Scheme 6.2. The method was adapted 
from Wolf et al.98 Refluxing the starting material with NaI over night gave the impure 
product 22 in a 34% yield. The low yield combined with low purity prompted the search 
for a different method. A variation of the Sandmeyer-reaction, which can be seen on the 
left of Scheme 6.2, was chosen as an alternative.99  
 
Scheme 6.2 Synthesis of 4-Iodopyridine (23) 
The yield increased to 42% and after sublimation of the crude product, pure 23 was ob-
tained as a white powder. However, 23 is both sensitive to both light and heat, and even 
stored at -18°C in the dark it slowly decomposed into a brown solid. It is therefore im-
portant to use 4-iodopyridine 23 shortly after its synthesis.  
The catechol synthesis was performed after a protocol by U. Kiehne and is described in 
Scheme 6.3.100  
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Scheme 6.3 Synthesis of 2,3-bis(methoxymethyl)-1-iodobenzene (25) 
The hydroxyl groups are protected with methoxymethyl ether-groups (MOM) for several 
reasons. Firstly, addition of the protecting groups increases the solubility of the molecule 
in organic solvents. Secondly, the MOM-groups direct the ortho-metallation much better 
than a hydroxyl-group. Deprotection of the MOM-groups is performed with acid. Using 
NaH as a base, the hydroxyl groups of the catechol were deprotonated and methoxymethyl 
chloride was added resulting in 24 in an excellent yield of 96%. Substance 24 was then 
subjected to ortho-lithiation with n-butyllithium followed by addition of iodide resulting in 
25. First the ortho-lithiation only produced 25 in yields ranging from 10% to 40%. A clos-
er examination of the byproduct revealed that significant amounts of unreacted starting 
material still remained in the reaction. Since incomplete ortho-lithiation had taken place, 
the amount of n-BuLi added was increased from 1.1 to 1.3 equivalents, resulting in a yield 
of 72%. 
The central building block of the ligand is synthesized starting from 1,4-iodobenzene in a 
Sonogashira-coupling Scheme 6.4).67 Using TMS-acetylene as described previously, 
(Chapter 4.2) the doubly TMS-protected 1,4-diethynylbenzene 26a was obtained in a yield 
of 91%. It was attempetd to partially deprotect 26a, thereby obtaining a building block, 
which could be asymmetrically substituted. However, deprotection with tet-
ra-n-butylammonium fluoride (TBAF) resulted in 27 without any traces of the mono-
protected product. Instead, triisopropylsilyl-group (TIPS) was used to synthesize 26b, 
since triisopropylsilyl is more stable towards deprotection than trimethylsilyl. The synthe-
sis was performed analogous to the synthesis of 26a and gave 26b in a quantitative yield. 
The deprotection with TBAF in THF, however, did not result in the desired mono-
protected product; instead no deprotection was observed at all 
Still it was hoped that it would be possible to perform a single Sonogashira-reaction on 27 
resulting in 28 as shown in Scheme 6.5. 
 
Scheme 6.4 Synthesis of central building block 27. 26a: X = TMS, 26b: X = TIPS 
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Scheme 6.5 Synthesis of the mono-substituted building block 28 
Even though only 0.8 equivalents of 25 were added, only the doubly substituted product 
was obtained along with the starting material. After several attempts this approach was 
abandoned in favor of a synthesis based on the (3-
cyanopropyl)diisopropylsilyl-protecting group (CPDIPS-group), 
introduced by Höger and Bonrad.101 CPDIPS-acetylene (Figure 
6.5) can be readily synthesized from (3-
cyanopropyl)diisopropylsilyl-chloride via a Grignard-reaction. 
The CPDIPS-protecting group distinguishes itself from the 
TMS- and the TIPS-group in that it is somewhat more stable and more polar. Höger et al. 
used CPDIPS-acetylene and TMS-acetylene in a stepwise Sonogashira-reaction to obtain a 
hetero-functionalized product.102 Having two different protecting groups makes it possible 
to deprotect selectively. It is also possible to perform this kind of reaction using TMS- and 
TIPS-acetylene. However, since the two protecting groups have very similar polarity, it is 
almost impossible to separate the hetero-substituted product from the two homo-substituted 
byproducts. The cyano-group adds enough polarity to the product and byproducts, to easily 
distinguish them by chromatography. Moreover, the difference in stability is greater be-
tween TMS and CPDIPS than between TMS and TIPS.  
The first attempt was carried out using 1,4-diiodobenzene and self-made CPDIPS-
acetylene and resulted in roughly equal amounts of the product 29 and the two byproducts 
30 and 26a (Scheme 6.6, X=I).  
 
Figure 6.5 [(3cyanopropyl) 
diisopropylsilyl]-acetylene 
(CPDIPS-acetylene) 
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Scheme 6.6 Synthesis of 29, 30 and 26a starting from 1,4-diiodobenzene (X=I) or 1-bromo-4-iodobenzene 
(X=Br) 
Even though it was possible to mono-deprotect 30 in a 40% yield, this result was still un-
satisfying considering the extra steps involved in the synthesis The reaction with 1-bromo-
4-iodobenzene was attempted, hoping that the difference in reactivity could help increase 
the yield of the desired unsymmetrical product 29 (Scheme 6.6, X=Br). Indeed, the yield of 
29 improved considerably from 22% to 70%, prompting the further use of 1-bromo-4-
iodobenzene for this reaction. 
Next, 29 and 30 were deprotected to yield the mono-protected diethynylbenzene 31 
(Scheme 6.7). Starting from the hetero-protected 29 the TMS-group can be selectively re-
moved using K2CO3 in methanol and THF. In order to deprotect the mono-substituted 30, 
one takes advantage of the fact, that the CPDIPS-group needs rather harsh conditions to be 
removed. Therefore TBAF in THF/H2O was used according to the method by Höger et 
al.102 The water is added to reduce the reactivity of the TBAF, making it possible to stop 
the reaction when only one of the CPDIPS-groups has been removed.   
29 30
CPDIPS
TMS
CPDIPS
CPDIPS
CPDIPS
31
K2CO3,
MeOH/THF
68%
TBAF
THF/H2O
40%
 
Scheme 6.7 Deprotection of 29 and 30 respectively, yielding 31 
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The yield for deprotection of the hetero-protected diethynylbenzene 29 (68%) is higher 
than for the deprotection of the homo-protected 30 (40%), reflecting the fact that the selec-
tivity is difficult to control during the latter reaction.  
With the mono-protected 31 it was now possible to add two different groups to either end 
of the ethynyl-ends. To this end we performed a Sonogashira-reaction using the catechol-
derivative 25 resulting in 32 in a yield of 90% (Scheme 6.8). Compound 32 was subse-
quently deprotected with TBAF yielding 28 in a good yield of 89%. 
Another Sonogashira-reaction with 4-iodopyridine 23 resulted in 33, which was verified 
by 1H – and 13C-NMR. The signal originating from the ethynyl-proton had disappeared and 
the signals of the central benzene core shift together and overlap indicating, that the chem-
ical and magnetic environment of the two seemingly different benzene protons has become 
very similar. This was surprising, since we had previously encountered problems perform-
ing Sonogashira-reactions with 4-iodopyridine and spirobifluorene (Chapter 4.2). Howev-
er, the product could not be found by mass-spectrometry. ESI-MS spectra only showed 
peaks originating from 4-iodopyridine and the starting material 28. Nevertheless, an at-
tempt was made to remove the MOM-groups with HCl in ether to produce ligand 34. Most 
likely, the coupling reaction did not work and instead obtained the deprotonated ligand 28, 
and the salt of iodopyridine 23.  
 
Scheme 6.8 Synthesis of MOM-protected ligand 33 
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Scheme 6.9 Attempted deprotection of 33 
The 1H-NMR-spectrum of the crude product revealed the presence of the MOM-groups, 
and the pyridine protons seemed to have disappeared. The deprotection did not seem to 
have worked, and in addition compound 33 seemed to have disintegrated. Taking the re-
sults from the ESI-MS measurements into account, it is possible that the product 33 was 
never formed.   
Deprotection of 28 into 35 was also attempted, since 35 could also be used as a ligand in 
complexation studies. The free ethynyl can be deprotonated and cis-directing Pt(II) can be 
complexated, which induces a defined angle into the complex. The catechol-unit was to be 
complexated to Ti(IV) in the same fashion as ligand 34. According to modeling studies the 
ligand would be suitable forming a trigonal bipyramid with Pt(dppp) and Ti(IV) (Figure 
6.6). 
 
Figure 6.6 Energy minimized structure of heterometallic complex of ligand 35 
However, deprotection of 28 to 35 with HCl also showed to be troublesome as shown in 
Scheme 6.10. 
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Scheme 6.10 Deprotection of 28 
The ligand 35 was isolated but 1H-NMR-spectroscopy indicated that it still contained im-
purities. However, the low solubility of 35 made purification by column chromatography 
very difficult and it was not possible to isolate the ligand in sufficient purity for the com-
plexation-experiments. Instead, we decided to perform the deprotection after the initial 
complexation of ligand 27 with Pt(dppp)Cl2 as described in chapter 0. 
All in all, the synthetic efforts towards synthesizing ligand 34 did 
not compare with the outcome, so instead we decided to look at a 
smaller molecule, which was expected to be easier to synthesize. 
Ligand 39 (Figure 6.7) was chosen because we already had synthe-
sized one of the building blocks (25), while the other (37, Scheme 
6.11) should be easily prepared by a Sonogashira-reaction.  
36 was synthesized from 23 using [Pd(PPh3)4] in Et3N yielding 
4-trimethylsilylethynylpyridine in a yield of 90% (Scheme 6.11). Apparently, the cross-
coupling reaction is not a problem when using trimethylsilylethylene. Deprotection with 
KF and subsequent precipitation of the crude product with HCl resulted in the HCl-salt of 
4-ethynylpyridine. This was done to increase the stability of 37.   
 
 
Scheme 6.11 Synthesis of 4-ethynylpyridine 37 
The following Sonogashira-reaction of 37 and 25 resulted in 38 in 58% yield (Scheme 
6.12). Of 4-Ethynylpyridine 37 two equivalents were added since, in spite of the higher 
stability, it was still light- and heat-sensitive.  
 
Figure 6.7 Ligand 39 
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Scheme 6.12 Synthesis of 38 via Sonogashira-reaction of 25 and 37 
The attempted deprotection of 38 using HCl in ether (Scheme 6.13) did not afford the de-
sired ligand 39 according to the 1H-NMR-spectrum. This prompted the search for an alter-
native method to deprotect MOM-ethers. A method found in a protocol by Sharma et al. 
used the Lewis acid ZrCl4 in dry isopropanol.103  
The reaction was performed under argon and yielded crude ligand 39 which could be puri-
fied by column chromatography in ethanol resulting in a yield of 79%.  
Even though deprotection of the MOM-groups posed several problems, a solution was 
found in form of the method of Sharma et al. and two ligands (28 and 39) were synthesized 
to be used in complexation studies.  
  
 
Scheme 6.13 Deprotection of 38 with HCl in ether and ZrCl4 in isopropanol resulting in 39 
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6.3 Complexation 
Multicomponent self-assembly was attempted with the two ligands 28 and 39, which both 
contain a hard and a soft metal binding site (Figure 6.8).  
 
Figure 6.8 Ligands for multicomponent self-assembly 28 and 39 
To obtain a multicomponent self-assembly we first attempted to use ligand 28 together 
with Pt(dppp) via the ethynyl-functionality of 28. The modeled structure of this complex is 
shown in Figure 6.6. 
This complexation proceeds through several steps. We are using the protected ligand 28, 
since deprotection of 28 was not possible (Chapter 6.2, Page 84). The complexation of the 
protected ligand 28 to the Pt(dppp) could increase the solubility of the complex enough to 
perform the deprotection. The deprotection of the MOM-groups is to be followed by the 
last complexation step including Ti(IV) (Figure 6.9). This method adds an extra step to the 
complexation since the MOM-groups would have to be removed first.   
 
Figure 6.9 Schematic representation of the complexation of ligand 28. Green = Pt(dppp), blue = ligand 28, 
red = Ti(IV). 
The complexation of 28 with Pt(dppp)Cl2 was carried out in a similar fashion to the So-
nogashira-reaction using Et3N and CuI under argon. The reaction was stirred for 48 hours 
and the crude product was purified by column chromatography using neutral ALOX. The 
product was isolated in a yield of 51 %, while the unreacted starting material was recov-
ered. The 1H-NMR-spectrum of the product compared to the free ligand 28 is shown below 
in Figure 6.10. 
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All the aromatic signals have shifted significantly, while the signals of the MOM-ether 
have only shifted slightly, as could be expected. The alkyne-proton is no longer present 
(not shown). Also, the relation of the integrals is consistent with the formation of a 1:2-
complex of Pt(dppp)2+ and ligand 28 into a tweezer-like structure. The protons belonging 
to central phenyl-ring (marked with a red and light blue star respectively) split up in two 
after complexation, due to the change in environment imposed by the Pt(II). Another indi-
cation of the complexation is that the signal of the ethynyl-proton, previously at 3.17 ppm 
has disappeared. An ESI mass sprectroscopy (positive mode) was also recorded and 
showed the presence of [Pt(dppp)282Na]+. Interestingly, all following attempts to synthe-
size more of the complex [Pt(dppp)(28)2] failed. According to the reaction-TLC, the prod-
uct had been formed but column chromatography only produced the Pt(dppp)(OTf)2. The 
column material was extracted with CH2Cl2, because of the good solubility of the product 
in this solvent, but neither 1H-NMR- nor mass spectra of the extract contained any signals 
corresponding to the desired complex. Lack of starting material prevented further attempts 
of purification.  
Nevertheless, the deprotection was performed on the obtained amount of [Pt(dppp)(28)2]  
with ZrCl4 as described earlier (Chapter 6.2). However, an 1H-NMR-spectrum of the crude 
product still showed the presence of the MOM-groups. Even prolonged heating did not 
 
Figure 6.10 1H-NMR-spectrum of a) ligand 27 in CDCl3 b) ligand 28  with Pt(dppp)Cl2 in CDCl3 
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deprotect the hydroxyl-groups. In the future, other methods with other Lewis acids such as 
ZnBr2104 or a heterogeneous catalyst such as silica supported NaHSO4 could be tested.105 
Complexation was also attempted with the second ligand 39 (Figure 6.8). The modeled 
structure of the complex is shown in Figure 6.11. Here, the pyridine can coordinate to the 
square planar Pd(dppp)2+, while the deprotonated hydroxylgroups assemble around the 
octahedral Ti(IV).   
 
Figure 6.11 Energy minimized structure of heterometallic complex of ligand 39 
Ligand 39 was mixed with TiO(acac)2 and Li2CO3 in DMF while heating the solution to 
80°C for 48 hours, which resulted in a dark brown solution. The resulting 1H-NMR-
spectrum is shown in Figure 6.13b. The complex spectrum is compared to a spectrum of 
the free ligand with Li2CO3 (Figure 6.13a). It is important to remember, that the ligands in 
the Ti(39)3-complex can point either up or down and this leaves two possible configura-
tions: All ligands in one direction (fac-diastereomer) or two ligands in one and one in the 
other direction (mer-diastereomer) as shown in Figure 6.12. At least three different sets of 
signals would be expected, one for the fac-diastereomer and two for the mer- diastereomer. 
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Figure 6.12 PM6-modeled structure of the complex of ligand 39 and TiO(acac)2 in the fac- (left) and mer-
conformation (right) 
Indeed, when looking at the 1H-NMR-spectra (Figure 6.13a and b) we see that more than 
one set of peaks is present, however, ten peaks are found in the spectrum, divided into only 
two sets; one with lower and one with a larger intensity. We did expect three sets, but it is 
possible that the two ligands in the mer-isomer pointing in one direction are not magneti-
cally and chemically significantly different from the three ligands in the fac-isomer, result-
ing in the same shifts. 
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We further observe a change in the relative intensities of the peaks depending on the heat-
ing time. The complex-mixtures were heated at 80°C and depending on the duration of the 
heating, the set of peaks initially smaller increases while the set initially larger, decreases 
(Figure 6.13b to d). This process was not reversible. To confirm this, a 1H-DOSY-NMR 
was recorded. 
The 1H-DOSY-experiment shows a slight difference in size between the two sets of sig-
nals. From the diffusion coefficient the hydrodynamic radii are calculated, and for the set, 
with an increasing intensity over time, the diameter is ca. 14.5 Å, while the diameter for 
the other set is ca. 13.5 Å. The difference is not large, but it is consistent for every peak in 
the spectrum. The obtained hydrodynamic diameters are compared to the diameters meas-
ured on the modeled structures (Figure 6.12), which are 13 and 19 Å for the fac- and mer-
isomers respectively. The measured and calculated values for the fac-isomer match very 
well, while the calculated value for the mer-isomer is somewhat smaller than the measured 
value. 
As mentioned earlier, the hydrodynamic radius of a molecule depends on how fast the 
molecule moves through the solvent, and therefore the shape of the molecule can change 
Figure 6.13 1H-NMR-spectrum of a) ligand 39 with Li2CO3 in DMF-d6 b) ligand 39 with Li2CO3 and 
TiO(acac)2 in DMF-d6 after 24h at 80°C c) ligand 39 with Li2CO3 and TiO(acac)2 in DMF-d6 after 48h at 
80°C d)  ligand 39 with Li2CO3 and TiO(acac)2 in DMF-d6 after 72h at 80°C 
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the measurement. While the fac-isomer is relatively globular, this is not the case for the 
mer-isomer, which can have the effect, that it looks smaller in the DOSY-experiment than 
it actually is. This could explain the discrepancy between the calculated and measured val-
ue. 
An ESI negative mass spectrum was also recorded and showed very large amounts of free 
ligand (Figure 6.14). Also, a small peak corresponding to the fragment [Ti(39)2(acac)]- was 
found. Two peaks corresponding to [TiH(39)3]- and [Ti(39)3Li]- were found in the spec-
trum. Since we don’t observe any free ligand in the 1H-NMR-spectrum, it is likely that the 
complex fragments during the measurements. 
 
Figure 6.14 ESI mass spectrum (negative mode) of ligand 39 with TiO(acac)2 in DMF-d6. The notation cor-
responds to Metal:Ligand:Cation. 
The DOSY-experiment strongly indicates that two different species, the fac- and mer-
isomers, are present in the solution. The 1H-NMR-spectra recorded after different heating 
intervals show that one of the two species is thermodynamically more stable than the other. 
By the help of the diffusion constant obtained from the DOSY-experiment, it is likely that 
the mer-isomer is increasingly formed during heating. This can cause difficulties in the 
following complexation with Pd(II) or Pt(II), since the mer-isomer is not able to form the 
desired trigonal bipyramidal complex. This assumption was confirmed when the metal 
salts Pd(dppp)(OTf)2 or Pt(dppp)(OTf)2 were added to the Ti(39)3-complex 24 hours after 
mixing. The metal-salts were dissolved in DMF and added to the solution of Ti(39)3 and 
the complex solution was heated over night. However, in neither case a change in shifts of 
the peaks was observed in 1H-NMR-spectrum compared to the Ti(39)3-complex. It was 
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also attempted to heat the Ti(39)32--complex for only 3 hours, followed by addition of ei-
ther the Pd- or the Pt-corner in DMF-d6. The resultant mixtures were subsequently stirred 
at room temperature over night to avoid isomerization of the fac-isomer into the mer-
isomer. The resultant 1H-NMR-spectrum shows the presence of the Pd- or Pt-corner along 
with only the fac-isomer. However, none of the signals has shifted even the slightest com-
pared to the 1H-NMR-spectrum of the pure Ti(39)32--complex, strongly indicating that no 
complexation steps beyond Ti(39)32- have occurred. The short heating time is probably the 
reason why only the fac-isomer is present, since the mer-isomer only forms upon pro-
longed heating. An ESI mass spectrum (positive mode) of the complex solution showed 
only Pd- and Pt-corner with chloride as the anion along with several unidentified peaks, 
while only one peak at 565.1 m/z was observed for both solutions in the ESI mass spec-
trum (negative mode) corresponding to Ti(39)2(acac)-. Prolonged stirring of the mixtures 
did not result in any changes in neither the 1H-NMR- nor the mass spectrum. We have con-
firmed the formation of the Ti(39)32--complex, and it is therefore difficult to explain, why 
the subsequent complexations with Pd(II) and Pt(II) are not proceeding. The fac/mer-
isomerism can halter complexation, however, it is unlikely that it will prevent it complete-
ly.  
Since the complexation of Pd(II) and Pt(II) with Ti(39)32- had not succeeded, we therefore 
decided to investigate the complexation of free ligand 39 to Pd(II) and Pt(II). Starting the 
complexation with Pd(II) and Pt(II) it should be possible to avoid the formation of different 
isomers and preorganize the ligand for the following complexation with Ti(IV). Therefore 
ligand 39 was complexated with Pt(dppp)(OTf)2 and Pd(dppp)(OTf)2 in the solvents 
CD2Cl2/CD3CN (3:1), acetone-d6 and DMF-d6.  
In DMF-d6, no change in the 1H-NMR-spectra was seen for the mixture of ligand 39 with 
Pd(dppp)(OTf)2 compared to the free ligand even after heating at 60°C. Mass spectra of the 
solution only showed peaks belonging to the Pd(dppp)(OTf)2. Mixing ligand 39 with the 
Pt(dppp)(OTf)2 and heating it to 60°C resulted in the 1H-NMR-spectra shown below 
(Figure 6.15). 
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Figure 6.15 1H-NMR-spectra of a) ligand 39 b) ligand 39 with Pt(dppp)(OTf)2 after 3 days  at RT c) ligand 
39 with Pt(dppp)(OTf)2 after 4h at 60 °C d) ligand 39 with Pt(dppp)(OTf)2 after 3days at 60°C all in 
DMF-d6. 
The signal belonging to the proton 2 of the pyridine (marked with a red star) exhibits 
broadening upon heating (Figure 6.15c). Additional heating beyond 4 hours did not pro-
duce any significant change in the spectrum (Figure 6.15d). Also, the signal did not shift as 
would be expected in the case of a complexation event at the pyridine. After three days of 
heating the DMF-solution was diluted in CH3CN and a mass spectrum was recorded 
(Figure 6.16). The base peak of the spectrum at 853.2 m/z corresponds to the monosubsti-
tuted Pt(dppp)(OTf)2 (1:1-complex). Two other peaks were not identified, but the isotope 
patterns suggest that one Pt-ion is present in the peak at 700.1 m/z while at least two Pt 
ions must constitute the peak at 1379.1 m/z. Fragments containing two Pt(dppp)(OTf)2 but 
no ligand have been observed before. It seemed that the complex has fragmented, facilitat-
ed by the presence of chloride ions. The complexations were performed again with new 
batches of solvents; however, this did not change the spectra. 
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As previously mentioned, the complexation of ligand 39 was also carried out in two other 
solvent mixtures: acetone-d6 and CD2Cl2/CD3CN (3:1). In both cases mixing with the 
Pd(dppp)(OTf)2 resulted in broadening of the signals in the 1H-NMR-spectra belonging to 
the pyridine and the bis(diphenylphosphino)propane. The mass spectra exemplified by the 
one in CH2Cl2/CH3CN (3:1) showed the presence of a peak corresponding to the 
1:1:1(Cl)+-complex as well as peaks belonging to the 1:0:1(Cl)+CH3CN– and the 
2:0:3(Cl)+-complexes (Figure 6.17). Again, only fragments with Cl– were obtained. 
 
Figure 6.16 ESI mass spectrum (positive mode) of ligand 39 with Pt(dppp)(OTf)2 in DMF-d6 after 3 days at 
60° . The notation corresponds to Metal:Ligand:Anion.  
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Using Pt(dppp)(OTf)2 on the other hand resulted in well resolved 1H-NMR-spectra, but the 
number of signals demonstrated that several species containing ligand 39 had been formed 
in both solvents. The 1H-NMR-spectrum of the complexation in CD2Cl2/CD3CN (3:1) is 
shown in Figure 6.18. Stirring at room temperature yielded a spectrum showing more than 
one species and it was hoped that heating could help overcome kinetic barriers to produce 
the desired Pt(dppp)(39)22--complex. Instead, more peaks appeared, suggesting that adding 
more kinetic energy to the complexation process brings about undesired coordination 
events (Figure 6.18b and c).  
 
Figure 6.17 ESI mass spectrum (positive mode) of ligand 39 with Pd(dppp)(OTf)2 in CH2Cl2/CH3CN (3:1) 
after 3h at 60°. The notation corresponds to Metal:Ligand:Cation. 
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The ESI mass spectrum (positive mode) of the solution was recorded and the resultant 
spectrum is shown in Figure 6.19. Here, only the peak at 853.2 m/z can be identified, 
which contains ligand 39. In addition, the peaks at 1231.1, 1379.2, 1495.3, 1531.3 and 
2174.4 m/z were not identified as well as many smaller peaks. All of the peaks mentioned 
above are singly charged and contain more than one Pt-ion according to the isotope pat-
tern. Nevertheless, none of them belong to the expected Pt(dppp)(39)22--complex or its 
fragments. Again, we only see Cl– as the anion, where we would have expected OTf– to be 
the dominant anion.  
In addition, the complexation of Pt(dppp)(OTf)2 with ligand 39 in CD2Cl2/CD3CN (3:1) 
was performed again but was only stirred at room temperature. This could help investigate 
the complex solution of the 1H-NMR-spectrum in Figure 6.18b. However, the ESI mass 
spectrum (positive) did not show any identifiable peaks (spectrum not shown).  
 
 
Figure 6.18 1H-NMR-spectra of a) ligand 39 b) ligand 39 with Pt(dppp)(OTf)2 after 3 days at RT c) ligand 
39 with Pt(dppp)(OTf)2 after 3h at 60°C all in CD2Cl2/CD3CN (3:1) 
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Figure 6.19 ESI mass spectrum (positive mode) of ligand 39 with Pt(dppp)(OTf)2 after 3h at 60°C in 
CD2Cl2/CD3CN (3:1). The notation corresponds to Metal:Ligand:Cation.  
In acetone-d6, without heating, a similar result as in CD2Cl2/CD3CN (3:1) was obtained in 
the 1H-NMR-spectrum (Figure 6.20). The mass spectrum of the acetone solution also 
showed the three peaks corresponding to the 1:1:1(Cl)+-, 1:0:1+CH3CN– and the 
2:0:3(Cl)+-complexes as seen previously (spectrum not shown). This does not correspond 
well with the 1H-NMR-spectra, from which we would expect several species containing 
the ligand 39.  
 
Figure 6.20  1H-NMR-spectra of a) ligand 39 b) ligand 39 with Pt(dppp)(OTf)2 after 3 days at RT both in 
acetone-d6. 
It was possible to confirm the formation of the monosubstituted Pt(dppp)(39)- and 
Pd(dppp)(39)-complex in the mass spectra in acetone and CH2Cl2/CH3CN (3:1), and the  
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Pt(dppp)(39)-complex in DMF. However, the 1H-NMR-spectra suggest that more than one 
species containing ligand 39 is present, so the question remains why we do not see these in 
the mass spectra. An answer to that could be the unidentified peaks at 1495.3, 1379.1 and 
700.1 m/z (Figure 6.16) which display the isotope pattern of the Pt-ion. It is possible that 
the desired complex [Pt(dppp)(39)2]2- fragments during the measurements.  
 
6.4 Conclusion 
The two ligands 28 and 39 have been synthesized and used in complexation experiments 
towards forming a multicomponent supramolecular system. 
The first step in the complexation of 28 resulting in [Pt(dppp)(28)2] has been performed 
and the product has been characterized by 1H-NMR- and mass spectrometry.  
Ligand 39 has been complexated with Pd(dppp)(OTf)2 and Pt(dppp)(OTf)2 resulting in the 
monosubstituted [Pd(dppp)(39)]2- and [Pt(dppp)(39)]2- respectively. The desired complex 
[Pd(dppp)(39)] was not obtained. Testing other solvents such as THF-d8 or CD3CN could 
help obtain the desired complex, which then could be complexes with Ti(IV).  
The ability of ligand 39 to bind to Ti(IV) has been successfully tested in this thesis, and we 
are therefore expect to obtain a supramolecular self-assembled multicomponent trigonal 
bipyramid in the near future. 
  
7 Outlook 
The 2:3-helix with thiophene ligand 10 and Fe(BF4)2•6H2O was not able to undergo spin 
crossover. In order to form a complex able to undergo spin transition, other ligands based 
on bipyridine with 2,4- and 2,5-thiazole as the core could be tested. Also, modification of 
ligand 10 with hexyloxygroups which increase the solubility could help solubilize the 
complex in CH2Cl2/DMSO. Moreover, changing the angle in ligand 10 by using 2,4-
thiophene as the core could change the coordination geometry in the complex with Fe(II) 
and possibly lead to a high spin complex. Investigation of the spin-transition abilities of 
these ligands is a promising approach to obtain a supramolecular spin-crossover metal-
complex. 
We have confirmed that racemic spirobifluorene ligand 12 has a preference towards for-
mation of heterochiral supramolecular rhombs in CD3Cl/CD3CN (3:1), and the next step 
would be to investigate self-sorting effects in different solvents such as acetone, DMF and 
CH3CN using the pseudo-enantiomer ligand 21.  
The catenane from spirobifluorene ligand (R)-15 has been confirmed by crystal structure. 
Since the crystal was obtained from the enantiomerically pure ligand it is not possible to 
determine if any self-sorting is working on the formation of the catenane. The use of the 
pseudo-enantiomer (S)-20 was not able to resolve this, because ligand 20 is not able to 
form a catenane. Instead, the complexation could be carried out with rac-15 and subse-
quently crystallized. Considering that we already know how to crystallize (R)-15, this ap-
proach is very promising.  
Further investigation of the selectivity of the ligands (R)-15 and (S)-20 in different solvents 
could possibly result in the discovery of solvent dependency. The production of crystals 
and the resulting structures are essential for the characterization of the complexes.  
The larger M2L4- and M6L12-aggregates formed from ligand (R)-22 and (R)-12 respectively 
need to be characterized further. New 1H-NMR-spectra of the M2L4-cage should be rec-
orded at higher concentrations along with 1H-DOSY-spectra to assess the size of the 
formed aggregate and fully confirm its formation. Further investigation of the assumed 
M6L12-sphere should be made, to assess the identity of the formed species. In both cases 
getting a crystal structure would be of great importance to the identification of the com-
plexes.  
The aspect of multicomponent self-assembly should be approached, starting with the syn-
thesis of [Pt(dppp)(28)2]. The work-up has to be optimized in order to gain enough starting 
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material for the following deprotection. Also, different deprotection methods should be 
tested, since the use of ZrCl4 in isopropanol did not result in the desired deprotected prod-
uct. When deprotection has been achieved, the complexation with Ti(IV) can be performed 
resulting in a supramolecular heterometallic trigonal pipyramid.   
The complex [Ti(39)3]2- was obtained, however, changing the spraying solvent could help 
gain better mass spectra. Complexation of ligand 39 with the Pd- and Pt-corner resulted in 
[M(dppp)(39)Cl]-- complexes (M = Pt(II) of Pd(II)) exclusively. Complexations in other 
solvents are to be made in order to obtain the desired complex. 
These additional experiments could contribute with valuable information about the rules 
that govern the self-sorting of chiral ligands. Obtaining the trigonal bipyramid using lig-
ands 28 and 39 paves the way to performing multicomponent self-assembly with chiral 
ligands and investigate self-sorting with more than two components present. Modifying 
ligand 10 could help produce a self-assembled supramolecular complex able to undergo 
spin crossover further elucidating how distortion of the ligand field of Fe(II) affects its 
electronic properties. Ultimately, supramolecular spin crossover-complexes could be used 
as switches in computing and memory storage.  
  
8 Conclusion 
During this thesis self-assembly and self-sorting of metallo-supramolecular aggregates 
have been investigated starting with small M2L2-rhombs based on spirobifluorene. To this 
end both the racemic and the enantiomerically pure ligand 12 with pyridine as the recogni-
tion unit was synthesized. Ligand 12 was used in complexation studies with 
Pt(dppp)(OTf)2 and Pd(dppp)(OTf)2 in CD3Cl/CD3CN (3:1) and the formation of the 
rhombs was confirmed by 1H-NMR- and mass spectroscopy. It was confirmed by NMR- 
and mass spectroscopy (using pseudoenantiomer ligand 21) that ligand 12 self-assembles 
preferably in a narcissistic way.  Furthermore, a crystal structure of the homochiral rhomb 
was obtained from the racemic complex mixture confirming the tendency for ligand 12 
towards self-recognition.  
A M2L2-rhomb with a larger internal cavity was formed using the Pd- or Pt-corners togeth-
er with spirobifluorene ligand 15, which has a ethynyl-spacer between the spirobifluorene 
and the pyridine. Ligand 15 was synthesized both racemically and in its enantiomerically 
pure (R)-form. The spectra of the complexes in CD3Cl/CD3CN (3:1)  indicated the for-
mation of a 4:4-catenane in addition to the expected 2:2-rhomb. The formation of the cate-
nane was confirmed by a crystal structure of the catenane from ligand (R)-15. To investi-
gate the selectivity of ligand (R)-15 the pseudo-enantiomer (S)-20 was synthesized and 
complexations of each of the ligands and the mixed ligand were performed in different 
solvents. It was found that the elongation of the linker resulted in loss of selectivity during 
self-assembly of the rhomb.  
Furthermore, the complexations of both ligand 12 and 15 was studied in several other sol-
vents and further experiments could determine if the self-sorting behavior of the spiro-
bifluorene ligands is solvent dependent.  
In order to form a self-assembled multicomponent system with two different metal centers 
ligand 28 with an ethynyl- and a MOM-protected catechol-group and ligand 39 with a pyr-
idine- and a catechol-group were synthesized. Ligand 28 was mixed with Pt(dppp)(OTf)2 
resulting in a well-defined tweezer-like structure. Deprotection of the MOM-groups was 
attempted with the Lewis acid ZrCl4 without success, however it is expected, that testing of 
other deprotection methods will result in the desired product. Ligand 39 was first complex-
ated with Ti(IV) resulting in fac- and mer-isomers of Ti(39)3. The mer-isomer is the ther-
modynamically stable isomer, making the following complexation with Pd(II) or Pt(II) 
difficult. Instead, ligand 39 was complexated with Pd(II) and Pt(II) in different solvents 
and the respective [M(dppp)(39)Cl]--complexes (M = Pt(II) of Pd(II)) were obtained.  
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In order to form a self-assembled supramolecular complex able to undergo spin crossover 
with Fe(II), ligand 10 was synthesized starting from 2,5-diiodothiophene. In spite of the 
problems with the solubility of the ligand, it was possible to form a triple helix with Fe(II) 
in CH2Cl2/CH3CN (3:1). The formation of the complex was confirmed by 1H-NMR-
spectroscopy as well as by mass spectrometry. Testing of the complex abilities to undergo 
spin transition turned out with negative results. However, first steps towards modification 
of the ligand, changing the angle between the metal binding pyridines, have been made and 
future complexation experiments will determine their potential in spin crossover.  
All in all, seven different ligands belonging to three different ligand systems were synthe-
sized in this thesis. Several complexation experiments on the ligand systems have been 
performed on the ligand systems while varying the solvents and the metal-centers and have 
given us valuable knowledge about metallosupramolecular self-assembly. Self-sorting ef-
fects have been investigated thoroughly, steps have been made towards the formation of a 
heterometallic aggregate via multicomponent self-assembly and a first complex of a poten-
tial system for spin crossover has been made. In the future, additional experiments will add 
to the information already obtained in this thesis, and help complete the picture of self-
assembly in supramolecular chemist. 
  
9 Experimentals 
NMR-Spectroscopy: 
1H – and 13C-NMR-spectra were recorded on either an Avance 300 (1H: 300.1 MHz, 
13C: 125.5 MHz), an AM 400 (1H: 400.1 MHz, 13C: 100.6 MHz) or a DMX 500 
(1H: 500.1 MHz, 13C: 125.8 MHz) by Bruker. Chemical shifts (δ) are given relative to the 
1H-signals of undeuterated solvents or the 13C-signals of the undeuterated solvent as inter-
nal standards respectively. The coupling constants (J) are given in Hz. Assignment of the 
1H – and 13C-NMR-spectra are based on H,H-COSY,  C,H-correlated HMQC-spectra and 
HMBC-spectra.  
The evaluation of the spectra was performed using either Top Spin 3.0 by Bruker or Spin 
Works. 
Mass-Spectroscopy: 
The EI-mass spectra were recorded on a MAT 95 XL or a MAT 90 spectrometer by Thermo 
Finnigan. The ESI-mass spectra were recorded either on a micrOTOF-Q-spectrometer or an 
Apex IV FT-ICR-spectrometer both by Bruker.  
Angle of rotation: 
The specific optical rotation was recorded on a Jasco P-1020 Polarimeter using a 10 cm 
cuvette from Jasco. 
CHN-analysis: 
The CHN-analysis was performed on a Vario EL by Hereaus. 
Thin Layer Chromatography:  
The reactions were monitored using TLC by Merck silica gel plates or Aluminum oxide 
plates.  
Column Chromatography: 
Column chromatography was performed by hand using silica gel 60 (0.040-0.063 mm) by 
Merck or ALOX neutral 60A (50-200 μm) by Acros.  
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Syntheses with water or air sensitive substances were performed under argon applying the 
Schlenck technique using dry solvents. The solvents were dried and distilled using standard 
methods and stored under dry argon in an airtight Schlenck flask.  
THF, acetonitrile, diisopropylamine, dichloromethane, diethyl ether and toluene were dried 
according to standard methods.106 Dry DMF and dry isopropanol were purchased at Acros 
or Sigma Aldrich. The solvents used for chromatography (except methanol and ethanol) 
were all distilled before use. 
The following substances, whose synthesis are not described but are mentioned in the the-
sis, were purchased at one of the following companies Alfa Aesar, ABCR, Sigma Aldrich, 
Merck or TCI Europe: 
CPDIPS-Cl, ethynyl magnesiumbromide, 4-pyridineboronic acid pinacol ester, 
3-pyridineboronic acid pinacol ester, K3PO4, 4-brompyridine hydrochloride, n-BuLi, 
B(OMe)3, TMS-acetylene, TIPS-acetylene CuI, Na2SO4, MgSO4, NaHCO3, 
1,4-diiodobenzene, 1-bromo-4-iodobenzene, 2,5-Diiodothiophene,  Tetra-n-
butylammonium fluoride (TBAF), PPh3, KF, ZrCl4. 
Following substances were available in the laboratory of Prof. Dr. Lützen: 
[Pd(dppp)Cl2], [Pd(dppf)Cl2], [PdCl2(PPh3)2], [Pd2(dba)2]·CHCl3, [Pd(PPh3)4], dppf.  
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9.1 Synthesis  
The following molecules were synthesized according to protocols known from the lit-
erature:  
Ditriflate(1,3-bis(diphenylphosphino)propane)palladium44, Dichloro(1,3-bis (diphe-
nylphosphino)propane)platinum44, bis(triphenylphosphine)palladium(II)dichloride44 and 
((3-cyanopropyl)dimethylsilyl)acetylene102. 
9.1.1 Ligands for spin crossover 
The following molecules were synthesized according to protocols known from the lit-
erature:  
2-bromothiazole (1)36,107, 2,5-dibromo-1,3-thiazole (2)36,108, 2-iodothiazole (3)36,109, 2,4-
dibromo-1,3-thiazole (4)36,108, 4-iodo-2-aminopyridine (5)37–39, 2-bromo-4-iodopyridine 
(6)37–39, 2-brom-4-(trimethylsilylethynyl)pyridine (7)34, 5-carboxymethyl-5'-
[(trimethylsilyl)ethynyl]-2,2'-bipyridine (8)34, 5-carboxymethyl-5'-ethynyl-2,2'-bipyridine 
(9)34,  
 
Synthesis of 2,5-bis(5-ethynyl-5'-carboxymethyl-2,2'-bipyridyl)-thiophene (10) 
2,5-Diiodothiophene (64 mg, 0.191 mmol), 9 (82 mg, 
0.366 mmol), CuI (5 mg, 0.026 mmol), and Pd(PPh3)4 
(9 mg, 0.008 mg) were added to a dry Schlenck flask and 
the flask was evacuated. Next, dry THF (10 mL) and dry 
Et3N (12 mL) was added and the reaction was heated to 
35°C for 120 h. 
The solution was cooled to room temperature and the re-
sulting yellow precipitate was filtered off and washed with 
CH2Cl2. The crude product was purified by refluxing it in 
THF and filtering it off while warm resulting in a yellow 
solid.  
Yield: 68 mg (67%)  
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1H-NMR (400 MHz, CF3COOD): δ 9.68-9.67 (m, 1 H, H-14), 9.17-9.15 (m, 2 H, H17 and 
H-7), 8.75-8,69 (m, 3 H, H-10 and H-11 and H-16), 7.59 (s, 1 H, H-3), 4.53 (s, 3H, H-19)* 
*Assignment not unambiguous 
Due to low solubility it was not possible to obtain a 13C-NMR-spectrum. 
EI-MS: m/z (556.1 [M]+•)   
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9.1.2 Spirobifluorene ligands 
The following molecules were synthesized according to protocols known from the lit-
erature:  
(R)-bis(trifluoromethylsulfoxyl)-9,9'-spirobifluorene ((R)-11)59, (S)-bis (trifluoromethyl-
sulfoxyl)-9,9'-spirobifluorene ((S)-11)59, (R)-2,2'-bis(trimethylsilylethynyl)-9,9'-
spirobifluoren (R)-1359, rac-2,2'-diethynyl-9,9'-spirobifluoren (rac-14)59, (R)-2,2'-
diethynyl-9,9'-spirobifluoren ((R)-14)59, rac-2,2'-dimethyl-9,9'-spirobifluorene (rac-16)59, 
(R)-2,2'-dimethyl-9,9'-spirobifluoren ((R)-16)59, (S)-2,2'-dimethyl-9,9'-spirobifluoren ((S)-
16)59, (R)-2,2'-dibromo-7,7'-dimethyl-9,9'-spirobifluorene ((R)-17)59, (S)-2,2'-dibromo-7,7'-
dimethyl-9,9'-spirobifluorene ((S)-17)59. 
Crystal structures were obtained of spirobifluorenes (R)-11 from rac-11 and (S)-14 from 
rac-14.  
Crystal data for (R)-11: 
 
Empirical formula:   C27 H14 F6 O6 S2          
Molecular weight:   612.50 g/mol  
Space group:    Monoclinic, P 21/c  
Unit cell dimensions:   a = 9.2475(2) Å  α = 90 deg.  
b = 22.9592(7) Å  β = 113.555(2) deg.  
c = 13.1192(4) Å  γ = 90 deg. 
Volume:    2553.32(13) Å3  
Absorption coefficient:  0.296 mm-1  
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F(000):    1240 
Crystal Size:    0.18 x 0.08 x 0.06 mm          
Θ-range for data collection:  1.91 to 28.00 deg.          
Limiting Indices:   -12<=h<=12, -30<=k<=30, -17<=l<=17          
Reflexions collected:   43760  
Unique reflexions:   6149 [R(int) = 0.0790] 
Completeness to theta:  28.00  99.9 %          
Absorption correction:  Semi-empirical  
Max. and min. Transmission:  0.9825 and 0.9487 
Refinement method:   Full-matrix least-squares on F^2           
Data/Restraints/Parameters:  6149 / 1 / 370 
Goodness-of-fit on F2:  0.898   
Final R indices [I>2sigma(I)]:  R1 = 0.0385, wR2 = 0.0815          
R indices (all data):   R1 = 0.0855, wR2 = 0.0940          
Largest diff. peak and hole:  0.266 and -0.421 e×A-3  
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Crystal data for (S)-14: 
 
Empirical formula:   C29 H16          
Molecular weight:   364.42 g/mol  
Space group:    Orthorhombic, Pbna          
Unit cell dimensions:   a = 7.9400(3) Å  α = 90 deg.  
b = 15.5848(4) Å  β = 90 deg.  
c = 15.8501(6) Å  γ = 90 deg. 
Volume:    1961.34(12) Å3  
Absorption coefficient:  0.070 mm-1  
F(000):    760 
Crystal Size:    0.38 x 0.26 x 0.20 mm          
Θ-range for data collection:  2.57 to 28.00 deg.          
Limiting Indices:   -10<=h<=10, -18<=k<=20, -20<=l<=20         
Reflexions collected:   27874 
Unique reflexions:   2374 [R(int) = 0.0758] 
Completeness to theta:  28.00  100.0 %          
Absorption correction:  Semi-empirical  
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Max. and min. Transmission:  0.9861 and 0.9739 
Refinement method:   Full-matrix least-squares on F^2           
Data/Restraints/Parameters:  2374 / 0 / 132   
Goodness-of-fit on F2:  1.011   
Final R indices [I>2sigma(I)]:  R1 = 0.0455, wR2 = 0.1125          
R indices (all data):   R1 = 0.0715, wR2 = 0.1228 
Largest diff. peak and hole:  0.154 and -0.235 eA-3  
 
Synthesis of substances known from the literature: 
Synthesis of (R)- or (S)-2,2'-Bis(trimethylsilylethynyl)-7,7'-dimethyl-9,9'-
spirobifluorene (18)59 
TMS-acetylene (1.9 mL, 13.7 mmol) was mixed with dry THF (29 mL) 
and cooled to -78°C. A solution of n-BuLi (8.5 mL, 1.6 M in n-Hexane) 
in dry THF (20 mL) was added dropwise. Subsequently B(OMe)3 
(1.54 mL, 2.3 mmol) was dissolved in dry THF (4.75 mL) and added 
drop wise to the TMS-acetylene solution. The reaction was stirred at 
room temperature. Next (R)- or (S)-17 (257 mg, 0.512 mmol) and 
[Pd(PPh3)4] (59 mg, 0.051 mmol) were dissolved in dry toluene (25 mL) 
and 10.25 mL of the TMS-acetylene solution was added. Subsequently 
an  aqueous solution of Na2CO3 (2 M, 1.7 mL) was added to the reac-
tion which was the heated to 110°C and stirred for 48 h after which 
TMS-acetylene solution (13.5 mL, 2.8 mmol) was added. The reaction 
was stirred for 72 h after which TMS-acetylene solution (10 mL, 2,1 mmol) was again 
added. The reaction was stirred for 24 h. 
When finished, the reaction was cooled to room temperature and the organic phase was 
washed twice with H2O and once with brine. Subsequently, the organic phase was dried 
over MgSO4. The solvents were removed in vacuo. The crude product was purified by re-
peated column chromatography on silica gel, first with n-hexane/ethylacetate (5:1) as the 
eluent, secondly with (cyclohexane  (cyclohexane/CH2Cl2 (1:1) as the eluent affording 
the title product as a yellow oil.   
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Yield:  
(R): 92 mg (34%) 
(S): 192 mg (71%) 
Rf: 0.63 (n-hexane/ethylacetate (5:1)) 
1H-NMR (400 MHz, CDCl3): δ 7.72-7.68 (m, 2 H, H-4 and H-6), 7.47 (dd, 1 H, 
J3,4 = 7.9 Hz, J3,1 = 1.4 Hz, H-3), 7.18 (d, 1 H, J5,6 = 7.7 Hz, H-5), 6.79 (d, 1 H, 
J1,3 = 1.4 Hz, H-1), 6.50 (s, 1 H, H-8), 2.20 (s, 3 H, H-17), 0.15 (s, 9 H, H-16)  
EI-MS: m/z (536.2 [M+•]) 
  
Synthesis of (R)- or (S)-2,2'-diethynyl-7,7'-dimethyl-9,9'-spirobifluorene ((R)-19)59 
(R)- or (S)-18 (92 mg, 0.171 mmol) was dissolved in THF and methanol 
(1:1, 20 mL) and K2CO3 (230 mg, 1.6 mmol) was added. The reaction 
was stirred at room temperature for 2 h. When finished the reaction was 
poured onto CH2Cl2 (90 mL) and the organic phase was washed twice 
with H2O and subsequently dried over Na2SO4. The solvents were re-
moved in vacuo.  
The crude product was purified by column chromatography on silica gel 
using n-hexane/ethylacetate (5:1) as the eluent affording the title prod-
uct as a yellow solid.  
Yield:  
(R): 30 mg (45%) 
(S): 25 mg (38%)  
Rf: 0.42 (n-hexane/ethylacetate (5:1)) 
1H-NMR (400 MHz, CDCl3): δ 7.73-7.69 (m, 2 H, H-6 and H-4), 7.51 (dd, 1 H, 
J3,4 = 7.9 Hz, J3,1 = 1.4 Hz, H-3), 7.20 (d, 1 H, J5,6 = 7.8 Hz, H-5), 6.83 (s, 1 H, H-1), 
6.54 (s, 1 H, H-8), 2.97 (s, 1 H, H-15), 2.22 (s, 3 H, H-16)  
13C-NMR (101 MHz, CDCl3): δ 148.8 (C-12), 128.3 (C-10), 142.4 (C-11), 138.6 (C-13), 
138.2 (C-7), 132.0 (C-3), 128.9 (C-5), 127.7 (C-1), 124.7 (C-8), 120.5 (C-2), 120.1 (C-4), 
119.5 (C-6), 83.9 (C-14), 77.1 (C-15), 65.2 (C-9), 21.5 (C-16)  
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Synthesis of the spirobifluorene ligands: 
Synthesis of rac- or (R)-2,2’-di-4-pyridyl-9,9’-spirobifluorene (12) 
Rac- or (R)-11 (151 mg, 0.246 mmol), 4-pyridineboronic 
acid pinacol ester (145 mg, 0.707 mmol), K3PO4 (224 mg, 
1.041 mmol) and [Pd(dppf)Cl2] (12 mg, 0.0147 mmol) 
were added to a flame dried round bottomed flask, which 
was subsequently evacuated. Dry THF (5 mL) was added 
and the reaction was heated to 65°C for 24 h. After the 
reaction was cooled to RT the solvent was removed in 
vacuo and the residue was taken up in CH2Cl2 and H2O and the phases were separated. The 
aqueous phase was extracted with CH2Cl2 and the collected organic phases were washed 
with H2O and brine and subsequently dried over MgSO4. The solvent was removed in vac-
uo. 
The crude product was purified by column chromatography on silica gel using metha-
nol/ethylacetate (1:1) as the eluent. After purification all fractions were dried, dissolved in 
CH2Cl2, and filtered affording the title product as a light brown oil.  
Yield:  
(R): 116 mg (100%) 
rac: 116 mg (100%)  
Rf: 0.79 (methanol/ethylacetate (1:1)) 
1H-NMR (400 MHz, CDCl3): δ 8.51 (dd, 4 H, J16,15A = 4.6 Hz, J16,15B = 1.6 Hz, H-16), 
7.97 (d, 2 H, J4,3 = 7.9 Hz, H-4), 7.91 (d, 2 H, J5,6 = 7.6 Hz, H-5), 7.69 (dd, 2 H, 
J3,4 = 7.9 Hz, J3,1 = 1.6 Hz, H-3), 7.42 (ddd, 2 H, J6,5 = 7.6 Hz, J6,7 = 7.5 Hz, J6,8 = 1 Hz, 
H-6), 7.33 (dd, 4 H, J15,16A = 4.6 Hz, J15,16B = 1.6 Hz, H-15), 7.16 (ddd, 2 H, J7,6 = 7.5 Hz, 
J7,8 = 7.6 Hz, J7,5 = 1 Hz, H-7), 7.02 (d, 2 H, J1,3 = 1.6 Hz, H-1), 6.78 (d, 2 H,  
J8,7 = 7.6 Hz, H-8) 
13C-NMR (100 MHz, CDCl3): δ 150.0 (C-16), 149.4 (C-10), 148.8 (C-12), 147.8 (C-14), 
142.8 (C-11), 140.8 (C-13), 137.7 (C-2), 128.5 (C-7), 128.1 (C-6), 127.0 (C-3), 
124.1 (C-8), 122.4 (C-1), 121.5 (C-15), 120.7 (C-4), 120.4 (C-5), 66.0 (C-9) 
ESI-MS(+): m/z (471.2 [M+H]+) 
HR-ESI:  Calculated for C35H22N2 : 471.1861 
    Found:  471.1856 
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CHN-analysis: C35H22N2·1Methanol·2/3Cyclohexane 
  Calculated [%]: C 85.74; H 5.33; N 5.36 
Measured [%]: C 85.99; H 6.13; N 5.01 
Specific rotation:  Ra: [�]��� = + 213 ° mL dm
-1 g-1 (c = 0.56; THF) 
 
Synthesis of rac- or (R)-2,2'-bis(4-ethindiylpyridyl)-9,9'-spirobifluorene ((rac)-15) 
Rac- or (R)-14 (96 mg, 0.26 mmol), [Pd2(dba)2]·CHCl3 (11 mg, 
0.010 mmol), dppf (9 mg, 0.16 mmol), and CuI (4 mg, 0.02 mmol) were 
added to a round bottomed flask, which was subsequently evacuated. 
Next, 4-brompyridine hydrochloride (205 mg, 1.05 mmol) was added 
and the flask was shaded from light. Dry THF (7 mL) and dry diiso-
propylamine (1.2 mL) were added and the reaction was heated to 60°C 
overnight.  
The reaction was cooled to room temperature and the reaction mixture 
was quenched with brine and was subsequently filtered. The filter was 
rinsed with CH2Cl2. The phases were separated and the aqueous phase 
was extracted thoroughly with CH2Cl2. The collected organic phases 
were washed with saturated aqueous NaHCO3 and dried over Na2SO4. 
The solvents were removed in vacuo.  
The crude product was purified by column chromatography on silica gel using cyclohex-
ane/ethylaceate (1:1) + 0.5% Et3N  ethylacetate + 0.5% Et3N as the eluent, affording the 
title product as a yellow foam.  
Yield:  
Rac:  129 mg (54%)  
(R): 105 mg (44%)  
Rf: 0.66 (ethylacetate) 
1H-NMR (400 MHz, CDCl3): δ 8.52 (dd, 2 H, J18,17 = 4.6 Hz,  J18,18’ = 1.6 Hz, H-18), 
7.87 (2d, 2 H, J4,3 = 7.9 Hz,  J5,6 = 7.7 Hz, H-4 and H-5), 7.58 (dd, 1 H, J3,4 = 7.9 Hz,  
J3,1 = 1.2 Hz, H-3), 7.41 (ddd, 1 H, J6,5 = 7.6 Hz,  J6,7 = 7.6 Hz,  J6,8 = 0.9 Hz, H-6), 
7.24 (dd, 2 H, J17,18 = 4.6 Hz,  J17,17’ = 1.6 Hz, H-17), 7.17 (ddd, 1 H, J7,8 = 7.6 Hz,  
J7,6 = 7.6 Hz,  J7,5 = 0.9 Hz, H-7), 6.94 (d, 1 H, J1,3 = 1.2 Hz, H-1), 6.76 (d, 1 H,  
J8,7 = 7.6 Hz, H-8). 
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13C-NMR (101 MHz, CDCl3): δ 149.6 (C-18), 148.4 (C-10 or C-12), 148.3 (C-10 or 
C-12), 142.8 (C-19), 140.8 (C-13), 131.9 (C-3), 131.2 (C-16), 128.7 (C-7), 128.2 (C-6), 
127.4 (C-1), 125.3 (C-17), 124.4 (C-8), 121.2 (C-2), 120.5 (C-5), 120.2 (C-4), 94.2 (C-14), 
87.1 (C-15), 65.6 (C-9). 
ESI-MS(+): m/z (519.3 [M+H]+) 
HR-ESI:  calculated for C39H22N2:  518.1783 
             Found:  518.1778 
CHN-analysis: C39H22N2·1/6ethylacetate 
  Calculated [%]: C 89.34; H 4.41; N 5.25 
 Measured [%]:  C 89.40; H 4.68; N 5.45 
Specific rotation:  Ra: [�]��� = + 621 ° • mL dm
-1 g-1 (c = 0.49; THF) 
 
Synthesis of (R) or (S)-2,2'-bis(4-ethindiylpyridyl)-7,7'-dimethyl-9,9'-spirobifluorene 
(20) 
(S)- or (R)-19 (113 mg, 0.288 mmol), 4-bromopyridine hydrochloride 
(344 mg, 1.770 mmol), [Pd2(dba)2]·CHCl3 (16 mg, 0.015 mmol), dppf, 
(20 mg, 0.036 mmol), and CuI (8 mg, 0.042 mmol) were added to a 
round bottomed flask and dissolved in dry THF (8 mL) and dry diiso-
propylamine (1.2 mL). The reaction was heated to 60°C over night and 
shielded from light. When finished the reaction was quenched with 
brine and CH2Cl2. The phases were separated and the aqueous phase 
was extracted thoroughly with CH2Cl2. The collected organic phases 
were washed with saturated aqueous NaHCO3 and dried over Na2SO4. 
The solvents were removed in vacuo.  
The crude product was purified by column chromatography on silica gel 
using n-hexane/ethylacetate (1:1) + 0.5% Et3N as the eluent affording 
the title product as a yellow solid.  
Yield:  
(S): 69 mg (44%) 
(R): 39 mg (25%, impure)  
Rf: 0.18 (n-hexane/ethylacetate (1:1) + 0.5% Et3N) 
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1H-NMR (400 MHz, CDCl3): δ 8.53 (d, 4 H, J18,17 = 4.6 Hz, H-18), 7.82 (dd, 2 H, 
J4,3 = 7.9 Hz, J4,1 = 0.5 Hz, H-4), 7.76 (d, 2 H, J6,5 = 7.8 Hz, H-6), 7.58 (dd, 2 H, 
J3,4 = 7.9 Hz, J3,1 = 1.5 Hz, H-3), 7.27-7.25 (m, 4 H, H-17), 7.23 (d, 2 H, J5,6 = 7.8 Hz, 
H-5), 6.91 (d, 2 H, J1,3 = 1.5 Hz, H-1), 6.65 (s, 2 H, H-8), 2.23 (s, 6 H, H-19) 
13C-NMR (101 MHz, CDCl3): δ 149.2 (C-18), 148.8 (C-12), 148.4 (C-10), 143.0 (C-11),  
139.0 (C-7), 138.1 (C-13), 131.9 (C-3), 131.7 (C-16), 129.1 (C-5), 127.4 (C-1), 
125.4 (C-17), 124.7 (C-8), 120.5 (C-6), 120.3 (C-4), 119.8 (C-2), 94.8 (C-14), 86.8 (C-15), 
65.2 (C-9), 21.5 (C-19)  
ESI-MS(+): m/z (547.2 [M+H] +) 
HR-ESI:  Calculated for C41H27N2:  547.2169 
             Found:  547.2167 
CHN-analysis: C41H26N4·1/6Ethylacetate·1/6H2O·1/3cyHEX·1/3CH2Cl2 
  Calculated [%]: C 85.14; H 5.25; N 4.51 
Measured [%]: C 85.29; H 5.26; N 4.62 
Specific rotation:  Sa: [�]��� = + 505 ° • mL dm
-1 g-1 (c = 0.264; CH2Cl2) 
 
Synthesis of rac-, (R)- or (S)-2,2’-bis(3-pyridyl)-9,9’-spirobifluorene (21) 
Rac-, (R)- or (S)-11 (130 mg, 0.212 mmol), 3-pyridineboronic acid pi-
nacol ester (214 g, 1.044 mmol), K3PO4 (184 mg, 0.866 mol), 
[PdCl2(PPh3)2] (10 mg, 0.014 mmol), and dppf (8 mg, 0.014 mmol) 
were added to a round bottomed flask and evacuated twice. Next, dry 
THF (5 mL) was added and the reaction was heated to 65°C overnight. 
When finished, the reaction mixture was cooled to RT and subsequently 
quenched with a saturated aqueous NaHCO3. The aqueous phase was 
extracted three times with CH2Cl2 and the collected organic phases 
were washed with H2O and brine and dried over MgSO4. The solvents 
were removed in vacuo. 
The crude product was purified by column chromatography on silica gel using cyclohex-
ane/ethylacetate (20:1)+0.5% Et3N as the eluent, affording the title product as a brown 
solid.  
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Yield:  
Rac: 63 mg (63%) 
(R): 108 mg (70%) 
(S): 61 mg (38%)  
Rf: 0.78 (cyclohexane/ethylacetate (20:1)+0.5% Et3N) 
1H-NMR (400 MHz, CDCl3): δ 8.69 (br s, 2 H, H-15), 8.48 (br s, 2 H, H-17), 7.98 (d, 2 H, 
J4,3 = 7.9 Hz, H-4), 7.91 (d, 2 H, J5,6 = 7.9 Hz, H-5), 7.73 (br d, 2 H, J19,18 = 7.8 Hz, H-19), 
7.63 (dd, 2 H, J3,4 = 7.9 Hz, J3,1 = 1.2 Hz, H-3), 7.42 (ddd, 2 H, J6,5 = 7.5 Hz, J6,7 = 7.5 Hz, 
J6,8 = 0.9 Hz, H-6), 7.28 (br s, 2 H, H-18), 7.16 (ddd, 2 H, J7,6 = 7.5 Hz, J7,8 = 7.5 Hz, 
J7,5 = 0.9 Hz, H-7), 6.95 (s, 2 H, H-1), 6.79 (d, 2 H, J8,7 = 7.5 Hz, H-8) 
13C-NMR (101 MHz, CDCl3): δ 149.5 (C-11), 148.7 (C-13), 141.9 (C-10), 141.0 (C-12), 
137.3 (C-14), 134.5 (C-19), 128.3 (C-7), 128.0 (C-6), 127.0 (C-3), 124.1 (C-8), 
122.6 (C-1), 120.7 (C-4), 120.3 (C-5), 66.0 (C-9), C-15, C-17, C-18 could not be found.  
EI-MS: m/z (470.2 [M]+•) 
HR-EI:    calculated for C39H21N2:  469.1710 
             Found:  469.1704 
Specific rotation:  Sa: [�]��� = - 242 ° • mL dm
-1 g-1 (c = 0.15; CH2Cl2) 
   Ra: [�]��� = + 233 ° • mL dm
-1 g-1 (c = 0.253; CH2Cl2) 
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9.1.3 Ligands for multicomponent self-assembly 
The following molecules were synthesized according to protocols known from the lit-
erature:  
4-Iodopyridine (23) from 4-aminopyridine99, 1,2-bis(methoxymethyl)benzene (24)100, 2,3-
bis(methoxymethyl)-1-iodobenzene (25)100, and 4-(trimethylsilyl)ethynylpyridine 
(36)110,111, 
 
Synthesis of substances known from the literature: 
Synthesis of 4-Iodopyridine (23) from 4-chloropyridine98  
NaI was dried at 120°C under vacuum prior to the synthesis.  
4-Chloropyridine·HCl (0.517 g, 3.47 mmol) and NaI (2.173 g, 14.50 mmol) 
were dissolved in dry CH3CN (13 mL) and heated to 75°C, and a color change to 
green was observed. The reaction was stirred for 20h at 75°C. The reaction was 
cooled to room temperature and a solution of 10% K2CO2 and 5% NaHSO3 in water was 
added. The aqueous phase was extracted with ethyl acetate and the collected organic phas-
es were dried over MgSO4.  
The crude product was purified by column chromatography on silica gel using metha-
nol/ethylacetate (1:1) as the eluent, and affording the title product as a brown solid.  
Yield: 240 mg (34 %) 
Rf: 0.63 
1H-NMR (400 MHz, CDCl3): δ 8.24-8.23 (m, 2H, H-2), 7.88-7.87 (m, 2H, H-3) (In 
agreement with literature data99)   
 
Synthesis of 4-ethynylpyridine (37)111 
36 (497 mg, 2.835 mmol) was dissolved in THF (5 mL) and methanol 
(1.5 mL) and KF (205 mg, 3.528 mmol) was added and the reaction was 
stirred at room temperature overnight. When the reaction was finished the 
solvents were carefully removed. The residue was extracted with Et2O and 
the organic phase was treated with HCl (2 M in diethyl ether) until no 
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more precipitate formed. The solid was filtered off and dried affording the title product as a 
a white solid. 
 Yield: 117 mg (30%) 
1H-NMR (400 MHz, DMSO-d6): δ 8.86 (d, 2 H, J1,2 = 5.3 Hz, H-2), 7.96 (d, 4 H, 
J2,1 = 5.3 Hz, H-3), 5.18 (s, 1 H, H-6) (In  agreement with literature data111) 
 
Synthesis of 1,4-bis(trimethylsilylethynyl)benzene (26a)112  
1,4-Diiodobenzene (513 mg, 1.555 mmol), CuI (15 mg, 0.078 
mmol) and PdCl2(PPh3)2 (72 mg, 0.102 mmol) were added to a 
Schlenck flask followed by dry Et3N (17 mL) as the solvent. 
Trimethylsilylacetylene (0.50 mL, 3.023 mmol) was added drop 
wise to the reaction. The reaction was stirred at room tempera-
ture for 24 h followed by removal of solvent in vacuo. The crude product was boiled twice 
in cyclohexane (12 mL) and filtered resulting in a brown solid. The solid was purified by 
column chromatography on silica gel using cyclohexane/ethylacetate (10:1) as the eluent.  
Yield: 383 mg (91%) 
Rf: 0.71 (cyclohexane/ethylacetate (9:1)) 
1H-NMR (300 MHz, CDCl3): δ 7.38 (s, 4 H, H1), 0.24 (s, 18 H, H5) 
13C-NMR (75 MHz, CDCl3): δ 131.9 (C-1), 123.1 (C-2), 104.5 (C-3), 
96.2 (C-4), -0.11 (C 5) (In agreement with literature)112 
EI-MS: m/z (270.1 [M]+•, 255.1 [M-CH3]+•)  
 
Synthesis of 1,4-bis(triisopropylsilylethynyl)benzene (26b) 
1,4-Diiodobenzene (93 mg, 0.612 mmol), CuI (6.9 mg, 
0.036 mmol), and [PdCl2(PPh3)2] (41 mg, 0.059 mmol) 
were added to a Schlenck flask and dry Et3N (7 mL) was 
added. TIPS-acetylene (0.27 mL, 1.211 mmol) was added 
dropwise to the reaction. The reaction was stirred at 50°C 
for 24 h followed by removal of solvent in vacuo.   
The crude product was boiled twice in cyclohexane (5 mL) 
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and filtered yielding an orange oil. 
Yield: 268 mg (100 %) 
Rf: 0.58 (cyHEX/Ethylacetate (9:1)) 
1H-NMR (300 MHz, CDCl3): δ 7.38 (s, 4 H, H-1), 1.12-1.09 (m, 42 H, H-5 and H-6)  
13C-NMR (75 MHz, CDCl3): δ 131.3 (C-1), 122.9 (C-2), 106.2 (C-4), 92.2 (C-3), 
18.2 (C-5), 10.9 (C-6) 
 
Synthesis of 1,4-ethynylbenzene (27)112 
26b (93 mg, 0.344 mmol) was dissolved in THF (4 mL) and TBAF 
(1000 mg, 1.031 mmol) was added. The reaction was run at room 
temperature for 3 h. When finished the solvent was removed in vacuo 
and the crude product was purified by column chromatography on 
silica gel using cyclohexane/ethylacetate (9:1) as the eluent affording the title product as a 
white solid.  
Yield:  28 mg (65%) 
Rf: 0.45 (cyclohexane/ethylacetate (9:1)) 
1H-NMR (300 MHz, CDCl3): δ 7.44 (s, 2 H, H-1), 3.17 (s, 1 H, H-4) 
13C-NMR (75 MHz, CDCl3): δ 131.9 (C-1), 122.5 (C-2), 83.0 (C-3), 79.0 (C-4) (In agree-
ment with literature)112 
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Synthesis of the ligands for multicomponent self-assembly: 
 
Synthesis of 1,4-bis(trimethylsilylethynyl)benzene (26a) 1-((3-
cyanopropyl)dimethylsilyl)ethynyl-4-trimethylsilylethynyl)benzene (29) and 1,4-(bis-
((3-cyanopropyl)dimethylsilyl)ethynyl)-benzene (30) 
Diiodobenzene (999 mg, 4.60 mmol), 
[Pd(PPh3)2Cl2] (60 mg, 0.08 mmol), CuI 
(31 mg, 0.16 mmol), and PPh3 (106 mg, 
0.41 mmol) were added to a dry Schlenck flask 
and were dissolved in dry diisopropylamine 
(5 mL). CPDIPS-acetylene (945 mg, 
4.60 mmol) was added and the reaction was 
run over night at room temperature.  
The next day TMS-acetylene (1.1 mL, 
6.81 mmol) was added and the reaction was 
heated to 50°C for two hours. Next the reaction was cooled to room temperature and 
poured into Et2O (150 mL) and H2O (48 mL). The organic phase was washed with H2O 
(3 × 50 mL) and brine (1 × 50 mL) and was subsequently dried over MgSO4. The solvents 
were removed in vacuo.  
The crude product was purified by column chromatography on silica gel using first cyclo-
hexane/CH2Cl2 (1:1) next cyclohexane/CH2Cl2 (1:2) as the eluent.  
26a: 
Yield: 242 mg (20 %)  
Rf: 0.74 (cyclohexane/CH2Cl2 (1:1)) 
29:  
Yield: 376 mg (22%) 
Rf: 0.44 (cyclohexane/CH2Cl2 (1:1)) 
1H-NMR (400 MHz, CDCl3): δ 7.39 (s, 4 H, H-1 + H-2), 2.42 (t, 2 H, J14,13 = 6.9 Hz, 
H-14), 1.88-1.83 (m, 2 H, H-13), 1.11-1.07 (m, 14 H, H-10 + H-11), 0.85-0.80 (m, 2 H, 
H-12), 0.25 (s, 9 H, H-7) 
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13C-NMR (75 MHz, CDCl3): δ 131.8 (C-2 or C-3), 131.7 (C-2 or C-3), 123.3 (C-1 or 
C-14), 122.9 (C-1 or C-14), 119.7 (C-12), 107.3 (C-5), 104.4 (C-13), 96.4 (C-14), 
91.4 (C-6), 21.2 (C-11), 20.7 (C-10), 18.7 (C-8 or C-8'), 17.9 (C-8 or C-8'), 11.6 (C-7), 
9.5 (C-9), -0.1 (C-15) 
ESI-MS(+): m/z (402.2 [M+Na]+)  
30:  
Yield: 457 mg (20%) 
Rf: 0.21 (cyclohexane/CH2Cl2 (1:1)) 
1H-NMR (400 MHz, CDCl3): δ 7.39 (s, 4 H, H-1), 2.42 (t, 4 H, J9,8 = 6.9 Hz, H-9), 
1.87-1.83 (m, 4 H, H-8), 1.11-1.07 (m, 28 H, H-5 + H-6), 0.85-0.80 (m, 2 H, H-7) 
13C-NMR (75 MHz, CDCl3): δ 131.5 (C-1), 122.7 (C-2), 119.3 (C-10), 106.8 (C-3), 
91.3 (C-4), 20.8 (C-5 or C-8), 20.3 (C-5 or C-8), 17.8 (C-9 or C-6), 17.5 (C-9 or C-6), 
11.3 (C-7) 
ESI-MS(+): m/z (511.3 [M+Na]+)  
 
Synthesis of 1-((3-cyanopropyl)dimethylsilyl)ethynyl-4-trimethylsilylethynyl)benzene 
(29) 
A Schlenck flask was evacuated twice and flushed with 
argon. 1-bromo-4-iodobenzene (216 mg, 0.763 mmol), 
[PdCl2(PPh3)2] (39 mg, 0.055 mmol), CuI (11 mg, 
0.057 mmol), PPh3 (10 mg, 0.038 mmol), and CPDIPS-
acetylene (140 mg, 0.675 mmol) was added. The rea-
gents were dissolved in dry THF (2 mL) and dry diisopropylamine (1 mL) and the reaction 
mixture was stirred at room temperature under Argon for 3 h resulting in a yellow mixture. 
TMS-acetylene (0.16 mL, 1.144 mmol) was added to the reaction mixture resulting in a 
colour change to brown. The reaction mixture was stirred at room temperature under argon 
for 96 h. Subsequently the reaction was poured onto a mixture of Et2O and H2O and the 
phases were separated. The organic phase was washed with H2O (3x) and brine and dried 
over MgSO4. The solvent was removed in vacuo. 
The crude product was purified by column chromatography on silica gel using cyclohex-
ane/CH2Cl2 (1:1) as the eluent. 
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Yield: 180 mg (70%)  
Rf: 0.18 (cyclohexane/CH2Cl2 (1:1)) 
1H-NMR (400 MHz, CDCl3): δ 7.39 (s, 4 H, H-1 + H-2), 2.42 (t, 2 H, J14,13 = 6.9 Hz, 
H-14), 1.88-1.83 (m, 2 H, H-13), 1.11-1.07 (m, 14 H, H-10 + H-11), 0.85-0.80 (m, 2 H, 
H-12), 0.25 (s, 9 H, H7) 
13C-NMR (75 MHz, CDCl3): δ 131.8 (C-2 or C-3), 131.7 (C-2 or C-3), 123.3 (C-1 or 
C-14), 122.9 (C-1 or C-14), 119.7 (C-12), 107.3 (C-5), 104.4 (C-13), 96.4 (C-14), 
91.4 (C-6), 21.2 (C-11), 20.7 (C-10), 18.7 (C-8 or C-8'), 17.9 (C-8 or C-8'), 11.6 (C-7), 
9.5 (C-9), -0.1 (C-15) 
ESI-MS(+): m/z (402.2 [M+Na]+)  
HR-EI:    Calculated for C23H33NSi2: 379.2151 
           Found: 379.2137 
 
Synthesis of 1-(2-((3-cyanopropyl)diisopropyl)-4-ethynylbenzene (31) from 1-((3-
Cyanopropyl)dimethylsilyl)ethynyl-4- trimethylsilylethynyl)benzene (29) 
29 (337 mg, 0.887 mmol) was dissolved in methanol (2 
mL) and THF (2 mL) and K2CO3 (606 mg, 4.384 mmol) 
was added. The reaction was run for 3 h. The reaction 
mixture was poured into Et2O (40 mL) and H2O (40 mL) 
and the phases were separated. The organic phase was 
washed with H2O (3 × 15 mL) and brine (15 mL) and 
dried over MgSO4. The solvent was removed in vacuo resulting in a brown oil. The crude 
product was purified by column chromatography on silica gel using cyclohexane/CH2Cl2 
(2:1) as the eluent. 
Yield: 185 mg (68%) 
Rf: 0.21 (cyclohexane/CH2Cl2 2:1) 
1H-NMR (400 MHz, CDCl3): δ 7.42 (s, 4 H, H-2 + H-3), 3.17 (s, 1 H, H-6), 2.42 (t, 2 H, 
J12,13 = 6.9 Hz, H-13), 1.88-1.83 (m, 2 H, H-12), 1.11-1.06 (m, 14 H, H-9 and H-10), 
0.85 0.81 (m, 2 H, H-11) 
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13C-NMR (75 MHz, CDCl3): δ 132.0 (C-2 or C-3), 131.9 (C-2 or C-3), 123.3 (C-1), 
122.3 (C-4), 119.6 (C-14), 107.1 (C-7), 91.6 (C-8), 83.1 (C-5), 79.0 (C-6), 21.2 (C-13), 
20.7 (C-12), 18.1 (C-10 or C-10') 17.9 (C-10 or C-10'), 11.6 (C-9), 9.5 (C-11) 
 
Synthesis of 1-(2-((3-cyanopropyl)diisopropyl)-4-ethynylbenzene (31) from 1,4-(bis-
((3-cyanopropyl)dimethylsilyl)ethynyl)-benzene (30) 
30 (527 mg, 1.08 mmol) was dissolved in THF (14 mL) and 
H2O (1.4 mL) and cooled to 0°C. TBAF (0.70 mL, 1 M in 
THF, 0.70 mmol) was added and the reaction was stirred at 
room temperature for 3 h. The reaction was quenched with 
H2O and poured into Et2O. The phases were separated and the organic phase was washed 
three times with H2O and once with brine and subsequently dried over MgSO4. The sol-
vents were removed in vacuo. The crude product was purified by column chromatography 
on silica gel using cyclohexane/CH2Cl2 (2:1) as the eluent affording the title product as a 
brown oil.  
Yield: 133 mg (40%) 
Analytical data described above.  
 
Synthesis of 4-(((2',3'-bis(methoxymethoxy)biphenyl-4-yl)ethynyl)diisopropylsilyl)- 
butannitrile (32) 
CuI (6 mg, 0.032 mmol) and [PdCl2(PPh3)2] 
(29 mg, 0.041 mmol) were added to a twice 
evacuated Schlenck-flask. 2,3-bis(methoxy-
methyl)-1-iodobenzene (25) (204 mg, 
0.629 mmol) was dissolved in dry Et3N 
(3 mL) and added to the flask. 
1-(2-((3-cyanopropyl)diisopropyl)-4-ethynyl
benzene (30) (174 mg, 0.565 mmol) was 
dissolved in dry Et3N (5 mL) and added. 
The reaction mixture was heated to 50°C 
under argon overnight. The reaction was cooled to room temperature and poured onto Et2O 
(40 mL) and H2O (10 mL) and the phases were separated. The organic phase was washed 
three times with H2O, once with brine and dried over MgSO4. The solvents were removed 
in vacuo. The crude product was purified by column chromatography on silica gel using 
 
 
9.1 Synthesis 133 
first cyclohexane/ethylacetate (1:1) then CH2Cl2/cyclohexane (10:1) as the eluent affording 
the title product as a brown oil. 
Yield: 257 mg (90%) 
Rf: 0.51 (cyclohexane/Ethylacetate (1:1)) 
1H-NMR (400 MHz, CDCl3): δ 7.45-7.44 (m, 4 H, H-10 and H-11), 7.26-7.16 (m, 2 H, 
H-4 and H-6), 7.03 (dd, 1 H, J5,6 or J5,4  = 7.8 Hz, J5,6 or J5,4  = 8.2 Hz, H-5), 5.28 (s, 2 H, 
H-21), 5.21 (s, 2 H, H-23), 3.66 (s, 3 H, H-22), 3.51 (s, 1 H, H-24), 2.43 (t, 2 H, 
J19,18 = 6.9 Hz, H-19), 1.91-1.83 (m, 2 H, H-18), 1.12-1.08 (m, 14 H, H-15 and H-16), 
0.86-0.81 (m, 2 H, H-17) 
13C-NMR (75 MHz, CDCl3): 150.2 (C-2), 147.7 (C-3), 132.0 (C-10 or C-11), 131.3 (C-10 
or C-11), 126.7 (C-5), 124.3 (C-4), 123.5 (C-9 or C-12), 122.8 (C-9 or C-12), 
119.7 (C-20), 118.4 (C-7), 117.5 (C-6), 107.4 (C-13), 98.8 (C-21), 95.2 (C-23), 95.2 (C-8), 
92.8 (C-14), 88.0 (C-1), 57.5 (C-24), 56.3 (C-22), 21.2 (C-18), 20.7 (C-19), 18.2 (C-16), 
17.9 (C-16'), 11.7 (C-15), 9.6 (C-17) 
ESI-MS(+): m/z (526.2 [M+Na]+, 521.3 [M+NH4]+, 504.2 [M+H]+) 
HR-ESI:  calculated for C30H37NNaO4Si+:  526.2390 
                         Found:  526.2385 
 
Synthesis of 1-((4-ethynylphenyl)ethynyl)-2,3-bis(methoxymethoxy)benzene (28) 
32 (474 mg, 0.942 mmol) was dissolved in THF (10 mL). 
TBAF (1.03 ml, 1.04 mmol, 1 M in THF) was added and the 
reaction was stirred at room temperature for 3 h. The reac-
tion was quenched with H2O and poured onto Et2O. The 
phases were separated and the organic phase was washed 
with H2O (3x) and brine and dried over MgSO4. The sol-
vents were removed in vacuo. The crude product was puri-
fied by column chromatography on silica gel using CH2Cl2/cyclohexane (10:1) as the elu-
ent affording the title product as a brown oil.  
Yield: 269 mg (89%) 
Rf: 0.44 (CH2Cl2/cyclohexane (10:1)) 
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1H-NMR (400 MHz, CDCl3): δ 7.46 (s, 1 H, H-10 and H-11), 7.18-7.14 (m, 2 H, H-4 and 
H-6), 7.10 (dd, 1 H, J6,4 = 1.49 Hz, J6,5 = 7.65 Hz, H-6), 7.15 (dd, 1 H, J4,6 = 1.49 
Hz, J4,5 = 7.65 Hz, H-4), 7.02 (dd, 1 H, J5,6 = J5,4 =  7.65 Hz, H-5), 5.29 (s, 2 H, H-15 or 
H-17), 5.21 (s, 2 H, H-15 or H-17), 3.66 (s, 3 H, H-18), 3.51 (s, 3 H, H-16), 3.17 (s, 1 H, 
H-14) 
13C-NMR (75.47 MHz, CDCl3): δ 150.2 (C-2), 147.7 (C-3), 132.0 (C-10 or C-11), 
131.3 (C-10 or C-11), 126.6 (C-5), 124.2 (C-4), 123.7 (C-9 or C-12), 121.9 (C-9 or C-12), 
118.4 (C-1), 117.5 (C-6), 98.8 (C-21 or C-23), 95.2 (C-21 or C-23), 92.6 (C-8), 87.9 (C-7), 
83.2 (C-13), 78.9 (C-14), 57.4 (C-22 or C-24), 56.2 (C-22 or C-24) 
ESI-MS(+): m/z (345.1 [M+Na]+, 340.2 [M-CH3+Na]+, 323.1 [M+H]+)  
HR-ESI:  calculated for C20H18NaO4+:  345.1103 
                   Found:  345.1096 
CHN-analysis: C20H16O4·2/3THF 
   Calculated [%]: C 73.49; H 6.35 
  Measured [%]: C 73.24; H 6.34 
 
Synthesis of 4-((4-((2,3-bis(methoxymethoxy)phenyl)ethynyl)phenyl)ethynyl)pyridine 
(33) 
28 (482 mg, 1.50 mmol) was added to a dry two-
neck round bottomed flask. Pd2(dba)3·CHCl3 
(54 mg, 0.052 mmol), CuI (16 mg, 0.084 mmol), 
and dppf (47 mg, 0.084 mmol) were added and 
the flask was evacuated. 4-Iodopyridine (342 mg, 
1.668 mmol) was added followed by dry THF 
(75 mL) and dry iPr2NH (25 mL). The reaction 
was heated to 60°C and stirred for 19 h. The reac-
tion was cooled to room temperature and saturated 
aqueous solutions of EDTA and Na2CO3 were 
added until the solution was basic. CH2Cl2, brine 
and H2O was added and the phases were separat-
ed. The aqueous phase was extracted three times with CH2Cl2 and the collected organic 
phases were washed with saturated aqueous NaHCO3 and dried over NaSO4. The solvents 
were removed in vacuo.  
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The crude product was purified by column chromatography on silica gel using first 
CH2Cl2/cyclohexane (10:1) and next CH2Cl2/cyclohexane (20:1) as the eluent affording the 
title product as a dark green solid.  
Yield:  86 mg (70%) 
Rf:  0.11 (CH2Cl2/ cyclohexane (10:1)) 
1H-NMR (400 MHz, CDCl3): δ 8.27 (d, 2 H, J17,16 = 6 Hz, H-17), 7.68 (dd, 2 H, 
J16,17 = 6 Hz, H-16), 7.50-7.49 (m, 4 H, H-10 + H-11), 7.18-7.15 (m, 2 H, H-4 + H-6), 7.02 
(dd, 1 H, H-5), 5.29 (s, 2 H, H-18 or H-20), 5.21 (s, 1 H, H-18 or H-20), 3.66 (s, 3 H, H-19 
or H-21), 3.51 (s, 3 H, H-19 or H-21) 
13C-NMR (100 MHz, CDCl3): δ 150.2 (C-2), 150.1 (C-17), 147.7 (C-3), 133.1 (C-16), 
132.4 (C-10 or C-11), 131.4 (C-10 or C-11), 126.7 (C-5), 124.3 (C-4), 124.2 (C-12), 
121.4 (C-9), 118.3 (C-1), 117.6 (C-6), 105.3 (C-15), 98.8 (C-18 or C-20), 95.2 (C-18 or 
C-20), 92.7 (C-8), 66.7 (C-7), 82.0 (C-13), 75.6 (C-14), 57.5 (C-19 or C-21), 56.2 (C-19 or 
C-21)  
Mass spectra were measured but the product 33 was not found.  
Synthesis of 4-((2,3-bis(methoxymethoxy)phenyl)ethynyl)pyridine (38) 
25 (250 mg, 0.768 mmol), CuI (6 mg, 0.031 mmol), and 
[PdCl2(PPh3)2] (23 mg, 0.032 mmol) were added to a dry round 
bottomed flask which was subsequently shielded from light. 
Next 28 (190 mg, 1.361 mmol) was added followed by dry Et3N 
(5 mL). The reaction was heated to 80°C for 72 h. When fin-
ished, the reaction was cooled to room temperature and CH2Cl2 
was added. The organic phase was washed three times with H2O and dried over MgSO4. 
The solvents were removed in vacuo. 
The crude product was purified via column chromatography on silica gel using ethylacetate 
as the eluent affording the title product as a yellow oil. 
Yield:  133 mg (58%) 
Rf: 0.56 (ethylacetate) 
 1H-NMR (400 MHz, CDCl3): δ 8.60 (dd, 2 H, J11,10 =4.4 Hz, J11,10' =1.6 Hz, H-11), 
7.37 (dd, 2 H, J10,11 = 4.4 Hz, J10,11' = 1.6 Hz, H-10), 7.21-7.19 (m, 1 H, H-6), 7.19-
7.17 (m, 1 H, H-4), 7.04 (dd, 1 H, J5,6 = 7.96 Hz, J5,4 = 7.96 Hz, H-5), 5.28 (s, 2 H, H-14), 
5.21 (s, 2 H, H-12), 3.66 (s, 3 H, H-13), 3.51 (s, 3 H, H-15) 
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 13C-NMR (101 MHz, CDCl3): δ 150.1 (C-1), 149.7 (C-11), 148.0 (C-2), 131.4 (C-9), 
126.7 (C-4), 125.3 (C-10), 124.3 (C-5), 118.1 (C-6), 117.6 (C-3), 98.8 (C-14), 95.2 (C-12), 
90.6 (C-7), 90.3 (C-8), 57.5 (C-13), 56.3 (C-15)   
ESI-MS(+): m/z (300.1 [M+H]+, 256.1 [M-CH3OCH2+H]+) 
HR-ESI:  Calculated for C17H17NaNO4+: 322.1055 
                Found: 322.1049 
 
Synthesis of 3-(Pyridine-4-ylethynyl)benzene-1,2-diol (39) 
38 (113 mg, 0.378 mmol) were added to a dry roundbottomed 
flask and dissolved in dry isopropanol (2 mL). Next, ZrCl4 
(49 mg, 0.210 mmol) was added and the reaction was heated to 
reflux for 2 h. The reaction was cooled to room temperature and 
the solvent was removed in vacuo. The crude product was puri-
fied by column chromatography on silica gel using ethanol as the 
eluent, affording the title product as a brown solid.   
Yield:  73 mg (91%) 
Rf: 0.80 (ethanol) 
1H-NMR (400 MHz, CD3OD): δ 8.54-8.53 (m, 2 H, H-11), 7.65-7.54 (m, 2 H, H-10), 
6.93 (dd, 1 H, J6,5 = 7.7 Hz, J6,4 = 1.3 Hz, H-6), 6.87 (dd, 1 H, J4,5 = 7.7 Hz, J4,6 = 1.3 Hz, 
H-4), 6.72 (dd, 1 H, J5,6 = 7.7 Hz, J5,6 = 7.7 Hz, H-5) 
13C-NMR (100 MHz, CD3OD): δ 150.2 (C-11), 148.7 (C-1), 146.9 (C-2), 134.6 (C-9), 
127.2 (C-10), 125.0 (C-5), 120.9 (C-4), 117.8 (C-3), 110.7 (C-6), 93.0 (C-8), 90.8 (C-7) 
ESI-MS(+): m/z (212.1 [M+H]+) 
HR-ESI:  Calculated for C13H10NO2+: 212.0706 
        Found:  212.0708 
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9.2 Complexations 
The general methods for assembly of the different complexes are described in this chapter. 
For solutions to be measured by NMR-spectroscopy, deuteriated solvents were used.  
9.2.1 Complexes for spin crossover 
The complexation of ligand 10 was carried out in two different solvent mixtures as de-
scribed below.  
[Fe2(10)3](BF4)4 in CD2Cl2/DMSO-d6 (3:1) 
Ligand 10 (11.37 mg, 0.020 mmol), Fe2(BF4)2•6H2O 
(5.22 mg, 0.015 mmol) was mixed in CD2Cl2/DMSO-d6 (3:1, 
1.5 ml) resulting in a yellow suspension which was stirred at 
room temperature over night.  
No NMR-spectra obtained 
 
[Fe2(10)3](BF4)4 in CD2Cl2/CD3CN (3:1) 
Ligand 10 (10.77 mg, 0.029 mmol), Fe2(BF4)2•6H2O 
(4.44 mg, 0.013 mmol) was mixed in CD2Cl2/CD3CN (3:1, 
1.5 mL) resulting in a red suspension which was stirred at room temperature overnight.  
1H-NMR (400 MHz, CD2Cl2/CD3CN (3:1)): δ 8.78-8.73 (m, 3 H)*, 8.36-8.35 (m, 1 H)*, 
7.78-7.61 (m, 2 H)*, 7.40-7.31 (m, 1 H)*, 3.88 (s, 3 H, H-19) 
* Protons could not be assigned unambiguously  
ESI-MS: m/z (445.3 [Fe2103]4+) 
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9.2.2 Complexes with spirobifluorene derivatives 
The complexation of the M2L2-rhombs of ligand 12, 15 and 20 are exemplified by the 
complexation of ligand (R)-12 with Pd(dppp)(OTf)2: 
(R)-12 (4,70 mg, 0.01 mmol) was dissolved in CD2Cl2 (1 mL) and 250 μL were drawn 
from the solution and filled up to 750 μL with CD2Cl2. Pd(dppp)(OTf)2 (9.71 mg, 
0.01 mmol) was dissolved in CD3CN (1 mL) and 250 μL were drawn from the solution and 
added to the diluted solution of (R)-12. The solution was stirred at room temperature for 
24 h.  
[Pd2(dppp)2((R)-12)2](OTf)2 from (R)-12  
1H-NMR (400 MHz, CD2Cl2/CD3CN (3:1)): 
δ 8.40-8.38 (m, 4 H, H-16), 7.89-7.85 (m, 4 H, 
H-4 and H-5), 7.43-7.41 (m, 18 H, H-18 and 
H-6), 7.19-7.08 (m, 26 H, H-7, H-17 and 
H-19), 7.04 (d, 4 H, J3,4 = 6.9 Hz, H-3) 
6.84 (br s, 4 H, H-15), 6.63 (d, 4 H, 
J8,7 = 7.5 Hz, H-8), 6.46 (s, 2 H, H-1), 3.02-2.95 (m, 8 H, H-20), 2.09-2.02 (m, 4 H, H-21).  
ESI-MS: m/z (707.8 [Pd2122OTf]3+; 1136.2 [Pd2122(OTf)2] 2+) 
 
[Pt2(dppp)2((R)-12)2](OTf)2 from (R)-12  
1H-NMR (400 MHz, CD2Cl2/CD3CN (3:1)): δ 8.44 (br s, 4 H, H-16), 7.90-7.86 (m, 4 H, 
H-4 and H-5), 7.49-7.29 (m, 18 H, H-18 and H-6), 7.21-7.10 (m, 26 H, H-7, H-17 and 
H-19), 7.04 (d, 4 H, J3,4 = 7.0 Hz, H-3) 6.88 (br s, 4 H, H-15), 6.65 (d, 4 H, J8,7 = 7.5 Hz, 
H-8), 6.46 (s, 2 H, H-1), 3.12-3.05 (m, 8 H, H-20), 2.14-1.98 (m, 4 H, H-21).  
ESI-MS: m/z (538.4 8 [Pt2122]4+; 767.5 8 [Pt2122OTf]3+; 1225.2 [Pt2122(OTf)2] 2+) 
Crystal Data for [Pt2(dppp)2((R)-12)2](OTf)2 
Empirical formula:   C144 H128 F12 N4 O20 P4 Pd2 S4        
Molecular weight:   2927.42 g/mol  
Space group:    Monoclonic, C 2/c          
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Unit cell dimensions:   a = 18.8830(5) Å  α = 90 deg.  
b = 23.7387(5) Å  β = 101.585 deg.  
c = 35.9013(6) Å  γ = 90 deg. 
Volume:    15765.2(6) Å3  
Absorption coefficient:  0.395 mm-1  
F(000):    6016 
Reflexions collected:   27330 
Unique reflexions:   14210 [R(int) = 0.0193] 
Completeness to theta:  99.4 %          
Restraints/Parameters:  669 / 942   
Goodness-of-fit on F2:  1.061   
Final R indices [I>2sigma(I)]:  R1 = 0.0505, wR2 = 0.1399 
Largest diff. peak and hole:  1.548 and -0.653 eA-3  
 
[Pd2(dppp)2((R)-15)2](OTf)2 from (R)-15 
in CD2Cl2/CD3CN (3:1) 
(R)-15 (5.2 mg, 0.01 mmol) was dissolved 
in CD2Cl2 (1 mL) and 250 μL were taken 
out and filled up to 750 μL. 
Pd(dppp)(OTf)2 (10.1 mg, 0.01 mmol) was dissolved in CD3CN (1 mL) and 250 μL were 
taken out and added to the solution of (R)-15. The solution was stirred at room temperature 
for 24 h.  
1H-NMR (400 MHz, CD2Cl2/CD3CN (3:1)): δ 8.53 (d, 8 H, J18,17 = 5.1 Hz, H-18), 7.88 (d, 
4 H, J5,6 = 7.5 Hz, H-5), 7.84 (d, 4 H, J4,3 = 7.9 Hz, H-4), 7.48-7.43 (m, 8 H, H-20), 
7.39 (dd, 4 H, J6,5 = 7.5 Hz, J6,7 = 7.5 Hz, H-6), 7.33-7.19 (m, 16 H, H-3, H-19 and H-21), 
7.14 (dd, 4 H, J7,6 = 7.5 Hz, J7,8 = 7.5 Hz, H-7), 6.82 (d, 8 H, J17,18 = 5.1 Hz, H-17), 6.69 (s, 
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4 H, H-1), 6.64 (d, 4 H, J8,7 = 7.5 Hz, H-8), 3.07-2.98 (m, 8 H, H-22), 2.18-2.11 (m, 4 H, 
H-23).  
ESI-MS: m/z (1186.2 [Pd2152(OTf)2]2+; 2522.6 [Pd2152(OTf)3]+) 
 
Pd4(dppp)4((R)-15)4](OTf)4 from (R)-15 in CD2Cl2/CD3CN (3:1) 
The complexation was described above, by the complexation of [Pd2(dppp)2((R)-
15)2](OTf)2 from (R)-15 in CD2Cl2/CD3CN (3:1). 
No proper 1H-NMR-data was obtained. 
ESI-MS: m/z (1631.7 [Pd4154(OTf)5]3+; 2522.4 [Pd4154(OTf)6]4+) 
Kristallstruktur: daten fehlen noch 
 
[Pd2(dppp)2((R)-15)2](OTf)2 from (R)-15 in acetone-d6 
(R)-15 (5.2 mg, 0.01 mmol) was dissolved in acetone-d6 (1 mL) and 250 μL were drawn 
from the solution and filled up to 750 μL with acetone-d6. Pd(dppp)(OTf)2 (10.1 mg, 
0.01 mmol) was dissolved in acetone-d6 (1 mL) and 250 μL was drawn from the solution 
and added to the solution of (R)-15. The solution was stirred at room temperature for 24 h.  
1H-NMR (400 MHz, (CD3)2CO): δ 8.82 (d, 8 H, J18,17 = 5.4 Hz, H-18), 8.09-8.07 (m, 
16 H, H-4 and H-5), 7.75-7.70 (m, 4 H, H-21), 7.61 (dd, 4 H, J3,4 = 7.9 Hz, J3,1 = 1.4 Hz, 
H-3), 7.52-7.46 (m, 8 H, H-19 or H-20), 7.41-7.33 (m, 8 H, H-19 or H-20), 7.26 (dd, 4 H, 
J7,6 = 7.5 Hz, J7,8 = 7.5 Hz, H-7), 7.09 (d, 8 H, J17,18 = 5.4 Hz, H-17), 6.79 (d, 4 H, 
J1,3 = 1.4 Hz, H-1), 6.74 (d, 4 H, J8,7 = 7.5 Hz, H-8), 3.60-3.63 (m, 8 H, H-22), 3.35-
3.29 (m, 4 H, H-23). 
 
 
Pd4(dppp)4((R)-15)4](OTf)4 from (R)-15 in acetone-d6 
The complexation is described above, by the complexation of [Pd2(dppp)2((R)-15)2](OTf)2 
from (R)-15 in acetone-d6). 
1H-NMR (400 MHz, (CD3)2CO): δ 8.72-8.70 (m, 16 H, H-18)*, 8.04 (d, 8 H, J = 7.6 Hz), 
7.98 (d, 8 H, J = 8.0 Hz), 8.85 (d, 8 H, J = 8.0 Hz), 7.16 (d, 8 H, J = 5.8 Hz), 7.05-7.02 (m, 
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8 H), 6.68 (s, 8 H), 6.58 (s, 8 H), 5.95 (dd, 8 H, J1 = 7.0 Hz, J2 = 7.0 Hz), 5.62 (dd, 8 H, 
J1 = 4.3 Hz, J2 = 4.3 Hz), 4,80 (dd, 8 H, J1 = 7.5 Hz, J2 = 7.5 Hz). 
* Protons could not be assigned unambiguously. 
ESI-MS: m/z (1631.7 [Pd4154(OTf)5]3+; 2522.4 [Pd4154(OTf)6]4+) 
 
[Pd2(dppp)2((S)-20)2](OTf)2 and 
from (S)-20 in CD2Cl2/CD3CN (3:1) 
(S)-20 (5.46 mg, 0.01 mmol) was dis-
solved in CD2Cl2 (1 mL) and 250 μL 
were drawn from the solution and 
filled up to 750 μL with CD2Cl2. Pd(dppp)(OTf)2 (8.17 mg, 0.01 mmol) was dissolved in 
CD3CN (1 mL) and 250 μL was drawn from the solution and added to the solution of (S)-
20. The solution was stirred at room temperature for 24 h.   
1H-NMR (400 MHz, CD2Cl2/CD3CN (3:1)): δ 8.56-8.55 (d, 8H, J18,17 = 5.5 Hz, H-18), 
7.79-7.74 (m, 8H, H-4 and H-6), 7.49-7.44 (m, 8H, H-20), 7.33-7.27 (m, 8H, H-3 and 
H-5), 7.25-7.20 (m, 12H, H-19 and H-21), 6.82-6.21 (d, 8H,  J17,18 = 5.5 Hz, H-17), 6.68-
6.67 (s, 4H, H-1), 6.47 (s, 4H, H-8), 3.07-3.02 (m, 8H, H-22), 2.85-2.83 (m, 4H, H-23), 
2.16 (s, 6H, H-24). 
 
[Pd2(dppp)2((S)-20)2](OTf)2 from (S)-20 in acetone-d6 
(S)-20 (5.46 mg, 0.01 mmol) was dissolved in acetone-d6 (1 mL) and 250 μL were drawn 
from the solution and filled up to 750 μL with acetone-d6. Pd(dppp)(OTf)2 (8.17 mg, 
0.01 mmol) was dissolved in acetone-d6 (1 mL) and 250 μL were drawn from the solution 
and added to the diluted solution of (S)-20. The solution was stirred at room temperature 
for 24 h.  
1H-NMR (400 MHz, (CD3)2CO): δ 8.82 (d, 8 H, J18,17 = 5.4 Hz, H-18), 8.01 (d, 4 H, 
J4,3 = 7.9 Hz, H-4), 7.95 (d, 4 H, J4,3 = 7.8 Hz, H-5), 7.75-7.70 (m, 16 H, H-20), 7.67 (d, 
4 H, J3,4 = 7.9 Hz, H-3), 7.48-7.31 (m, 24 H, H-19 and H-21), 7.08 (d, 8 H, J18,17 = 5.4 Hz, 
H-17), 6.75 (d, 4 H, J1,3 = 1.3 Hz, H-1), 6.55 (s, 4 H, H-8), 3.34-3.29 (m, 8 H, H-22), 
3.22-3.15 (m, 4 H, H-23), 2.23 (s, 6 H, H-24).  
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The complexation of ligand 21 into M2L4-complexes was carried out in two different sol-
vent mixtures as described below: 
[Pd2((R)-21)4](BF4)2 in CD3CN 
(R)-21 (4.70 mg, 0.01 mmol) and [Pd(CH3CN)4](BF4)2 (2.33 mg, 0.005 mmol) were dis-
solved in CD3CN (1.52 mL) and either stirred at room temperature or heated at 65°C.  
1H-NMR (400 MHz, CD3CN (3:1)): δ 8.21-8.19 (m, 
8 H, H-4), 8.13-8.12 (m, 8 H, H-5), 7.98-7.96 (m, 8 H, 
H-3), 7.93-7.86 (m, 8 H, H-19), 7.56-7.54 (d, 8 H, H-17), 
7.49-7.45 (m, 8 H, H-6), 7.27-7.22 (m, 8 H, H-18), 
7.18-7.10 (m, 8 H, H-7), 6.47-6.47 (m, 8 H, H-8), H-1 
and H-15 could not be found.   
ESI-MS: m/z (523.1 [Pd2214]4+; 727.2 [Pd2214BF4]3+; 1134.2 [Pd2214(BF4)2]2+) 
 
[Pd2((R)-21)4](BF4)4 in CD2Cl2/CD3CN (3:1) 
(R)-21 (4.70 mg, 0.01 mmol) and [Pd(CH3CN)4](BF4)2 (2.33 mg, 0.005 mmol) were dis-
solved in CD3CN (0.52 mL) and CD2Cl2 (1 mL) and either stirred at room temperature or 
heated at 65°C.  
1H-NMR (400 MHz, CD2Cl2/CD3CN (3:1)): δ 8.02-7.80 (m, 32H, H-4, H-5, H-15 and 
H-17),* 7.43-7.37 (m, 8H, H-19),* 7.16-7.09 (m, 16H, H-3 and H-6),* 6.83 (m, 4H, H-1),* 
6.63-6.57 (m, 8H, H-18),* 6.50-6.40 (m, 8H, H-7),* 6.15 (m, 4H, H-1),* 5.90-5.89 (m, 8H, 
H-8).* 
* Protons could not be assigned unambiguously.  
ESI-MS: m/z (523.1 [Pd2214]4+; 727.2 [Pd2214BF4]3+; 1100.2 [Pd2214Cl2]2+; 1134.2 
[Pd2214(BF4)2]2+) 
 
Complexation of ligand (R)-12 into M6L12-complexes was carried out in the different sol-
vent mixtures as described below: 
[Pd6((R)-12)12](BF4)12 in DMSO-d7 
(R)-12 (4.76 mg, 0.01 mmol) and [Pd(CH3CN)4](BF4)2 (2.52 mg, 0.006 mmol) were mixed 
in DMSO-d7 (1.5 mL) and heated for three hours at 65°C.  
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[Pd6((R)-12)12](BF4)12 in CD2Cl2/CD3CN (3:1) 
(R)-12 (4,76 mg, 0.01 mmol) and [Pd(CH3CN)4](BF4)2 (2.52 mg, 0.006 mmol) were mixed 
in CD2Cl2/CD3CN (3:1, 1.5 mL) and heated for 12 h at 65°C.  
9.2.3 Complexes of multicomponent self-organizing ligands 
The complexation of ligand 39 and 28 were performed as described below.  
[Ti(39)3]Li2 
Ligand 39 (5.85 mg, 0.28 mmol), Li2CO3 (8.52 mg, 
0.115 mmol), and TiO(acac)2 (4.80 mg, 0.18 mmol) were mixed 
in DMF-d7 (1.5 mL) and heated over night at 80°C.  
Fac-[Ti393]2- (after 24 h): 
1H-NMR (400 MHz, DMF-d7): δ 8.56 (dd, 2 H, J11,10a = 6.0 Hz, 
J11,10b = 1.5 Hz, H-11a and H-11b), 7.40 (dd, 2 H, J10,11a = 6.0 Hz, J10,11b = 1.5 Hz, H-10a 
and H-10b), 6.62 (dd, 1 H, J2,3 = 7.8 Hz, J2,4 = 1.4 Hz, H-2), 6.44 (dd, 1 H, J3,2 = 7.8 Hz, 
J3,4 = 7.8 Hz, H-3), 6.19 (dd, 1 H, J4,3 = 7.8 Hz, J4,2 = 1.4 Hz, H-4). 
ESI-MS: m/z (565.1 [Ti393C5H8O2]-; 676.1 [Ti393H]-) 
1H-DOSY-NMR: (500 MHz, DMSO-d6, 300 K): 
D [m2 · s-1] = 4.134 · 10-10 
 
Mer-[Ti393]2- (after 24h): 
1H-NMR (400 MHz, DMF-d7): δ 8.52 (dd, 2H, J11,10a = 5.0 Hz, J11,10b = 1.5 Hz, H-11a and 
H-11b), 7.38 (dd, 2H, J10,11a = 5.0 Hz, J10,11b = 1.5 Hz, H-10a and H-10b), 6.51 (dd, 1 H, 
J2,3 = 7.8 Hz, J2,4 = 1.4 Hz, H-2), 6.31 (dd, 1 H, J3,2 = 7.8 Hz, J3,4 = 7.8 Hz, H-3), 6.17 (dd, 
1 H, J4,3 = 7.8 Hz, J4,2 = 1.4 Hz, H-4). 
1H-DOSY-NMR: (500 MHz, DMSO-d6, 300 K): 
D [m2 · s-1] = 3.823 · 10-10 
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[Pt(dppp)(28)2] 
Ligand 28 (29 mg, 0.089 mmol), Pt(dppp)Cl2 (32 mg, 
0.471 mmol), and CuI (1.5 mg, 0.008 mmol) were added to a 
dry Schlenck-flask and dry Et3N (10 mL) was added. The reac-
tion was stirred for 48 h under argon and with exclusion of 
light. When finished the solvent was removed in vacuo and the 
residue was extracted with CH2Cl2. The organic phase was 
washed with H2O and dried over MgSO4. The solvent was re-
moved in vacuo. The crude product was purified by column 
chromatography on neutral ALOX using CH2Cl2/cyclohexane 
(10:1) as the eluent affording the title product as a brown solid.  
Yield: 28 mg (52%) 
Rf: 0.62 (CH2Cl2/cyclohexane (10:1)) 
1H-NMR (400 MHz, CDCl3): δ 7.78-7.73 (m, 8 H, H-20), 7.38-7.31 (m, 12 H, H-19 and 
H-21), 7.15 (dd, 4 H, J10,11a = 8.1 Hz, J10,11b = 1.7 Hz, H-10), 7.12-7.08 (m, 4 H, H-5 and 
H-3), 6.97 (dd, 2 H, J4,5 = 8.2 Hz, J4,3 = 8.2 Hz, H-4), 6.76 (dd, 4 H, J11,10a = 8.2 Hz, 
J11,10b = 1.7 Hz, H-11), 5.26 (s, 4 H, H-15), 5.18 (s, 4 H, H-17), 3.63 (s, 6 H, H-16), 
3.49 (s, 6 H, H-18), 2.54-2.48 (m, 4 H, 22), 2.21-1.98 (m, 2 H, H-23) 
ESI-MS: m/z (1273.4 [M+Na]+) 
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